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Abstract 
Hospital discharge is a complex process that can result in errors and delays for patients, 
particularly around the supply of medicines and communication of information. This 
programme of work (PoW) aimed to develop an innovative model of care for the supply 
of medication at hospital discharge to provide safe, quality and effective transfer for 
patients from hospital to community care. 
 
The PoW consisted of four phases which used both quantitative and qualitative 
approaches. Phase 1 involved semi-structured telephone interviews with 13 Chief 
Pharmacists. Analysis identified the current discharge process across the range of 
hospitals as well as key issues and examples of good practice at discharge. Discharge 
processes were similar across hospitals with issues common to all. Phase 2 used 
questionnaires to establish patient perceptions of the current discharge process in a 
large city-centre teaching hospital. The 104 inpatients recruited were 60% (n=62) male, 
average age was 55 (range 19-93), from both medical and surgical wards. Most patients, 
89% (n=87) were satisfied with their hospital discharge but believed it took too long. The 
perceived main cause of delay was waiting for medicines. Other highlighted issues 
included limited counselling by pharmacists and a need for more patient involvement at 
discharge. Phase 3 utilised findings from phases 1 and 2 to inform the development of a 
new model of care for patient discharge.  
 
Phase 4 consisted of semi-structured interviews and focus groups with stakeholders in 
patient discharge (n=37), to evaluate the proposed new model of care. Stakeholders 
successfully evaluated the new model, highlighting areas of the new model of care that 
would work well and where problems may arise. The model of care was refined based 
on these findings, with the suggestions for overcoming logistical issues considered. The 
PoW successfully developed an innovative model of care for patient discharge.  
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Chapter 1 – Setting the scene 
This chapter will provide an informative overview of the thesis, to set the scene as to 
why and how the research was undertaken. This thesis represents a programme of work 
(PoW) which intended to improve patient discharge from hospital. The aim of the work 
described in this thesis was to develop an innovative model of care for patients’ 
medication supply at hospital discharge. This model should provide safe, quality and 
effective transfer for patients from hospital to community care. The innovative model 
of care relates specifically to medication supply at discharge, rather than other aspects 
of patient discharge from hospital. For ease, it will hereafter be referred to as a model 
of care for patient discharge. The thesis covers the stages involved in the development 
of an innovative model of care for patient discharge from hospital and describes the final 
model of care.  
 
The researcher graduated from Liverpool John Moores University in 2009 and qualified 
as a pharmacist in 2010. Since then, she has practised as a hospital pharmacist in a wide 
variety of clinical specialties. The opportunity to undertake this PhD arose in a field of 
interest to the researcher, whilst maintaining some clinical pharmacy work. The 
researcher has enjoyed the experience, particularly working collaboratively with the 
Centre for Pharmacy Innovation. The researcher has continued to practice as a hospital 
pharmacist at The Royal Liverpool and Broadgreen University Hospital NHS Trust 
throughout her three-year PhD studentship. In July 2016 the researcher was married, 
resulting in a change in surname from Bullock to Wright. Consequently, any documents 
submitted or published prior to July 2016 were in the name Sally Bullock and those after 
this date were submitted under Sally Wright. 
 
Providing a clinical pharmacy service to inpatients admitted to an array of hospital wards 
meant that the researcher was routinely involved in organising the supply of patients’ 
medication for discharge. As noted by Corbin, ‘Professional experience frequently leads 
to the judgement that some features of the profession or its practice is less than 
effective, efficient, humane or equitable. So it is believed that a good research study 
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might help to correct that situation’.(1) The researcher’s personal experience of 
witnessing the difficulties for both patients and healthcare staff during hospital 
discharge, provided the initial incentive to investigate and improve the discharge 
process.  
 
Patient discharge from hospital is a complex, multi-stage process, involving a variety of 
healthcare professionals. Despite overwhelming evidence describing the problems that 
result from patient discharge, successfully discharging patients from hospital remains a 
challenge.  
 
1.1 Literature search 
To fully understand the field of patient discharge from hospital, an extensive systematic 
literature search of the following databases was undertaken prior to commencing the 
PoW: AMED, BNI, EMBASE, Pubmed (for Medline), CINAHL and Cochrane Library. These 
databases were chosen to cover all healthcare related journal articles, conference 
proceedings and summaries. Key words to identify discharge processes published in the 
English language were used to detect relevant articles. The following key words were 
used in all databases: “hospital discharge”, “hospital discharge” AND “medication”, 
"trans* of care", "continuity of care" AND “medication”, "continuity of care" AND 
“hospital discharge”, "adverse event*" AND “hospital discharge”, “pharmacist” AND 
“hospital discharge”, “healthcare quality” AND “hospital discharge”, "community 
pharmac*" AND “hospital discharge”, "medic* use review*", “primary medical care” 
AND “hospital discharge”, “handover” AND “hospital discharge”, "information 
technology" AND “hospital discharge”, "information technology" AND “medication”, 
"incomplete discharge", "electronic discharge", “computer*” AND “discharge”, “medical 
record” AND “information technology”, “discharge prescription”, “patient perspectives”, 
“patient involvement” 
 
Full details of the literature search, including the number of hits for each search can be 
seen in the literature search strategy in Appendix 1. 
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1.2 Thesis overview 
The PoW involved a multi-perspective investigation into the problems associated with 
the current discharge process. This was followed by the development of an innovative 
model of care for the supply of patients’ medication at discharge from hospital. The PoW 
consisted of four phases, introduced below and discussed in detail in section 3.2 
Overview of programme of work.   
 
Chapter 2 provides a comprehensive review of the background to the thesis, beginning 
with a broad introduction to the NHS, relevant policies and patient discharge. It then 
focusses on the problems with discharge and the attempts to resolve the problems 
discussed in the literature. 
 
Chapter 3 describes the PoW in detail, discussing the approach taken and the methods 
utilised for each of the four phases of the PoW. 
 
Chapter 4 presents the findings from phase 1 of the PoW, which involved telephone 
interviews with Chief Pharmacists from acute NHS hospitals across North West England. 
This phase looked to identify and evaluate the discharge processes used across a range 
of acute NHS hospitals.  
 
Chapter 5 presents the findings from phase 2 of the PoW. This second phase involved 
questionnaires to determine the patients’ perspective of the current discharge process. 
 
Chapter 6 presents phase 3 of the PoW. This third phase involved triangulation of the 
data collected and the development of a new model of care for patient discharge. The 
proposed new model of care for patient discharge is described within this chapter, along 
with a rationale.  
 
Chapter 7 presents the findings from phase 4 of the PoW. This final phase involved 
feasibility testing of the proposed model of care described in chapter 6. This was 
undertaken using qualitative interviews and focus groups to determine a range of 
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stakeholders’ views of the proposed model of care. The model of care was refined and 
the final, refined innovative model of care for patient discharge is presented within this 
chapter.  
 
The thesis concludes in chapter 8 with a general discussion of the overall findings and 
their implications for practice.  
 
1.3 Significance of the research 
This research is particularly timely as the NHS is currently under pressure to provide 
quality patient care with limited resources. Patient discharge from hospital is known to 
be problematic and resolving these issues would have a significant impact. There are 
many potential beneficiaries to an efficient hospital discharge process. There are two 
main aspects to this, benefits for the hospital and benefits for patients. Improvements 
to the discharge process will be beneficial for hospitals in terms of tackling delayed 
discharges, encouraging efficiencies and cost savings. Equally as important is the patient. 
Improving the patient experience is essential; however the potential to improve patient 
outcomes and reduce hospital readmissions is integral to this PoW. 
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Chapter 2 – Introduction  
This first chapter will provide an introduction to the thesis, beginning with background 
information on the topic of patient discharge from NHS hospitals. A discussion of the 
current literature in the field of hospital discharge will follow. 
 
2.1 The National Health Service  
The National Health Service (NHS) is the world’s largest publicly funded healthcare 
service(2) and is responsible for the diagnosis, treatment and prevention of disease and 
for public health.  Since launching in 1948, the NHS has been constantly changing and 
expanding to provide the best possible, most cost effective health and social care for 
patients. The most recent changes took place in April 2013, after the commencement of 
the Health and Social Care Act 2012.  
 
The government’s Department of health (DH) and its agencies are responsible for 
producing national policies which impact on practice. The aim of these policies is to 
ensure that healthcare services and staff are able to deliver the highest standard of 
health and social care to patients at a local level. A major change occurred in 1998, when 
devolution of NHS operational powers to each of the four countries within the UK took 
place. This study will focus on health and social care in England. NHS England is the public 
body of the DH that oversees the budget, planning, delivery and day-to-day operation 
of the commissioning side of the NHS in England.  Public Health England is another body 
within the DH responsible for the protection of the public’s health and to reduce health 
inequalities throughout England. 
 
Among the responsibilities of NHS England is the provision of funding to both 
community care services and local Clinical Commissioning Groups (CCGs) across England. 
CCGs are organisations responsible for commissioning services both in the community 
and in secondary care within their local area.(3) As per the Health and Social Care Act 
2012, local authorities have the responsibility of looking after the health care, social care 
and public health in order to shape local districts.(4) Local authorities are better placed 
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to know the needs of their locality and have the ability to shape services to meet local 
needs and promote health and wellbeing.(4,5)  
 
The majority of patient care is undertaken in the community, this is known as 
community or primary care. The first point of contact for a patient seeking medical 
attention in the community is usually their General Practitioner (GP), but can be from 
other providers, for example a community pharmacy or dental surgery. The GP practice 
is usually responsible for coordinating the medical care for each patient. This includes 
keeping an accurate and up-to-date record of medical history and medication i.e. a 
treatment plan. The record should also include details of any treatment received from 
other healthcare providers.  If the patient has been admitted to hospital, the record 
should have a summary of the reason for admission, investigations and procedures that 
took place, diagnosis, outcomes, changes to treatment plan and details of follow up if 
required. 
 
Secondary care generally involves hospital care. A patient may be referred to a hospital-
based specialist, or admitted through the accident and emergency (A&E) department 
for acute, severe illness. Non-specialist hospitals are referred to as acute NHS hospitals. 
They provide acute services such as A&E departments, inpatient and outpatient 
medicine, surgery and in some cases very specialist medical care. They range in size and 
location, from relatively small district hospitals, to large city teaching hospitals.(6) This 
thesis will focus on the services provided by acute NHS hospitals. Further details about 
the participating sites in the PoW are given in Chapter 3 – Programme of work. 
 
For a patient with chronic health conditions, for example diabetes, most of their care 
will be by a team of practitioners based in the community. This could include, but is not 
limited to their GP, practice nurse or community pharmacist. A range of other 
community services also exist. The patient may occasionally require secondary care 
services requiring admission to hospital. The community team will then continue with 
the patient’s usual care once they have returned home. Certain patients require 
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specialist care without admission to hospital and can be seen by a specialist in a hospital 
outpatient clinic.  
 
Community Pharmacists are an easily accessible resource for community based patient 
healthcare. Alongside offering essential services such as dispensing prescriptions, many 
pharmacies provide a range of public health and medicines management services, 
including: healthy living advice, weight management, smoking cessation services, NHS 
health checks, flu vaccinations, sexual health screening, minor ailments schemes, the 
New Medicine Service (NMS) and Medicines Use Reviews (MURs).(7)  The NMS involves 
a community pharmacist assessing adherence and identifying problems with newly 
prescribed medication. This service is targeted at specific conditions, such as asthma. 
MURs are in-depth reviews of patients’ medication to ensure they understand how and 
when to use their medicines.(7) An increase in support for the use of community 
pharmacies for first line patient care has been seen over recent years. After a 
consultation regarding urgent and emergency care, NHS England agreed that 
“Community pharmacies are an under-used resource: many are now open 100 hours a 
week with a qualified pharmacist on hand to advise on minor illnesses, medication 
queries and other problems. We can capitalise on the untapped potential, and 
convenience, that greater utilisation of the skills and expertise of the pharmacy 
workforce can offer.”(8)  
 
2.2 The changing care environment 
There are many pressures that threaten to overwhelm the NHS. The population is ageing 
and there is a significant increase in the number of people with long-term conditions 
requiring health and social care.(9) Additionally, the NHS is under a huge financial 
pressure due to a lack of funding. Subsequently, the NHS needs to increase its 
productivity and improve services using the limited funding available. 
 
The NHS is in the midst of a changing care environment. There will be many changes to 
the way that care is delivered; which is essential to provide quality care for all patients, 
within the restraints of the limited resources available. Currently, there is a drive to 
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move care back into the community. Moving patient’s care from hospital into the 
community is a high priority in the UK and internationally.(10,11) The consensus is that as 
much care as possible should be delivered in a local, more convenient setting for 
patients. This is to improve patient experience and reduce the burden on the NHS by 
removing the focus from treating patients at expensive hospitals.(10) This means a radical 
change from current ways of working. NHS England's Five Year Forward View has 
suggested that new models of care are required (see section 2.9 Developing new models 
of care) to improve care and deliver care closer to patients through integrated care 
models. (12) This will involve a breakdown of the barriers of how care is currently 
provided.  
 
The Kings Fund suggest that creating patient-centred care that is more coordinated 
across care settings should be a priority for commissioners, along with supporting 
medicines management to reduce the likelihood of medication errors and hence patient 
harm.(13)  
 
2.2.1 Changes in pharmacy services 
The changing care environment also impacts pharmacy services. It is thought that 
hospital pharmacy services should operate more efficiently and safely. Through the 
optimal use of medicines, technology and workforce, alongside collaboration amongst 
providers, unnecessary variation in services can be avoided. This will deliver value for 
money for the taxpayer and good clinical outcomes for all patients seven days a week.(14)  
 
The hospital pharmacy transformation programme as set out by the Lord Carter report 
suggested many mechanisms that hospital pharmacy departments can implement to 
help deliver improved services. These include: pharmacist prescribers and increased 
time in patient-facing medicines optimisation roles (for example, medicines 
reconciliation, which involves obtaining a complete and accurate list of all medication 
taken by a patient). Hospital pharmacy departments can contribute to increased 
efficiency in the NHS, by implementing tools such as: effective communication, 
signposting, breakdown silo working and seven day working. 
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Recent papers(15–18) suggest that community pharmacists need to play a more prominent 
role in new areas, providing easy access to medicines and services which are integrated 
with other health professionals so that care is seamless. Community pharmacies have 
successfully become involved in the dispensing of outpatient prescriptions, a role 
traditionally carried out by hospital pharmacies only. The success of outsourcing hospital 
pharmacy outpatient tasks to a range of community pharmacy chains,(19,20) suggests that 
there is scope to investigate how community pharmacy could have an active role in the 
discharge process. 
 
Another change for pharmacy as a result of the Five Year Forward View, was the initial 
£100m of investment to support extra clinical pharmacists to work in general practice 
by 2020/21.(21) This emerging role involves GP-based clinical pharmacists working as part 
of the general practice team to resolve day-to-day medicine issues and consult with and 
treat patients directly. This includes providing help to manage long-term conditions, 
including running clinics as well as providing advice for patients on multiple 
medications.(21) The role of a clinical pharmacist within a GP practice is thought to be 
pivotal to improve the quality of care and ensure patient safety.(21) Having a clinical 
pharmacist in GP practices also means that GPs can focus their skills where they are 
most needed, helping GPs to manage the demands on their time.(21)  
 
2.3 Securing high quality care for all patients 
NHS England’s goal is to secure high quality care for all patients now and for future 
generations.(22) Several key policy areas have been identified in their recent business 
plan.(22) These include patient safety, ensuring patients have a positive experience of 
care, reducing hospital readmission rates and improving quality of life for patients with 
long-term conditions.(22)  
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2.3.1 Patient safety 
Patient safety is a key policy area for the NHS and is important in providing a high quality 
service. Since 2012 the responsibility of informing and supporting the health sector to 
ensure that patient safety is at the heart of the NHS has laid with NHS England.(3) All NHS 
treatment should be provided safely. As drug therapy is the most frequent treatment 
provided by the NHS, ensuring that drug treatment is safe is central to this strategy.(23) 
Despite most medication being provided safely, mistakes are made. Errors can arise in 
all stages of the prescribing process; including prescribing, dispensing or administration 
of medication.(23) In an attempt to reduce the number of medication errors, the DH 
offered guidance on good practice to improve medication safety during each of these 
stages of treatment with medication.(23)  
 
2.3.2 Positive patient experience 
As mentioned above, NHS England’s mission is to secure high quality care for all.(22) High 
quality care is defined by three components: clinical effectiveness, patient safety and 
patient experience. (24,25) In order to assess whether NHS services are providing high 
quality care, performance is measured on these three components being achieved. High 
quality care historically focussed on ensuring clinical effectiveness and safety of service 
provision. More recently however, focus has shifted to improving the patient 
experience.(5,25,26) Experience of care can be understood by both what the patient 
experiences when they receive care, and how it makes them feel.(27)  
 
Measuring patient experience is important for a variety of reasons. Firstly, in 
determining whether NHS services are providing humane, empathic care.(28) Additionally, 
research has demonstrated positive associations between patient experience, clinical 
effectiveness and patient safety outcomes, indicating that patient experience is clinically 
important to improve other aspects of high quality care.(28) 
 
Service providers within the NHS should strive to ensure patient experience is amongst 
the best in the world.(27) NHS England are involved in many programmes of work aiming 
to improve the patient experience.(24) One example is the medicines optimisation 
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programme, which involves ensuring that the right patients get the right choice of 
medicine, at the right time.(29) By focusing on patients and their experiences, the 
programme aims to improve patient outcomes, quality and value from medicine use.(29) 
 
2.3.3 Reducing hospital readmission rates 
The rate of urgent readmissions within 28 days of discharge from hospital is used as a 
quality of care indicator.(30)  High readmission rates equate with poor quality of care, 
poor patient experience and quality of life in general. The cost of readmissions to a 
nation’s health service is high(31) in terms of both financial burden and impact on 
patients and their relatives.  One qualitative study carried out by the charity Age UK 
found that older patients felt traumatised and frustrated by their readmissions.(32) Every 
attempt should be made to reduce the risk of patients being readmitted to hospital after 
discharge.  In practice, there has been a continuous increase in these readmissions since 
2001/02 of 2.6% per year.(9) It appears that many of these readmissions may be 
avoidable. A review for the DH of sixteen published studies assessing avoidability of 
readmissions within 28 or 30 days suggest that between 5% and 59% of readmissions 
may be avoidable.(33) Another systematic review of the literature found that between 5-
79% of hospital readmissions were deemed avoidable.(34) Although there are many 
factors involved with readmissions to hospital,(35) studies have shown that medication 
errors and adverse drug reactions have a significant impact on readmission 
rates.(35,36)  Poor quality discharge has been cited as one of the perceived reasons by 
older patients for readmission to hospital.(32) 
 
2.3.4 Improving quality of life for patients with long-term conditions 
In England, more than 15 million people have a long-term condition - a health problem 
that cannot be cured but can be controlled by medication or other therapies. This figure 
is set to increase over the next 10 years, particularly those people with three or more 
conditions at once.(37) Living with long-term conditions can affect many parts of a 
person’s life, from their ability to work and have relationships to housing and education 
opportunities.(37) The Five Year Forward View stated that ‘long-term conditions are now 
a central task of the NHS; caring for these needs requires a partnership with patients 
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over the longer term rather than providing single, unconnected “episodes” of care’.(12) 
This fits in with a mandate produced by the previous government, which gave NHS 
England responsibility for coming up with plans to help improve the quality of life for 
people with long-term conditions. It aimed to: help patients to get the skills to manage 
their own health, agree with patients a care plan that is based on their personal needs 
and make sure that their care is better coordinated.(37)  
 
Management of long-term conditions is ideally undertaken within the community, 
rather than in hospital. This requires the patients’ community-based care to adequately 
support their conditions. Discharge from hospital will also play an important role in this 
support; particularly in terms of providing joined up, coordinated care. Transfer of 
information at discharge and communication with patients is essential to ensure that 
their conditions can be adequately managed and their care is not interrupted by an 
admission to hospital. 
 
2.4 Patient involvement 
Patient involvement in their care is high on the Government’s agenda and thought to be 
important in improving patient outcomes. The Government’s aim is for all patients to be 
fully involved in decisions about their own care and that this becomes the norm across 
the NHS.(38) The Francis report, published following an intensive investigation into the 
failings of an NHS hospital, identified that although the overarching value and principle 
of the NHS Constitution should be that patients are put first,(39) this was not the case in 
practice. Recommendations included that staff should be open and honest with patients 
and communication should be maintained.(39)  
 
Patient involvement in their care is a major component of the medicines optimisation 
programme.(40) In particular, good communication between healthcare professionals 
and patients is needed for involvement of patients in decisions about medicines and for 
supporting adherence.(40) This communication with patients is key at discharge to 
support them with their medicines. One study showed that healthcare professionals did 
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not sufficiently prioritise discharge consultations with patients and family members due 
to time restraints and competing care obligations.(41)  
 
2.5 Continuity of care 
There is no universally agreed definition of continuity of care. It has been defined by one 
research team as ‘quality health care resulting from the ongoing management of issues 
which cause disruption to optimal patient care’.(42) It has been suggested that continuity 
of care can be described as a hierarchal structure, which consists of three different 
hierarchal levels. Firstly, continuity of care should involve an organised collection of 
medical and social information about each patient, accessible by all healthcare 
professionals involved in the patient’s care.(43) Secondly, an organised team of providers 
should coordinate and assume responsibility for the quality of care (this is usually the 
GP surgery’s responsibility).(43) Thirdly, there should be an ongoing relationship between 
the patient and a personal health care professional.(43) Systems should aim to 
encompass all three levels of continuity of care where possible. Monitor, the sector 
regulator for health services in England, published guidance for commissioners on 
ensuring the continuity of health services. While this document provides an overall 
policy approach, continuity is not always evident on a day-to-day basis.(44)  
 
Evidence suggests that patients recognise and value seeing the same GP and maintaining 
that relationship in the community.(45) Patient perspectives on continuity of care 
between hospital and community have not been widely studied. Since good continuity 
involves seamless processes between professionals and agencies that are generally 
invisible to the patient, it is difficult for them to assess the work involved in achieving it. 
Continuity of care often only becomes apparent when co-ordination breaks down and 
impacts negatively on the patient’s experience of care.(45,46)  
 
As long-term conditions become more common in an ageing population,(9) it becomes 
difficult for a single healthcare provider to manage one patient. There are more people 
with ‘complex health needs’ – more than one health problem – who require a 
combination of health and social care services. Consequently, patients are increasingly 
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seen by an array of providers in a wide variety of organisations and places, raising 
concerns about fragmentation of care.(47) By involving more care providers, the risk of a 
breakdown in continuity of care increases and procedures should ensure that this risk is 
minimised. It should never be acceptable for patients to be discharged from hospital at 
any time without knowledge that the patient in need of care will receive it on arrival at 
their destination.(39) This ongoing responsibility for continuing care should also embrace 
GPs and their practices. GPs should, as a part of their professional obligations, check on 
their patient after any hospital treatment and assess whether the outcomes were 
satisfactory.(39)  
 
When a patient is admitted to hospital, their GP may be unaware of the hospitalisation 
or the care received during the admission.  Inevitably there is a risk of breakdown in 
continuity of care if this care is not communicated to the GP.  One study suggested that 
many frail older patients reported problems after discharge and were twice as likely to 
do so when their primary care provider was not aware of the hospitalisation.(48) Both 
community-based and hospital-based care providers should strive to ensure that there 
are no gaps in continuity of care when patients are transferred between care settings. 
Systems need to be developed to improve communication between the two sectors in 
order to provide high quality care,(49,50) as effective communication and information-
sharing between primary and secondary care remains an area of concern.  
 
Effective electronic data sharing could improve continuity during transfer between care 
settings. The creation of a live, interactive patient record that all health professionals 
can access from whatever setting is seen as the key component to ensure that all 
patients receive “the right care in the right place, at the right time.”(51) In terms of 
transfer between different care settings, this would ensure that changes made to the 
treatment plan are known to the GP as soon as they occur. Health and social care staff 
from all areas would have direct access to up-to-date information about the medication 
prescribed to a patient.(51)  
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The NHS ‘Spine’ is a national IT infrastructure that was initially developed in order to 
hold patient care records. It also provides the means for which the electronic 
prescription service (EPS) transmits prescriptions within the community. The Spine is 
undergoing constant development and improvement, but is currently capable of holding 
the Summary Care Record (SCR) for patients. Each individual SCR holds information 
about what medication the patient takes and any allergies or medication problems they 
have encountered. The SCR provides the information that assists in improving patient 
safety, quality of healthcare, clinical effectiveness and better administrative 
efficiency.(52) Although the Spine is a starting point, the ideal system for communication 
does not currently exist. In the absence of an all-encompassing system where 
information can be instantly shared between all healthcare professionals, innovative 
methods to improve patient experience, patient safety, continuity of care and reduction 
of staff workload need to be identified. 
 
2.6 Discharge from hospital 
For those patients admitted to hospital – known as inpatients – hospital discharge is the 
point at which they leave the hospital. Patients can be discharged to their own home, or 
transferred to another facility if appropriate. Examples of such facilities include care 
homes or intermediate care facilities. After recovery from the illness causing their 
admission to hospital, patients are classed as medically fit. Depending on the social 
aspects of their care, the patient can then be discharged from hospital. The series of 
events that takes place to execute a successful discharge, allowing patients to be safely 
discharged from hospital is known as the discharge process. 
 
Discharging patients from acute NHS hospitals can be a complex multistage process. 
Depending on the individual patient’s health and social care needs, the process can 
involve a range of healthcare professionals from across the multidisciplinary team 
(MDT)(53) as well as the patient.(54) Consequently, good coordination and communication 
between the healthcare professionals involved is essential to ensure that patients are 
discharged safely with robust, ongoing care. Coordination of patient discharge can be 
carried out by a discharge coordinator, a staff nurse or a junior member of the medical 
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team,(55) depending on hospital resources. Recent NICE guidance suggests that a single 
health or social care practitioner should be responsible for coordinating a person's 
discharge from hospital.(56)  
 
As mentioned, depending on the individual patient and their needs, a variety of health 
and social care issues may need to be taken care of prior to discharge. The full range of 
interventions available at discharge are outside the scope of this thesis, for example 
providing social care services to patients. The position of this research is to focus on 
improving the issues that surround medication at discharge. This includes: the supply of 
medication and communication of the relevant information to patients and their 
community healthcare providers. This focus is important because ensuring that these 
processes are carried out correctly is vital to promote medicines adherence and to allow 
the correct medication to continue to be supplied after discharge.  
 
2.6.1 Discharge planning 
Discharge planning is a process that aims to improve the coordination of services after 
discharge from hospital by considering the patient’s needs in the community.(57) 
Discharge planning involves the development of an individualised discharge plan for the 
patient prior to leaving hospital, with the aim of containing costs and improving patient 
outcomes.(58) A structured discharge plan was thought to bring about a reduction in 
hospital length of stay and readmission rates, and an increase in patient satisfaction.(58) 
A Cochrane review found that despite positive findings, a conclusion around whether 
discharge planning led to a significant reduction in readmission rates was uncertain. 
Discharge planning is recommended and should involve the patient, their family 
members, and the multidisciplinary team(54) and should begin as early as possible during 
the patient’s admission.(55)  
 
2.6.2 The discharge process 
The supply of medication at discharge begins with the creation of a discharge 
prescription, which is commonly referred to as the TTO (‘To Take Out’). The TTO is a 
complete and accurate list of all medication the patient should take after discharge from 
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hospital. The TTO should also highlight any changes to medication that have occurred 
during the hospital stay. The discharge process involves multiple stages and can vary 
between hospitals. A typical discharge process begins when a patient is medically fit for 
discharge and involves a doctor from the medical team providing care during the 
inpatient admission writing a TTO for a patient. The ward based pharmacy team (which 
usually includes a pharmacist and a pharmacy technician) are informed that the TTO has 
been written, so that the pharmacist can carry out a clinical check of the prescribed 
medication. Once the pharmacist is satisfied the TTO is accurate, safe and complete, 
they will verify it. 
 
Patient’s own medication, if available, is assessed for suitability and quantity to take 
home. Patients receive at least 7 days’ supply of all medication to take home, unless a 
specified course length of medication is prescribed, in which case the full course would 
be supplied. This should ensure that the patient has sufficient time to reorder their 
regular medicines from their own GP. Any medication needed is dispensed by the 
hospital pharmacy. This is usually only items of which the patient does not already have 
their own supply. The completed TTO and medication are sent back to the ward, where 
the nurse looking after the patient will check the TTO and the medication before giving 
them to the patient along with the discharge summary.  
 
The next important step at discharge is the transfer of patient care back to the 
community. This involves a discharge summary (a summary of the inpatient episode, 
also written by the doctor) and the TTO, being sent to the patient’s GP within 24 hours 
of patient discharge.(56) Providing a complete and accurate discharge summary aids the 
transfer of care from hospital into the community and allows the GP to coordinate 
appropriate ongoing care.(53) To perform its crucial role in continuity of care, it is 
essential that the discharge summary contains all relevant information regarding the 
episode of inpatient care. In an attempt to promote uniformity of content there are 
published standards detailing the necessary information to include in a discharge 
summary.(59,60) Some of the information that should be included is: reason for admission, 
tests and procedures undertaken during admission, outcomes, medication to be taken 
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on discharge including reasons for any changes and any follow up required. Transfer of 
the discharge summary to the GP was traditionally via post, but can now be transferred 
electronically. Electronic transfer of information in theory makes transfer between the 
ward, hospital pharmacy and GP practice easier. Prompt transfer of information to the 
relevant parties is essential for continuity of care.   
 
2.6.3 Community pharmacy involvement at discharge 
Another aspect of transfer of care from hospital to the community is the role of the 
community pharmacist in assisting patients discharged on medication. The extent of 
follow-up received after hospital discharge differs depending on the patient’s ongoing 
health needs. Community-based follow-up for medication is not routinely provided for 
patients. Community pharmacists are ideally positioned to provide routine support with 
medicines after hospital discharge. Research in the late 1990s found that providing 
community pharmacists with a copy of patient discharge summaries was an effective 
method of reducing unintentional medication discrepancies.(61) Further research has 
demonstrated the value of the community pharmacist in separating old and new 
medications, disposing of any unnecessary medication, counselling patients and 
answering medicine-related questions,(62) ensuring continuity and quality of patient care 
during the discharge process.(15–18)  
 
More recently, community pharmacies offer the NMS and targeted MURs to support 
patients recently discharged and improve transfer of care between the hospital and 
community.(7) Section 2.1 The National Health Service, contains further information 
about these services. There are four target groups of patients for MURs, which are based 
on their medicines or clinical condition. One of these target groups is patients recently 
discharged from hospital with changes to their medicines.(63) Both the NMS and MURs 
can be provided for patients after discharge in order to help the patient’s understanding 
of new medication and improve continuity of care. For patients that are housebound, 
home visits are also possible. Home visits are a widely underused service due to time 
and cost restraints. A study in Australia found that after discharge from hospital only 
25% of patients saw their GP within 4 days of leaving hospital, whereas the majority of 
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patients visited their community pharmacist within 2 weeks of admission.(64) Patients 
visiting their community pharmacy after discharge could make use of the services 
offered.  
 
2.7 Current problems at discharge  
Discharge from hospital is known to be fraught with issues. Transfer of patient care has 
been identified as a vulnerable point in the care process as this presents an increased 
opportunity for errors that may result in patient harm.(65,66) The common problems that 
arise at discharge are discussed below. 
 
2.7.1 Delayed discharges 
Delayed discharges are common and add to the increasing burden on the NHS. A delayed 
discharge occurs when a clinical decision has been made that a patient is ready for 
transfer from a hospital bed, but is still occupying that bed.(67) When patients are 
medically fit for discharge, but there another factor is causing delay to their discharge 
this is commonly referred to as ‘bed-blocking’. Bed-blocking is a term used to refer to 
elderly patients that are medically fit for discharge, but are unable to leave the hospital 
due to other reasons, examples of which are discussed below. Bed-blocking is a huge 
problem for the NHS, who are under pressure to reduce this. The Carter report published 
that on any given day, up to 8500 beds could be blocked by patients with delayed 
discharge. This is estimated to cost the NHS around £900 million per year(68) and has 
gained a lot of interest in the media over recent years who have informed the public 
about the issues with patient discharge, often sensationalising stories.(69–72)  
 
There are various causes of delayed discharges. Examples of potentially long-term 
causes of delay include patients awaiting social care packages, or care home 
placement.(67) The wait for medications at discharge can also delay patient discharge. 
This is a short-term delay, but the process of discharging patients from hospital can be 
time consuming, often resulting in patients waiting for their medicines and temporarily 
blocking beds(73) leading to a delayed discharge.  
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2.7.2 Medication errors at discharge from hospital 
The time of discharge is a point at which prescribing errors are likely to occur.(74) A 
significant percentage of older patients experience medication discrepancies after 
transferring from hospital to home(75) leading to medication errors. Medication errors 
can cause unnecessary harm to patients and can result in readmission to hospital.(76) 
According to a 2014 report, preventable harm from medicines is thought to cost the NHS 
anywhere between £1 billion-£2.5 billion annually.(77)  
 
There are a number of well documented factors that can contribute to medication 
discrepancies as a result of hospital discharge.(51,54) These include: incomplete 
information in discharge summaries sent to GPs,(51,54,78,79) lack of prompt transfer of 
discharge information to GPs,(48,51,54,79) patient misunderstanding of discharge 
instructions(51,54,80) or lack of adequate patient counselling.(49)  
 
Research indicates that if discharge summaries do not contain sufficient information 
about any changes to the treatment plan that occurred during the inpatient episode, 
this can result in treatment failures, continuation of inappropriate medication and 
discontinuation of required medication.(79) A study conducted across 45 hospitals in 
England found that two-thirds of discharge prescriptions were inaccurate or incomplete 
prior to pharmacy screening. Clinical screening by pharmacists was thought to 
contribute significantly to patient safety.(81) A further study in Switzerland found that 
drug omissions and unjustified medications on discharge prescriptions were frequent.(82) 
In another study conducted in one hospital in New Zealand, an audit of 100 medication 
charts and discharge summaries found that there were 1.42 discrepancies in medication 
per medicine discharge summary.(83)  
 
Issues can arise when patients’ regular medication is not noted on admission to hospital 
and therefore not included in the discharge summary. Errors and misunderstandings are 
particularly common in medications unrelated to the primary diagnosis.(80) Patients’ 
regular medications that are not directly involved with the reason for admission will 
often be omitted on admission and therefore will not be included on the discharge 
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prescription. One study found that errors in preadmission medication histories lead to 
more discharge reconciliation errors.(84) Other studies have found that more accurate 
medicines reconciliation on admission and rectifying any problems identified will lead 
to more accurate medication lists on discharge from hospital. One audit of discharge 
summaries received by GP surgeries highlighted that regular medication was 
documented in only 30% of summaries. Regular medication was stopped for 59% of 
patients during their hospital stay with no reason stated and, at discharge, 39% were 
prescribed new drugs, again with no reason stated.(79)  
 
Another problem can occur as a result of patient confusion. Patients tend to view their 
hospital medication and home medication as different and may take both, thus taking 
double doses of some medicines.(54) This can be dangerous with many medications and 
requires adequate patient counselling to reduce this risk. Conversely, some patients 
inappropriately revert to their pre-admission medication after discharge.(54) This would 
be especially problematic for patients who were originally admitted with adverse drug 
reactions caused by their pre-admission medication.  
 
Lack of adequate communication on discharge from hospital leads to situations where 
patients will struggle to obtain the correct medication,(49) or struggle to understand what 
medication they should be taking, how they should be taking it and why. Inevitably, this 
will leave the patient confused and at risk of emergency readmission to hospital.  
 
As previously mentioned in section 2.6.2 The discharge process, prompt transfer of 
information to the relevant parties is essential for continuity of care. It is an expectation 
that discharge summaries should be sent to patients’ GP surgeries within 24 hours of 
discharge. One audit in 2011 indicated that GP surgeries only received discharge 
summaries in 58% of cases. Of these, only 6% arrived within 48 hours of discharge from 
hospital.(79) The advent of electronic transfer of discharge information may have 
improved these figures, however if the GP does not receive discharge information 
promptly, this can disrupt patient care. Problems and adverse reactions can arise for 
patients because GP computer prescriptions following discharge are not always up-to-
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date with the revised hospital medication plan.(54)  This can be due to the discharge letter 
arriving at the practice after the repeat prescription has been issued by the GP,(85) or if 
the discharge letter has been received but the GP system has not been updated with the 
information. This leads to medication errors, omissions, confusion, and all that follows 
from poor communication.(85)  
 
2.7.3 Problems with community pharmacist involvement after discharge 
from hospital 
Recommendations have been made previously to improve communication on discharge, 
including involving the patient’s community pharmacist,(49) however these are not 
always followed in practice.  Despite the evidence suggesting the patient benefits of 
community pharmacist involvement after discharge from hospital, a lack of 
communication between the hospital pharmacist and the patient’s community 
pharmacist is common.(51,54) In the main, community pharmacists are not aware that 
their patients have been into hospital.(86)  
 
Little work has been done to develop the role of the community pharmacist in managing 
patients after discharge from hospital. Evidence-based community pharmacist services 
are available, however studies show that uptake of discharge medication reviews is 
limited.(87,88) A questionnaire-based study carried out involving 19 community 
pharmacists demonstrated that despite community pharmacists’ positive responses 
about providing discharge MURs, patient engagement was difficult.(89)  
 
2.7.4 Patient perspectives of discharge 
Effectively managing the patient journey is crucial to improving patient experience of 
the NHS(49) and patient discharge from hospital back into the community is an important 
aspect of the patient journey. Hospital discharge is a complex, multistage process with 
many potential sources of error and delay, particularly with regards to the supply of 
discharge medicines.(90,91) Medication problems caused by discharge from hospital are 
discussed in section 2.7.2 Medication errors at discharge from hospital. Despite the 
23 
 
evidence suggesting problems affecting patients are common after hospital discharge, 
few studies explore this from the patients’ perspective.  
 
Of the studies that have assessed hospital discharge from the patient's perspective there 
are some conflicting results. Surprisingly Horwitz found that despite the gaps in their 
discharge care, patients were uniformly positive in their assessments of discharge care 
and education.(92) Similarly, the National NHS Inpatient Survey which assesses patient 
experience at hospitals across England showed that 84% of respondents rated their 
hospital experience as at least 7 out of 10, despite 42% of respondents’ discharges being 
delayed.(93) A large proportion (61%) of those delayed discharges were perceived to be 
caused by waiting for medicines.(12) These studies suggest that patients may not be 
aware of some of the internal problems that occur during discharge, or that patient and 
service providers priorities may not align. 
 
One study found that 42% of older patients reported at least one post-discharge 
problem.(48) Current evidence suggests that many problems on discharge occur due to a 
breakdown in communication. Patients highlighted that they experienced breakdowns 
in communication between different healthcare providers during transitions of care(94,95) 
and between themselves and their healthcare providers.(95) Inadequate information 
regarding follow up care after discharge from hospital was a particular concern to 
patients.(95–97) Patients in various studies experienced anxieties about their impending 
discharge, whether or not these were expressed to hospital staff.(98) These anxieties 
could be reduced by improving patient–provider communication. Patients perceived 
that healthcare professionals did not sufficiently prioritise discharge consultations with 
patients and family members due to time restraints and competing care obligations.(41) 
 
A collaboration between patients, carers and healthcare professionals in Devon led to 
the development of a list of good outcomes on discharge for patients with complex 
needs.(99) Many of the statements were around joined up, coordinated care involving 
the patient. With regards to their medications, patients stated that they would like to 
be provided with a supply of medication to last until they could see their GP, along with 
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sufficient information that they or their carer could manage the medication. Whilst a 
good basis, these vague statements are open to interpretation as they do not provide 
much detail around patient needs. Further research is required to identify if these 
outcomes are routinely experienced by patients. 
 
There are gaps in the evidence around patient experience of hospital discharge. More 
needs to be known about what patients want with regards to the supply of medication 
at discharge.  
 
2.7.5 Patient involvement during discharge 
Research suggests that patient involvement appears to be limited during hospital 
discharge.  The National Inpatient Survey 2014 found that 54% of patients strongly 
agreed that they were involved in decisions about their discharge,(7) this increased to 
56% in the 2015 survey(100) but clearly there needs to be an increase in patient 
involvement at discharge.  
 
Several studies have explored the reasons for low levels of patient participation at 
discharge. Patients cited the following reasons: many older people can be passive in 
relation to discharge planning,(98) some people may be less assertive when they are 
ill(96,98) and perceive their contribution to be unnecessary or not valued by their 
providers.(101) Interestingly, one study suggests that healthcare professionals’ and 
patients’ views differ on whether patients are involved.(98)  
 
2.7.6 Patient counselling 
Counselling patients on their prescribed medication is considered beneficial for patient 
outcomes. A study carried out in elderly heart failure patients demonstrated that 
providing patient counselling improves medication adherence and decrease 
readmission rates.(102) Another study demonstrated that patient knowledge of 
medicines newly prescribed in hospital is increased by targeted counselling by hospital 
pharmacists. This was in comparison to patients receiving counselling by the doctor or 
nurse looking after them. Not all patients benefitted from this intervention and the 
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authors considered the impact of hospital discharge being a potentially stressful time 
when patients are waiting to be allowed to go home and therefore not ideal for 
information provision.(88) Despite positive associations between patient counselling and 
patient outcomes, the extent to which inpatient counselling routinely occurs during 
admission to hospital was found to be limited.(103)  
 
2.8 Improving hospital discharge 
As a result of the issues surrounding patent discharge from hospital, numerous guides 
have been published to improve the effectiveness and efficiency of patient discharge, 
particularly with regards to the supply of medication at discharge.(51,60,104) These guides 
focus on improving the existing discharge process, along with some ideas of how to do 
so. There is a gap in the evidence around looking into new models of care for patient 
discharge, instead of improving the current, failing process.   
 
2.9 Developing new models of care 
As discussed, today’s NHS faces a range of challenges. Whereas patients require high 
quality, coordinated services, nearly all experience care that is fragmented and of 
varying quality.(105) This is particularly true of the hospital discharge process for patients.  
 
This PoW has adopted the stance that for a radical improvement at discharge, an entirely 
new discharge process is required to overcome the current problems. One mechanism 
to achieve this and improve patient care is to develop a new model of care. A “model of 
care” broadly defines the way health services are delivered. It outlines best practice care 
and services for a person, population group or patient cohort as they progress through 
the stages of a condition, injury or event.(106) A model of care aims to ensure people get 
the right care, at the right time, by the right team and in the right place.(107) 
 
This is a timely project, as the NHS is currently undergoing much change and trying to 
encourage the development of new models of care. See section 2.2 The changing care 
environment for more information.  
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There are a number of ways in which a new model of care could be developed. This PoW 
took a multiphase approach, which was adapted from a range of published frameworks, 
guidelines and tools that utilised stepwise approaches to developing new models of care. 
This included the: ‘changing models of care framework’, (108) ‘Understanding the process 
to develop a Model of Care: An Agency for Clinical Innovation (ACI) Framework’,(106) 
‘Model of Care Overview and guidelines’(107) and Quality and Service Improvement Tools 
from the NHS Institute for Innovation and Improvement.(109)  
 
For example, the stepwise approach to develop a new model of care recommended by 
the ACI involved the following five stages: 
• Project initiation – identify the area of need 
• Diagnostic – define the problem and understand the root cause 
• Solution design – develop and select solutions, create model of care 
• Implementation – support the health system to implement the model of care 
• Sustainability – optimise use of the model of care, monitor the results and 
evaluate the impact 
 
The multiphase approach taken involved identifying and evaluating the current 
discharge process. This helped to map not only the current discharge process, but also 
the common issues and their causes. Once the process map has been drawn the next 
step is to identify where the process can be improved by re-designing or removing 
elements of the existing process.(109) This method followed the existing approaches to 
developing new models of care. Advice was also sought on lean methodology on how to 
optimise the flow of services to maximise value with limited resources. New models of 
care should be tested to ensure their suitability and effectiveness. The most effective 
method of testing complex interventions is using a randomised controlled trial, as 
described by Campbell et al.(110)  The initial stages of their steps involved in designing a 
randomised controlled trial have been followed in this PoW. This allows for an easy 
transition to conducting a randomised controlled trial to evaluate the new model of care, 
although outside the scope of this PoW.  
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When tackling complex problems in service provision across multiple settings, it is 
important to acknowledge and work with multiple perspectives systematically. Applying 
a combination of qualitative and quantitative operational research methods is one 
approach to achieving this.(111) This is one reason why mixed methods were chosen to 
explore a multi-perspective view of patient discharge from hospital and develop a new 
model of care based on this.  
 
The guiding principles followed whilst developing a new model of care should be that 
it:(106)  
• is patient-centric 
• has localised flexibility and considers equity of access 
• supports integrated care 
• supports efficient utilisation of resources 
• supports safe, quality care for patients 
• has a robust and standardised set of outcome measures and evaluation 
processes 
• is innovative and considers new ways of organising and delivering care 
• sets the vision for services in the future 
 
The following factors should be considered during the development of a model of 
care:(106) 
• it is based on the best available evidence 
• it links to strategic plans and initiatives (local, national, state) 
• it is developed in collaboration with clinicians, managers, health care partners, 
the community, and with patients, their carers, and or organisations that 
represent them 
• costing, funding and revenue opportunities for the model of care are identified, 
and assessed 
• it extends across the patient journey through different care providers 
• specialty and priority populations of patients have been considered 
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To ensure the success of a new model of care, the patient should be kept at the centre 
of the plans and the potential for a ripple effect through the organisation should be 
considered. Improving one aspect of a system does not help the patient if another part 
of their journey is made worse as a result. The new model of care should be tested for 
improvement, which will help to identify any potential unwanted side effects.(109)   
 
2.10 Interventions to improve hospital discharge 
Problems at discharge are common and well documented. Much of the evidence found 
during the literature search highlights these problems and have been discussed 
throughout the relevant sections within this chapter. A number of interventions have 
been attempted over the years which have looked at improving different aspects of the 
discharge process. This section specifically covers a review of the literature around the 
interventions employed to improve hospital discharge.  
 
The literature search found that despite the well documented issues with the discharge 
process, there have been few successful methods to solve the problems on discharge 
within the UK. There have been several large-scale projects worldwide which involve 
training programmes designed to help hospitals improve their transitions of care. These 
include; BOOST,(112) Project RED,(113) ARC,(114) Care Transitions Intervention,(115) 
European Handover(116) and MATCH.(117)  However many projects carried out within the 
United Kingdom (UK) tend to be completed on a smaller scale in individual hospitals and 
have not managed to get the evidence to prove their effectiveness. Some of the 
published studies are discussed below. 
 
2.10.1 Interventions during hospital admission 
The literature search highlighted that a number of hospitals had trialled pharmacists 
writing discharge prescriptions in place of doctors in an attempt to improve the quality 
of discharge prescriptions.(73) One short study in a single hospital found that pharmacist-
written discharge prescriptions contained fewer errors and considerably fewer issues 
that required clarification in comparison to those written by doctors. The authors felt 
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that the high quality of pharmacist-written discharge prescriptions should result in a 
reduction in prescribing or transcribing errors on discharge, and a reduction in 
interruptions to the discharge process while queries are resolved.(118) One significant 
issue with this system was that the process was considered transcription as the 
pharmacists were not prescribers. This resulted in a doctor having to validate the 
discharge prescription before it went to a second pharmacist for a clinical check, adding 
a further step to the process.  
 
A pilot study carried out on one hospital ward provided an idea of some of the benefits 
that could be gained from having a ‘board round’ meeting with the MDT to identify 
patients for discharge the following day. By pre-empting any issues and organising 
discharge prescriptions in advance, preliminary data suggests that patients were 
discharged earlier in the day and pharmacy and ward staff experience was improved as 
a result of being organised in advance.(119) Although the data appears positive, further 
research with a robust method is required to determine the true extent of the benefits.  
 
Interim results published by one hospital in the process of piloting a dedicated ward 
pharmacy service looked positive. This involved ensuring a dedicated ward pharmacist 
attended ward rounds to assist with prescribing tasks. Clear benefits were apparent in 
terms of drug costs, readmission rates, length of stay, number of patients discharged 
before lunchtime and the number of pharmacy interventions made.(120) This was a pilot 
study and a full evaluation had not been undertaken at the time of writing.  
 
Deeks, 2000(121) investigated the effect of patients self-administering their medicines 
during their hospital admission on patient satisfaction with the discharge process and 
the way information was given to them. This UK survey-based study had a response rate 
of 193/309 questionnaires which could have resulted in response bias. The study was 
carried out on two acute medical wards within one hospital, the study findings are 
unlikely to be generalisable. The study concluded that patients who self-administered 
their medication rated their discharge care and information more highly than those who 
had not self-administered. 
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A randomised controlled trial in one hospital in Australia demonstrated that there was 
a significant reduction in the number of errors on discharge summaries if pharmacists 
completed a medicines management plan in the discharge summary.(122) One well 
conducted appropriately randomised controlled trial carried out in the USA 
demonstrated that there was no clinically significant reduction in medication errors as a 
result of a pharmacist intervention. The intervention involved a pharmacist carrying out 
medicines reconciliation on admission, discharge counselling, compliance aids where 
appropriate and a post-discharge follow up phone call. The study was limited to patients 
with heart failure or acute coronary syndrome and therefore not generalisable.(123)  
 
Blewett 2010(124) undertook a retrospective small study in the USA in an attempt to 
improve geriatric transitional care through inter-professional care teams. These inter-
professional teams (IPT) consisted of a geriatrician, a nurse and a pharmacist. The IPT 
cared for a proportion of patients on a transitional care unit and were solely responsible 
for their care. The intervention was to determine the impact of the IPT on patient's 
length of stay and average costs of care per patient.  It was not stated if patients were 
randomly selected. Half of the patients were seen by the IPT, the other half on the 
transitional care unit were seen by regular staff. Results suggested that patients 
reviewed by the IPT had shorter lengths of stay, fewer patient days and lower total 
charges compared to other patients. 
 
Other hospital pharmacy initiatives have been referred to in the literature, however they 
lack sufficient evidence as to their effectiveness. Examples of such initiatives included: 
patient information booklets for patients to take with them when they move between 
care providers, green bags to collect patients’ own medication, domiciliary MURs after 
discharge,(125) and dispensing for discharge, where original packs were dispensed for use 
in hospital and at discharge to ensure smooth discharge.(51) 
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2.10.2 Interventions during transfer of care 
Royal, 2006(126) conducted a UK based systematic review looking at interventions 
undertaken in primary care to reduce medication related adverse events and hospital 
admissions. The review addressed a clearly focused issue and was an appropriately 
searched literature review. Relevant interventions included 17 pharmacist led 
interventions where a medication review was performed in primary care. The review 
concluded that there was weak evidence to indicate that pharmacist-led medication 
reviews are effective in reducing hospital admissions. However, there was no evidence 
to suggest the effectiveness of other interventions which aim at reducing admissions or 
preventable drug related morbidity.   
 
One study by Harrington et al 2014(127) evaluated a post-discharge medication 
reconciliation programme. Patients discharged from one hospital on high risk 
medication or admitted with a high risk condition, for example diabetes, were referred 
to the pharmacist. The pharmacist performed post-discharge medicines reconciliation 
with them. The study was not powered to show effect but anecdotal evidence suggested 
that it had benefit. 11% of participants were re-hospitalised. There was no comparator 
group.(127)  In one hospital in the USA, a Care Transitions Service has been introduced. 
This is a pharmacy-driven programme for medication reconciliation throughout the 
continuum of care for patients on three or more long-term medicines. The service 
involves each patient receiving medicines reconciliation on admission to hospital, 
medicines review on discharge and a full handover to their community pharmacist on 
discharge. After discharge, patients receive a follow up phone call as a reminder and an 
outpatient appointment for further medicines reconciliation. A two month review of the 
service by Conklin et al, 2014 looked at the frequency and type of medicines related 
problems. They found that the number of medicines related problems decreased 
throughout the continuum of care.(128) Further work is required to determine the impact 
on patient safety and readmission rate. Kind 2012 introduced the C-TraC Program, which 
was similar to the Care Transitions Intervention. The difference being that the phone 
contact is by nurses rather than pharmacists. The nurse made a call 48-72 hours post 
discharge to check on the patient and perform medicines reconciliation. This was a 
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cohort study, with results compared to pre-intervention group. There was no 
randomisation and participants included veterans only, mostly over seventy years old 
and white. Results indicated that emergency readmissions were reduced from 34% in 
the pre-intervention group, to 23% in the intervention group.(129) 
 
Kripalani et al 2012 led a pharmacist-delivered intervention in two American hospitals 
whereby patients with cardiovascular disease were provided with medicines 
reconciliation, inpatient counselling, medicines adherence aids and a follow up 
telephone call after discharge from hospital. The intervention was assessed by means of 
an appropriately powered, blinded randomised controlled trial. The results indicated 
that clinically important medication errors were present among half of patients after 
hospital discharge and were not significantly reduced by the health-literacy sensitive, 
pharmacist delivered intervention.(123) 
 
The evaluation of a nurse led Liaison and Continuity of Care programme in Spain from 
the patients’ perspective found that although patients are satisfied at hospital discharge, 
they received insufficient preparation to cope with subsequent doubts and 
difficulties.(130) The programme involved liaison between different groups of healthcare 
professionals, to ensure continuity of information (e.g. discharge instructions) and the 
organisation and management of patients from 24 hours after hospital release. All 83 
patients in the programme were interviewed over the telephone. No control group for 
comparison was used.  
 
One study was conducted in the USA to assess the impact of a pharmacist transition 
coordinator on evidence-based medication management and health outcomes in older 
adults undergoing transfer from a hospital to a long-term care facility for the first time. 
The intervention included medication-management transfer summaries from hospitals, 
timely coordinated medication reviews by accredited community pharmacists and case 
conferences with physicians and pharmacists. The primary outcome was the quality of 
prescribing. There were 110 patients recruited, 88 of which completed the intervention. 
The results of the randomised single blinded, controlled trial by Crotty, 2004(131) showed 
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an increase in appropriate medication use. A decrease in hospital readmissions and 
emergency department visits was also noted in the intervention group, however this 
was a secondary outcome and the study may not have been powered to show statistical 
significance. 
 
A systematic review performed by Lamantia, 2010 looked at interventions undertaken 
to improve transitional care between nursing homes and hospitals. It reviewed five 
relevant studies, although all were small studies. This highlighted the need for large 
randomised controlled trials for more robust results. The interventions were found to 
be successful and included providing the following to the nursing home: the use of a pre-
order form for life sustaining medication, medicines reconciliation and a summary sheet 
with medication on including time of last dose administration.(132) 
 
A literature review including papers from USA, Canada, Australia and Europe assessed 
whether continuity of care impacted quality care outcomes for people experiencing 
chronic conditions. The outcomes were primarily patient-focused with a wide range of 
functional status, quality of life, and patient satisfaction indicators. The review 
concluded that papers did not address if continuity of care increased quality of care, 
despite patient satisfaction increasing.(133)  
 
2.10.3 Interventions involving community pharmacists 
A systematic review has recently studied the potential contribution of community 
pharmacists to improve transfer of care of patients from hospital back to the community. 
The review found inconsistencies in the implementation and process evaluation of the 
interventions in the reviewed studies and therefore was unable to draw a conclusion as 
to whether patient outcomes were improved. However, the review did conclude that 
there was sufficient evidence to suggest drug related problems were improved by 
involving community pharmacists during transfer of care.(134) Bigger, carefully 
constructed studies are required to adequately evaluate the impact of community 
pharmacists at discharge.  
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Duggan 2012 investigated the involvement of community pharmacy services at the 
primary-secondary care interface. This was a small study conducted in Dublin and 
involved a questionnaire to ask the opinions of both hospital and community 
pharmacists of the current discharge process. A logbook of communication between 
hospital pharmacists and one community pharmacy was also kept for 365 days. 
Although limited, when communication was made the issues were resolved in 81% of 
cases. Both parties would like the introduction of processes to improve seamless 
care.(135) A separate questionnaire-based study asking similar questions was undertaken 
on a much larger scale across Europe by the European Association of Hospital 
Pharmacists and EuroPharm forum. Communication was found to be non-existent in the 
majority of cases, however both parties recognised the importance of collaborative 
working.(136) 
 
Several interventions involving the utilisation of community pharmacy in the discharge 
process have been reviewed. One study assessed the continuity in patient care upon 
hospital discharge by evaluating a detailed clinical pharmacy discharge form sent to 
community pharmacists from the clinical pharmacist.(137) This was a small study involving 
eighteen patients from two teaching hospitals. Only twelve community pharmacists 
received the discharge form. Of these, ten thought that it improved continuity of care 
and gave positive feedback. Forms took 25 minutes on average for the clinical 
pharmacist to complete which was thought to be a drain on clinical pharmacists’ time. 
Results seem promising, however due to the very small sample and the absence of 
feedback from hospital pharmacists, further evaluation is required to determine overall 
impact. 
 
Discharge MURs are those performed on a patient who has been discharged from 
hospital within the last 4 weeks after changes have been made to their original 
medication. One multi-method study looked at the determinants of the uptake of all 
MURs by community pharmacies in England.(138) The aim was to explore and identify the 
key determinants influencing the uptake of MURs. This involved a survey of all primary 
care organisations in UK (74% response rate) then interviews with stakeholders. This 
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was a well-planned study with defined objectives and clear conclusions. A spilt was 
identified between multiple and independent pharmacies in their approach to the 
service, multiple pharmacies were more target driven and therefore more likely to 
complete MURs for patients. This study also indicated a need for greater communication 
and collaboration with GPs regarding MURs and highlighted that the service may benefit 
from the establishment of quality measures.  Another study took place across Yorkshire, 
consisting of a survey to determine community pharmacists' experiences of managing 
patients' medicines after discharge from hospital, focusing on discharge MURs.(87) Only 
23 pharmacists responded, limiting the generalisability of results. Initial findings were 
that discharge MURs are seldom used. Responses suggested that community 
pharmacists disagreed that patients are well educated about their discharge medication 
and would like to be more involved in the discharge process. 
 
Walgreens pharmacy in America offers the WellTransitions service. This involves 
community pharmacists working onsite in hospitals in collaboration with hospital clinical 
staff, to align prescription therapy, deliver discharge medications to the bedside, 
counsel patients about their drug therapy and follow up with patients post discharge. 
The primary goals of the programme were to reduce preventable hospital admissions 
and to improve patient satisfaction and health outcomes.(139) Walgreens released the 
results of a review undertaken which stated that there was a reduction in emergency 
readmissions of 46% in patients who received the intervention. However, the report 
provided insufficient detail of the method used. 
 
In an attempt to improve the communication between hospital and community 
pharmacists, several recent initiatives have involved implementation of electronic 
referral systems for hospital pharmacists to refer patients for community pharmacy 
services after discharge. Several small-scale studies have demonstrated the benefits in 
terms of readmission rates and length of patient stays,(140,141) however larger studies are 
required to determine the full benefits of the referrals.  
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Summary  
That problems occur in numerous areas at discharge is evident. However, many gaps 
exist in the literature relating to patient discharge from hospital. In particular the specific 
causes of these problems, how patients perceive these problems and what successful 
measures have been undertaken to resolve these issues. For this reason, the PoW was 
undertaken to fill these gaps and subsequently identify a new model of care to improve 
patient discharge from hospital.  
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Chapter 3 – Programme of work  
 
This chapter will outline the programme of work (PoW) for the thesis. It will discuss the 
aim and objectives of the PoW and how they were achieved using a multiphase 
approach. The methods adopted for each individual phase within the PoW are described 
next, followed by a methodological rationale for the design of the PoW. The chapter 
concludes by addressing the ethical issues, robustness, reflexivity and limitations within 
the PoW.  
 
3.1 Aim and Objectives of PoW 
The overall aim of the PoW was to provide the evidence to develop an innovative model 
of care for patients’ medication supply at hospital discharge that will provide safe, 
quality and effective transfer for patients from hospital to community care. 
 
The objectives of the PoW were to:  
1. Identify the current discharge process used in a range of acute NHS 
hospitals  
2. Explore the perceptions of pharmacists and patients of the current 
discharge process 
3. Develop an innovative model of care to resolve the issues associated with 
patient discharge from hospital  
4. Evaluate the proposed model of care using stakeholder feedback  
 
3.2 Overview of programme of work 
To develop the new model of care a multiphase approach was taken, which was adapted 
from a range of published frameworks, guidelines and tools based around developing 
new models of care and service improvement as described earlier in Chapter 2 (see 
section 2.9 Developing new models of care). The multiphase approach taken was 
broadly to establish the current problems at discharge, plan and develop the new model 
of care and then to evaluate the new model of care. Subsequent implementation of the 
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model is beyond the scope of this PoW. A multiphase approach was adopted within the 
PoW, to develop the new model of care. This was to ensure that multiple perspectives 
could be taken into account during the development. The PoW comprised four phases 
and an overview in Figure 3-1 illustrates how all four phases link together. The phases 
were carried out sequentially and throughout the PoW, findings from earlier phases 
informed the design of later phases.  
 
Figure 3-1 – Overview of programme of work (PoW) 
 
The four phases of the PoW are as follows: 
Phase 1: telephone interviews with chief pharmacists to identify and evaluate the 
current discharge process 
Phase 2: questionnaires to determine patient perceptions of the discharge 
process 
Phase 3: development of a new model of care for patient discharge from hospital 
Phase 4: interviews and focus groups with stakeholders in patient discharge to 
evaluate the proposed model of care 
 
Phases 1 and 2 identified and evaluated the hospital discharge process from two 
different stakeholder perspectives, providing a comprehensive understanding of the 
PHASE 1: Identification and 
chief pharmacist perceptions 
of current discharge process 
PHASE 2: Patient perceptions 
of current discharge process 
PHASE 3: Development of new 
model of care 
Literature search 
PHASE 4: Stakeholder review of new model of care, refinement of 
new model of care based on this stakeholder review 
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research problem. A flowchart providing a visual representation of the current discharge 
process was produced based on the findings of phase 1. The findings from phases 1 and 
2, along with findings in the literature helped to establish a clear picture of the current 
discharge process and were used to develop a new model of care in phase 3 of the PoW. 
Phase 4 involved feasibility testing of the new model of care using stakeholder feedback.  
 
A description of the methods adopted within each phase of the PoW is discussed next. 
Phases 1, 2, 3 and 4 are described in sections 3.3, 3.4, 3.5 and 3.6 respectively and the 
findings from each phase are presented in chapters 4 – 7.  
 
3.3 Phase 1: telephone interviews to identify and evaluate the 
discharge process 
This initial phase of the research was an exploratory study, investigating current patient 
discharge care from the perspective of NHS hospital pharmacists. This involved 
qualitative telephone interviews with chief pharmacists or a nominated senior 
pharmacy staff member from acute NHS hospitals across North West England.  
 
This phase of the research study was classed as an evaluation of NHS services involving 
members of staff and did not require NHS ethics approval, as patients were not involved. 
However, Liverpool John Moores (LJMU) Research Ethics Committee (REC) approved this 
phase of the research study on 16/1/15, reference number 14/PBS/008.  The approval 
letter can be seen in Appendix 2. 
 
 
3.3.1 Phase 1 research rationale 
Using a qualitative approach enabled a thorough exploration of the current discharge 
process and an examination of the operation of services in the context of their particular 
settings or circumstances.(142) As qualitative data collection and analysis relies on the 
researcher being heavily involved in the process, the findings are often interpreted 
according to their biased view. This risk of bias was outweighed by the benefits of 
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gaining a detailed insight into participants’ views to identify and explain the research 
problem in a way that quantitative methods would not allow. 
 
Interviews were the preferred data collection method to conduct a detailed 
investigation of the discharge process. Qualitative interviews enabled the researcher to 
probe for more information where appropriate during the interview to determine 
reasons for the participant’s answers and views. The depth of participant response 
ensured a detailed discussion around possible reasons, problems and barriers 
associated with the discharge process. A semi-structured approach was taken for the 
interviews, to enable the researcher to maintain some consistency over the concepts 
that are covered in each interview(1) and ensure participants’ views on the main issues 
were discussed. Equally, interviews do have disadvantages. Interviewing is time 
consuming and obtaining cooperation from potential participants can be difficult,(143) 
particularly for longer interviews.(143) Attempts to overcome these issues have been 
discussed throughout this section. Telephone interviews were chosen in preference to 
face-to-face interviews as they enabled interviews to be conducted within a limited time 
frame by eliminating travel time and costs, within the large geographical area of North 
West England. The participants in the study are very busy with work commitments and 
arranging a face-to-face interview at a mutually convenient time would have been 
difficult. A rapport can be difficult to build over the telephone and the absence of non-
verbal cues can also be a disadvantage during telephone interviews.(143) This could result 
in bias during data collection. In order to minimise this effect, every opportunity to build 
a rapport with the participants was made in the initial contact emails and during the 
interviews.  
 
3.3.2 Phase 1 aim and objectives 
The aim of this phase was to identify and evaluate the discharge process(es) used in a 
range of acute NHS hospitals across the North West of England. 
 
The objectives were to: 
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• Identify the current discharge process(es) in acute NHS hospitals across 
North West England 
• Determine which members of staff are involved in the current discharge 
process(es) 
• Explore which parts of the current discharge process(es) are considered 
effective and ineffective 
• Investigate any innovative ways of working employed by hospitals in order to 
improve the discharge process 
• Identify staff suggestions for the development of the current discharge 
process(es) 
• Determine the current role of community pharmacists in the hospital 
discharge process 
 
3.3.3 Phase 1 research method 
This section details the research method adopted along with a rationale for each 
decision. It describes the research sites, participants, inclusion and exclusion criteria as 
well as the recruitment of participants.  
 
3.3.3.1 Research sites 
The study was carried out in acute NHS hospitals across the North West of England. The 
North West of England was chosen as it contained a diverse range of types of acute 
hospital, from small rural district general hospitals, to large inner city teaching hospitals. 
The range of hospitals was similar to those across the rest of the UK and allowed for a 
degree of generalisation of the findings. Extending the study to include NHS hospitals 
across the whole of the United Kingdom (UK) was not considered feasible. The 
anticipated volume of data from the whole of the UK was unwieldly and unmanageable 
within the time frame and unlikely to be necessary to meet the study objectives. 
 
3.3.3.2 Participants 
Participants for the study were chief pharmacists at acute hospitals across North West 
England or an appropriate senior member of pharmacy staff. Chief pharmacists were 
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considered the most appropriate member of staff within the hospital to participate 
because they see the discharge process from an organisational standpoint and how this 
relates to NHS policies and procedures, as well as the wider aspects of providing quality 
health care. Their experience provides them with an awareness of how the discharge 
process runs in practice and they were best placed to provide the information necessary 
to meet the study aim and objectives. In some hospitals, the Chief Pharmacist may not 
play a significant role in the development of the discharge process and in these cases, 
they were then asked to nominate a more appropriate senior staff member to 
participate in their place. This ensured that an accurate representation of the process in 
each hospital was gathered. 
 
3.3.3.3 Inclusion and exclusion criteria 
The inclusion criteria for the study were chief pharmacists or an appropriately 
nominated member of pharmacy staff from any of the 22 acute (non-specialist) hospitals 
in North West England. Each participant required knowledge of the discharge process 
within their hospital; as stated in the recruitment email which can be seen in Appendix 
3. 
 
The exclusion criteria for this phase were participants from specialist hospitals, for 
example children’s, oncology, cardiothoracic, neuroscience and mental health hospitals. 
This is on the basis that their discharge procedures may be tailored specifically to their 
speciality and are unlikely to be relevant to an acute general hospital. 
 
3.3.3.4 Recruitment of participants 
The names and NHS hospital email addresses of chief pharmacists from acute hospitals 
in the North West was obtained via the North West Chief Pharmacists Network and the 
NHS choices website. Participants were initially contacted by email by the researcher via 
their NHS hospital email account. This initial email included an overview of the study 
and a summary of the topics with the interview schedule. The specific demographic 
details that would be asked during the interview were included to allow them to find 
such data. For example, the number of hospital discharges daily, the pharmacy staffing 
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levels at each hospital and the number of beds at each hospital. Potential reasons for 
non-response (for example time, confidentiality, content of interview, reason and 
importance of study) were addressed in this initial email to ensure that any questions or 
concerns would be answered early on in an attempt to increase response rates. The 
email can be seen in Appendix 3. A more detailed outline of the study was provided in a 
participant information leaflet (PIL) which was attached to the initial email. The PIL can 
be seen in Appendix 4. This allowed participants to read through the information and 
contact the researcher if they had any questions prior to agreeing to participate. 
Participants were asked to sign and return the consent form which was also attached to 
the initial email (see Appendix 5). The consent form could be returned electronically or 
via post as the researcher would not be seeing the participant in person. All participants 
consented on the premise that if any quotes were to be used that may identify their 
hospital in future publications, approval will be sought from them first. 
 
A reminder email was sent within three working days of the initial email to identify 
interested participants. This was considered sufficient time for participants to review 
the study documents, make an informed decision and nominate an appropriate person, 
if necessary. Dates for interviews were arranged either via email correspondence with 
the participant or via contact with their personal assistant. The study response rate was 
further maximised with a second reminder email to any non-responders after two weeks. 
This was followed up with a telephone call to the personal assistant of non-responders 
within one month of sending the initial email.  
 
3.3.4 Phase 1 data collection 
This section details the method for data collection in used phase 1 and covers the 
interview schedule, the procedure for data collection and any safety issues thought to 
affect phase 1. 
 
3.3.4.1 The interview schedule 
An interview schedule was developed by the researcher taking into account the aim and 
objectives of the study, the published literature and prior knowledge of the discharge 
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process in hospital. Questions and prompts were developed to ensure that they were 
not leading or biased. The interview schedule was reviewed by the supervisory team to 
ensure the trustworthiness of data collected. The language used was appropriate for the 
potential participants and this was checked during the pilot interviews. The interview 
schedule containing a full list of questions and prompts can be seen in Appendix 6. 
 
The interview schedule was divided into two sections. The first section contained closed 
questions collecting hospital demographic details. These questions were asked to 
provide context to the participants’ answers to open questions. The second section 
contained open questions about the discharge process and the participants’ opinions of 
the process. The interview schedule also contained a number of prompts which were 
used to facilitate the researcher to probe participants for more information about 
different aspects of the discharge process. With the semi-structured approach to the 
interviews, there was a risk that any issues participants found important may not have 
been mentioned. To overcome this risk, all participants were asked if they would like to 
add anything else at the end of each interview. 
 
3.3.4.2 Procedure 
Having pre-arranged the interview at a mutually convenient time, each interview began 
with a verbatim introductory script, ensuring that each participant was given the same 
information about the study before the interview. As part of the introduction, the 
researcher confirmed with all participants that a signed consent form was completed 
and returned. In some cases, the participants had arranged a time to conduct the 
interview without returning a signed consent form. If the researcher had not received 
this from the participant, then the consent form was read out and verbal audio-recorded 
consent was obtained from the participant before the telephone interview commenced. 
 
Closed questions were asked initially as an ice-breaker, to collect individual hospital 
demographic data including: hospital type, number of pharmacy staff and number of 
hospital discharges per day. Where appropriate, any closed questions were followed up 
with an open question for more detailed information. The participants were then asked 
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to freely describe the discharge process at their hospital and were probed for more 
detail using a set list of prompts. Participants were prompted to express their 
experiences, priorities and concerns throughout the interview. No topics were discussed 
that any of the participants found distressing during the interviews. 
 
The interview schedule served as a guide during the interviews, but the order and 
wording of the questions were modified based on the flow of each individual interview. 
All questions were asked at some point during each interview. Any specific comments 
worthy of investigation were explored by the researcher. Care and attentiveness was 
maintained by the researcher during questioning and listening to responses in each 
interview to ensure that all interviews were conducted to a similar high standard. The 
researcher strived to conduct the interviews in a neutral manner regardless of 
participant response in order to reduce bias. However the researcher’s experience and 
background knowledge aided the discussion and helped participants add additional 
information to gain a more rounded and rich dataset. 
 
Telephone interviews were conducted in the participant’s ‘natural setting’ by 
telephoning them at their workplace. The interviewee was advised to be in a quiet room 
in order to minimise distractions and interruptions whilst the interview took place. This 
also allowed them to answer questions freely without fear of being overheard.  The 
same researcher conducted all interviews in the same quiet research office free from 
interruptions, to ensure robustness of data collected. The researcher ensured that no 
others were present in the research office whilst the interviews took place. 
Trustworthiness of data collected was aided by building rapport, trust and openness 
with interviewees during the interview to enable them to express their views.  The 
interview allowed sufficient time to ensure all questions were asked and answered 
thoroughly.  
 
Telephone interviews were recorded using an audio-recording device, which was tested 
prior to each interview by the researcher. Key messages and reminders were 
handwritten on a printed version of the interview schedule during the interviews to aid 
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the researcher during data analysis or to recap on certain points during the interview 
itself. During data collection and the beginning of analysis, the researcher realised that 
data saturation had been reached. Data saturation is thought to be achieved when 
nothing new is generated from data collection.(144) Data saturation is an important 
measure of the adequacy of the sample size in qualitative research, as it is a way of 
determining whether sufficient depth and breadth of data has been collected. At this 
point, the researcher assessed the range of participants and undertook only several 
more interviews to ensure that participants were from a variety of hospitals with 
different experiences.  
 
3.3.4.3 Safety issues 
Neither the researcher nor any of the participants were put at risk or under any undue 
pressure during data collection. Telephone interviews allowed both the interviewer and 
the interviewee to be in a safe environment during the interview. No obvious sensitive 
topics were discussed. If the interviewee had found any topics distressing, this would 
have been handled tactfully by the interviewer.  
 
3.3.5 Phase 1 data analysis 
The previous section discussed how data collection took place for phase 1 of the PoW. 
This section will describe the data analysis used for phase 1. 
 
3.3.5.1 Interview transcription  
Transcription of interviews, coding and analysis of data were carried out by the 
researcher and any participant identifiable data were removed at this stage. The 
recorded interviews were transcribed in Microsoft Word immediately after each 
interview by the researcher in order to reduce the risk of transcription errors and 
memory recall. The transcriptions included indications of long pauses and other non-
verbal communication, such as laughter, in brackets to ensure that the context of the 
discussion remained intact. Any field notes relevant to the analysis taken during the 
interviews were added to the transcriptions as comments so as not to become confused 
with the interview data. During transcription, the researcher was aware that 
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transcription error could lead to issues with the content of the data. Subsequently, to 
increase robustness, the transcripts were thoroughly checked against the audio-
recording prior to analysis to ensure content and meaning was maintained. The 
supervisory team also checked a sample of the transcriptions to ensure trustworthiness 
of data.  Respondent validation of interview transcripts was not a viable option for this 
study, given the busy nature of the participants’ roles.   
 
3.3.5.2 Coding and analysis 
Demographic data collected were used only to inform the qualitative data collected. 
Thematic analysis was undertaken, using the process of constant comparisons (see 
section 3.7 Methodology for further detail) to analyse the qualitative data collected. 
NVivo 10 software was used to manage the data. 
 
Analysis started with a detailed, reflective exploration of each transcription. Each 
transcript was then imported into NVivo and coded line by line to identify the concepts 
during the process. Similar extracts from the data were coded into the same node. A 
node is a collection of references about a specific theme, place, person or other area of 
interest. The references are gathered by 'coding' sources such as interviews, focus 
groups, articles or survey results.(145) Nodes of interest were developed both from the 
objectives of the study and from points of interest within the interview transcript data 
itself. The nodes were then collated into categories related to the research questions. 
These categories were continually reorganised and combined throughout the analysis 
process and relationships were investigated until the final eight themes were identified. 
The supervisory team was involved in discussions around collation of data into themes. 
Using a coding process that involved attention to detail of the text itself helped to focus 
attention on the text rather than the researcher’s preconceptions. This helped to reduce 
bias in the analysis. Once the themes were identified, the researcher went back to the 
original transcript data to check if any themes had been missed. 
 
48 
 
3.3.5.3 Generic discharge process flowchart 
In addition to the generation of themes during the analysis (as discussed above), another 
major output from phase 1 was the generation of a flowchart to provide a visual 
representation of the current discharge process. A generic discharge process, in the 
form of a flow chart, applicable to every hospital that participated in the study was 
generated. This flowchart helped to capture and describe the discharge process(es) 
within each hospital as well as identify any variations in the process(es). The areas of the 
discharge process where problems commonly arose, as per the study findings, were 
highlighted on the flowchart. This flowchart was utilised in later phases of the PoW to 
aid development of a new model of care for discharge.    
 
3.3.6 Phase 1 pilot  
A pilot study was undertaken with two senior pharmacists who met the inclusion criteria 
for the study. This was to verify the recruitment procedure, obtaining consent, 
evaluation of the interview schedule and development of transcribing and data analysis 
skills prior to commencing data collection. Some of the pilot data were included in the 
main study, see section 4.4.1 Outcome of the pilot for details. 
 
Section 3.3 has detailed the method used for phase 1 of the PoW. The following section 
will move on to discuss the method used in the second phase of the PoW, phase 2. 
 
3.4 Phase 2: questionnaire to determine patient perceptions of 
the discharge process 
This phase was a questionnaire-based survey completed by inpatients at the Royal 
Liverpool and Broadgreen University Hospital NHS Trust (RLBUHT) to explore the current 
discharge process from the perspective of NHS patients and their suggestions for 
improving hospital discharge. 
 
This evaluation of hospital-based services involving inpatients also included questions 
investigating patient suggestions for improving the hospital discharge process, which 
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could be perceived as research rather than service evaluation. As such ethical approval 
was required prior to data collection taking place. Indemnity insurance and ethical 
approval was granted via proportionate review by the following RECs: 
 
 NHS REC on 29/10/15 reference: 15/SC/0669 (see Appendix 7) 
 LJMU REC on 3/11/15 reference: 15/PBS/012 (see Appendix 8)  
 RLBUHT Research Development and Innovation (RD&I) department on 25/11/15 
RD&I number 5123 (see Appendix 9) 
 LJMU liability insurance certificate can be seen in Appendix 10 
 
3.4.1 Phase 2 research rationale 
A quantitative approach was considered appropriate for this study to determine the 
opinions from a large number of patients experiencing the discharge process. 
Qualitative methods would have allowed for collection of only a small number of 
respondents’ views and therefore be less likely to represent the views of the general 
population. This was important as the findings from this phase were used to inform the 
development of a new model of care for the population as a whole. Subsequently, 
collecting the views of a large, varied sample of patients yielded findings that could 
reasonably be taken as an overall consensus of what patients want from their hospital 
discharge, which could be used to inform a new model of care. 
 
A questionnaire was considered the most appropriate method to collect data on the 
opinions and experiences of a large number of patients in a short period of time,(146) as 
well as to allow continuity of questions for each respondent and ease of data analysis 
after the data collected had been quantified. Questionnaires with direct questions also 
help to keep patients’ answers focussed on the area of interest as interviews could lead 
off topic. The questionnaire also enabled the researcher to be objective during the 
analysis, to reduce the risk of bias in the findings. Questionnaires are known to have 
disadvantages, such as the potential for poor response rates, or bias if questions are 
answered incorrectly by participants. These issues were addressed in the design of the 
phase and have been discussed throughout this section. 
50 
 
 
3.4.2 Phase 2 aim and objectives 
The aim of this phase was to explore patient perceptions and experiences of the current 
discharge process at the RLBUHT.  
 
The objectives for the phase were to: 
• Investigate patients’ views of their discharge from hospital 
• Explore issues identified in the phase 1 findings from the patients’ 
perspective  
• Identify patients’ suggestions for improving the current discharge process 
• Explore current relationships between patients and community pharmacists 
 
3.4.3 Phase 2 research method 
This section details the research method adopted along with a rationale for each 
decision. It covers the research site, participants, inclusion and exclusion criteria, 
gatekeepers as well as the recruitment of participants.  
 
3.4.3.1 Research site 
The study was carried out across medical and surgical wards at the RLBUHT. The RLBUHT 
was chosen for several reasons. Firstly, as phase 1 identified that the discharge process 
and the associated issues were similar across a range of hospitals; this reduced the need 
to carry out this study across several sites as the results were expected to be similar.  
Secondly, the RLBUHT is a large city-centre acute NHS teaching hospital with a variety of 
specialities. This provided diversity amongst the patients who participated in the study. 
The RLBUHT has approximately 30 inpatient wards from which patients could be 
discharged. Recruitment of patients took place across a range of general medical and 
surgical wards to ensure a diverse sample was included. Finally, as an employee at the 
RLBUHT the researcher had background knowledge of this hospital which allowed for 
ease of data collection.   
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3.4.3.2 Participants 
Ward-based adult inpatients (hereafter known as patients) ready for discharge were 
deemed appropriate for inclusion in this study.  These patients had experience of the 
discharge process and were therefore well placed to answer questions concerning the 
topic. If a patient was unable to participate for any reason a family member or carer 
could be asked to participate on their behalf, where appropriate. See section 3.4.3.3 
Inclusion and exclusion criteria below for full details on both the inclusion and the 
exclusion criteria for this phase of the PoW. 
 
3.4.3.3 Inclusion and exclusion criteria 
Inclusion criteria required respondents to be a patient or a family member/carer 
completing the questionnaire on the patient’s behalf. The potential respondent had to 
be awaiting discharge from the RLBUHT that day, to their usual place of residence, i.e. 
to their own home or to a care home. 
 
Patients were excluded from the study if they had cognitive impairment and thus unable 
to consent and those patients discharged to an intermediate care facility as this was 
considered an extension of their hospital admission. 
 
3.4.3.4 Gatekeepers 
The ward manager or charge nurse for each ward acted as the gatekeeper, and was 
approached to authorise the study to take place prior to recruiting participants. 
Gatekeepers were provided with information and shown the study Participant 
Information Leaflet (PIL) (see Appendix 11) if required, to allow an informed decision to 
be made regarding their ward’s participation. A gatekeeper consent form was signed at 
the first visit to the ward (see Appendix 12). The gatekeepers were consulted at each 
ward visit to identify patients due for discharge that day and asked to recommend 
suitable patients, based on the study inclusion and exclusion criteria. 
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3.4.3.5 Recruitment of participants 
Patients were approached at their bedside to determine if they were well enough and 
willing to participate, based on referral by individual ward managers or the charge nurse 
(see section 3.4.3.4 Gatekeepers). Recruitment took place on the day of the patient’s 
discharge so the patient had a clear recollection of their experience and was able to give 
their immediate impressions. Each potential participant was given a participant 
information leaflet (PIL) to provide enough detail about the study to allow them to make 
an informed decision before consenting (see Appendix 11 and section 3.8.1 Informed 
consent for more detail). Potential respondents were left alone for a minimum of 15 
minutes to read the PIL and given the option of going through the information with the 
researcher on their return. A consent form was provided in the event that the 
respondent was someone completing the questionnaire on behalf of the patient (see 
Appendix 13). For patients completing the questionnaire themselves, consent was 
assumed with completion of the questionnaire and therefore no additional consent 
form was required. A copy of the questionnaire was handed to the patient at the same 
time as the PIL for completion. 
 
3.4.4 Phase 2 data collection 
This section details the research method adopted for phase 2 and covers the 
questionnaire and its development, the procedure for data collection and any inherent 
safety issues. 
 
3.4.4.1 Questionnaire development 
Development of the questionnaire took existing evidence into account. Firstly, the 
findings from phase 1, detailed in chapter 3 were used as a basis for the topic of 
questions. Then published literature relating to patient experiences of the discharge 
process, existing validated questionnaires on similar topics and the researcher’s 
background knowledge of the discharge process were all used to help generate the 
specific questions. Questions were also drawn from the National NHS Inpatient 
Survey,(93) which contains a section dedicated to discharge. Guidance was sought from 
the supervisory team during the development of the questionnaire. 
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One of the objectives of this phase of the PoW was to build on knowledge of issues 
inherent in the discharge process that were identified in phase 1. Issues identified were 
from a managerial and operational perspective, whilst this second phase aimed to 
determine patients’ perspective of these issues. The NHS strives to be patient-centred, 
so it was important to explore the patients’ perspective of these findings. Only the issues 
from the phase 1 themes thought to be patient-facing have been investigated in this 
phase, so that patients would be familiar enough with the topic to be able to comment. 
The following themes from phase 1 were explored with patients in phase 2: 
• Planning for discharge 
• Medication supply for discharge 
• Post-discharge community pharmacy involvement 
• Patient involvement  
The questions were constructed and amended until the questionnaire was felt to 
contain enough detail to elicit the information required from respondents, without 
being too long. This was achieved by writing a rationale for each question to ensure they 
were aligned with the research objectives. The rationale can be seen in Appendix 14. 
Care was taken to ensure questions were easy to understand and not ambiguous, to 
improve trustworthiness of the data yielded.  Once finalised the questions were 
formatted and structured to make the questionnaire easy to follow. The questions were 
structured in a way that allowed patient responses to be easily quantified for analysis 
purposes. This included ensuring that the questions and answers could be entered into 
SPSS for quantitative data analysis.  
 
The questionnaire was pre-tested by several members of the public known to the 
researcher. Each respondent read through the questions and gave constructive 
comments regarding the wording and understanding of the questions. Any changes 
were made to the questionnaire after consultation with the supervisory team. No major 
changes were required and therefore the approving REC did not need to be notified. The 
questionnaire was then piloted prior to data collection. See section 3.4.6 Phase 2 pilot 
for details. 
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The final version of the questionnaire was divided into four sections: 
• Part A – About you 
• Part B – About your medicines during your stay in hospital 
• Part C – About your discharge 
• Part D – After your discharge from hospital 
The questionnaire contained 20 questions, consisting of mainly closed questions with a 
tick-box format for ease of use by participants. A range of topics relating to different 
aspects of the discharge process from the patient’s perspective were covered. Individual 
demographic questions were asked initially, to collect data such as age, gender and 
whether the patient took any regular medication. Several questions required an open 
format for patients to elaborate on their responses. A copy of the final questionnaire 
can be seen in Appendix 15. 
 
3.4.4.2 Procedure 
On data collection days, the researcher visited the wards where patients would 
potentially be discharged from that day. The gatekeeper was asked for suitable patients 
to potentially participate and each was then approached by the researcher. The 
researcher continued to collect data for as long as was feasible within the study period, 
to obtain as large a sample size as possible.  Patients were recruited from a range of 
clinical specialities to ensure a diverse sample of respondents with different medical 
conditions and backgrounds.    
 
Patients may be reluctant to discuss sensitive issues, which could lead to 
misrepresentative data being collected. As the topic of discharge was not considered 
sensitive, this was not thought to be a serious threat to this study. Nevertheless, in order 
to reduce the risk of bias, the researcher ensured that respondents were aware that any 
answers they provided were confidential and anonymous. As the questionnaire was 
carried out at the patient’s bedside, there was a possibility of patients or the researcher 
being overheard. Most respondents completed the questionnaire themselves and no-
one wanted to discuss any of the topics privately. Patient identifiable data was not 
collected during the study. 
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Respondents completed the questionnaire with the researcher nearby to enable them 
to ask for support when completing the questionnaire. This helped to increase the 
diversity of the sample and generalisability of the findings, by allowing patients with 
reading or writing difficulties to participate. The researcher provided information about 
the study questionnaire directly to each respondent, to build rapport and encourage 
participation whilst minimising pressure. Building rapport, trust and openness with 
respondents enabled them to express their honest views, improving robustness of the 
study. Answers to questions were recorded on the pre-printed questionnaire handed to 
patients. The time taken to complete the questionnaire varied between 5–20 minutes 
depending on the individual. 
 
3.4.4.3 Safety issues 
Neither the researcher nor any of the respondents were put at risk or under any duress 
during data collection. The questionnaire was designed not to cause any discomfort or 
emotional stress to the respondents.  In the event a patient had become upset during 
the study, the researcher’s experience of working as a hospital pharmacist and dealing 
with patients, allowed her to confidently resolve any issues that may have arisen. The 
researcher would have either discussed the issue with the patient or sought assistance 
from an appropriate member of ward staff. In the event that the researcher was unable 
to manage an issue, she would – where appropriate - remind the patient of the 
complaints procedure, as detailed in the PIL (Appendix 11). Questionnaires were 
conducted at the respondent’s bedside, minimising risk of physical harm to the patient.  
The researcher was not involved in any of the respondents’ care so questions or 
concerns highlighted by patients were passed immediately to an appropriate member 
of staff involved in their care. If evidence of poor practice arose, for example a patient 
raising concerns to the researcher, the researcher would advise nursing or pharmacy 
staff responsible for that patient to ensure the patient received appropriate support. 
Should any serious incidents have arisen, the researcher would have also reported them 
to the Chief Pharmacist and discussed them with the supervisory team. 
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3.4.5 Phase 2 data entry and analysis 
A database was set up prior to data collection and piloted (see section 3.4.6 Phase 2 
pilot) to ensure that it was suitable for data analysis. A code scheme was developed for 
each question within the questionnaire to facilitate data entry into SPSS, this can be 
seen alongside the questionnaire rationale in Appendix 14. Data were entered into the 
SPSS database by the researcher. An internal consistency check was undertaken by the 
researcher and 10% of the sample was checked by a member of the supervisory team. 
The data was ‘cleaned’ using the crosstab function in SPSS.  
 
Descriptive statistics (using the frequency and descriptive analysis tools in SPSS version 
22) were used to analyse the data. Open questions generating free text data were 
entered into the SPSS database and subsequently coded to allow responses to be 
analysed using quantitative descriptive statistics. Free text responses are also cited 
where appropriate throughout the phase 2 findings section to provide context to the 
quantitative findings from the questionnaire. 
 
3.4.5.1 Generic discharge process flowchart 
A generic discharge process flowchart was generated in phase 1 of the PoW (see section 
3.3.5.3 Generic discharge process flowchart for details of how this was generated). In 
addition to the quantitative analysis within this phase, the areas of the discharge process 
where patients felt that problems commonly arose, as per the study findings, were 
highlighted on this flowchart. This flowchart containing the issues from the patients’ 
perspective was utilised – along with the flowchart from phase 1 – in later phases of the 
PoW to aid development of a new model of care for discharge.    
 
3.4.6 Phase 2 pilot 
A pilot study was undertaken with patients at the RLBUHT to verify the recruitment 
procedure, obtaining consent, evaluation of the survey and development of data entry 
and data analysis skills prior to commencing data collection. The pilot involved the 
researcher handing out the questionnaires for completion and asking for informal 
patient feedback after completion to determine if the questions were comprehensible, 
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unambiguous and the questionnaire was well structured. The pilot data were used to 
test the data entry process and subsequent analysis using SPSS.  
 
This chapter has so far detailed the methods for phases 1 and 2 of the PoW. The next 
section discusses the method used in phase 3. Whilst the first two phases were 
standalone, the third phase of the PoW utilises the findings from the earlier phases.  
 
3.5 Phase 3: development of a new model of care for patient 
discharge from hospital 
This third phase of the PoW involved developing a new model of care for patient 
discharge and was informed by the findings from phases 1 and 2 of the PoW along with 
data from the literature (see chapter 2 – Introduction). 
 
3.5.1 Phase 3 rationale 
The findings from phases 1 and 2 provided the evidence to support the overall PoW by 
highlighting the need to develop a new model of care for patient discharge to improve 
patient care. Triangulation of the phase 1 and 2 findings was undertaken to obtain a rich, 
robust and comprehensive account of the current discharge process.(147) This process of 
combining the findings was undertaken to facilitate a deeper understanding of the 
issues associated with current hospital discharge from different stakeholder 
perspectives. This process emphasised the problems requiring solutions and examples 
of good practice to incorporate in a new model of care. 
 
3.5.2 Phase 3 aim and objectives 
The aim of this phase was to develop an innovative model of care for patient discharge 
from hospital that provides safe, quality care in a timely manner and improves patient 
experience. 
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The objectives were to: 
• Explore and triangulate the findings from phases 1 and 2, to determine 
the issues that require solutions and the examples of good practice at 
discharge 
• Use the findings and data from the literature to generate a new model of 
care for discharge 
• Define and map out the new model of care 
• Explain how the new model of care overcomes the issues identified in 
phases 1 and 2  
• Explain how the new model of care encompasses the good practice 
identified in phases 1 and 2 
 
3.5.3 Phase 3 method 
Overall, this phase involved utilising the findings from phases 1 and 2, alongside findings 
from the literature to inform the development of a new model of care for patient 
discharge. Several steps were necessary to achieve the aim of developing a new model 
of care. 
 
Initially, the findings from phases 1 and 2 were explored. This began with the generic 
discharge process flowchart, which was created in phase 1 of the PoW (see Figure 4-1). 
The main issues associated with the discharge process from the pharmacists’ 
perspective had been highlighted on this flowchart. In the same way in phase 2 of the 
PoW, the issues from the patients’ perspective had been mapped onto the generic 
discharge process flowchart (see Figure 5-1). Triangulation of the results began here, as 
the two flowcharts containing the findings from phases 1 and 2 were integrated, 
creating a third flowchart illustrating the combined problems at discharge (see Figure 
6-1). The combined flowchart was used to determine if the issues surrounding discharge 
were similar from a pharmacist and a patient perspective. The combined flowchart 
covered the issues at discharge, but not the examples of good practice. The examples of 
good practice were recapped from the main findings of phases 1 and 2 to be taken into 
consideration for the new model.  
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Two main aspects were taken into consideration when developing the new model of 
care: the highlighted issues and the examples of good practice. As already discussed, the 
issues within the discharge process highlighted by the pharmacists in phase 1, and 
patients in phase 2 were considered together to provide a deeper understanding of the 
issues from each perspective. The discharge process flowchart detailing the combined 
issues helped the researcher to easily identify stages of the current discharge process 
that were considered redundant, or needed improvement. When creating the new 
model of care for discharge, it was important to consider the impact of redesigning 
specific aspects of the discharge process on the wider discharge process. For example, 
that removing a rate-limiting step in one area of the current discharge process did not 
create another elsewhere. The second area that was taken into account was examples 
of good practice at discharge found in phases 1 and 2, and in the literature. The proposed 
model of care was described using a flowchart to provide a visual aid (see Figure 6-2). A 
detailed rationale was also written to describe the reasons for the choice of new model.  
 
This section has discussed how the new model of care for patient discharge was 
developed in phase 3 of the PoW. The following section will discuss the method used in 
phase 4 of the PoW, which was a test for feasibility of the new model of care. 
 
3.6 Phase 4: interviews and focus groups to evaluate the 
proposed model of care 
Phase 4 of the PoW involved feasibility testing of the proposed new model of care using 
qualitative interviews and focus groups with relevant stakeholders in the discharge 
process (see section 3.6.3.2 Participants for further details). The findings were then used 
to refine the new model of care. 
 
This formative evaluation of a proposed service involved members of staff and expert 
patients from patient and public involvement groups.  This phase did not require NHS 
ethics approval, as participants were not current patients within the NHS. However, 
LJMU REC approval was granted on 25/6/16. Reference: 16/PBS/002 (see Appendix 16).  
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3.6.1 Phase 4 research rationale 
This phase of the research was a feasibility test, to determine if the proposed new model 
of care emerging from Phase 3 was considered feasible and acceptable by the target 
population. Feasibility testing allowed the new model of care to be modified before 
implementation if necessary. By pre-empting any major issues with the new model of 
care, as well as gauging stakeholder engagement, this increases the likelihood that the 
proposed new model would be a success once implemented. 
 
Qualitative methods were considered appropriate for this phase to allow a thorough 
exploration of each step within the new model of care. It also enabled depth of response 
around participants’ views, potential problems and barriers that could affect the new 
model of care. 
 
Qualitative data relies on the researcher being heavily involved in the process and the 
researcher’s involvement in the development of the new model of care could lead to 
bias during data collection. However, the researcher’s background was important when 
explaining the new model of care in detail with participants to ensure that an accurate 
picture was formed and therefore appropriate feedback was obtained. This risk of bias 
was therefore outweighed by the benefits of gaining a detailed insight into participants’ 
views of the new model of care. 
 
Semi-structured interviews and focus groups were used to carry out the qualitative data 
collection for this study. These data collection methods were preferred to enable the 
researcher to probe for more detailed information where appropriate. Focus groups 
were chosen to allow opinions of the new model of care to be freely discussed within 
the group. An advantage of a focus group is that it allows several different perspectives 
to be explored and promotes discussion.(146) The role of the researcher is key to ensure 
that the focus group is successful, without leading the group and influencing the data 
collected.(146) Qualitative interviews elicit people’s thoughts and therefore they can be 
attributed to an individual person. Despite qualitative interviews not having the 
advantage of multiple perspectives to promote discussion within a group as in focus 
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groups, they are still an appropriate method of data collection as they enable a detailed 
discussion of the discharge process between the researcher and the participant as the 
final phase explored any potential issues with the proposed new model of care and 
therefore it was important to highlight as many perspectives as possible. Qualitative 
interviews were preferred to focus groups as not all participants could attend a focus 
group due to the busy nature of their roles. Offering both methods of data collection 
ensured that a diverse range of stakeholders participated to generate feedback from 
different perspectives, which was key to the successful development of the new model. 
 
3.6.2 Phase 4 aim and objectives 
The aim of this final phase of the PoW was to explore stakeholder views of the proposed 
new model of care for patient discharge from hospital.  
 
The objectives were to: 
• Explore perceptions of the proposed model of care with relevant 
stakeholders in the new model including patients and healthcare 
professionals from hospital and community settings 
• Identify any potential issues with the new model of care 
• Identify the knowledge and skills required to deliver the new model of care 
to establish future training needs 
• Identify the resources required to deliver the new model of care 
• Refine the new model of care based on stakeholder feedback 
 
3.6.3 Phase 4 research method 
The following section details the research method adopted along with a rationale for 
each decision. It covers the research sites, participants, inclusion and exclusion criteria 
as well as the recruitment of participants.  
 
3.6.3.1 Research sites 
Potential participants were drawn from hospital staff at RLBUHT and other North West 
England hospitals. Community healthcare staff were also identified from GP practices, 
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community pharmacies and patients through local patient and public involvement 
groups in the Liverpool area. Liverpool was identified as an appropriate area due to the 
diversity of patient groups in the area and types of services available. 
 
3.6.3.2 Participants 
Potential participants included either service users or anyone involved in the delivery of 
the proposed model of care.  This included hospital and community-based staff involved 
in the discharge process: hospital pharmacists, pharmacy technicians, nursing staff, 
hospital doctors, community pharmacists and GPs. This varied range of service providers 
were considered best placed to identify issues and suggest improvements to the model 
as they will be familiar with different aspects of patient discharge and their own 
capabilities. Expert patients from patient and public involvement groups were also 
invited to participate, to consolidate findings from phase 2 and determine if they think 
patients would be happy to use this type of service. 
 
3.6.3.3 Inclusion and exclusion criteria 
The inclusion criteria for this phase required participants to be either involved in 
delivering the current discharge process, involved in delivering the proposed model of 
care or an expert patient with knowledge of the current discharge service. Those 
unfamiliar with any aspect of patient discharge were excluded as their contribution was 
considered to be limited. 
 
3.6.3.4 Recruitment of participants 
Potential participants were identified via a snowballing sampling method(146) via 
informal professional networks and invited to participate due to their involvement in 
the discharge process. Participants were approached either in person or via email (see 
Appendix 17) as appropriate. A participant information leaflet (PIL) (see Appendix 18) 
was provided to enable participants to make an informed decision as to whether they 
would like to take part. The PIL highlighted that the focus group/interview would be 
audio-recorded to ensure that they were comfortable with this. The PIL was sent to each 
participant before the focus group or interview via email allowing sufficient time for it 
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to be read. Each participant was asked to sign a consent form prior to participation (see 
Appendix 19). All participants consented on the premise that if any quotes were to be 
used that may identify their hospital in future publications, approval will be sought from 
them first. Participants were asked if they would be happy to participate, having been 
given at least 24 hours to consider the study information. A mutually convenient time 
for the session was arranged as appropriate. 
 
3.6.4 Phase 4 data collection 
Section 3.6.3 detailed the research method adopted for phase 4. Section 3.6.4 will 
introduce the method for data collection used in phase 4. It covers the topic guide, the 
procedure for data collection and any safety issues thought to affect phase 4. 
 
3.6.4.1 Topic guide development 
A topic guide was developed to meet the study aim which was suitable for use in either 
interviews or focus groups to ensure trustworthiness of data. General themes for 
discussion were determined based on the findings from phases 1, 2 and 3 of the PoW, 
the available literature and discussions with the research supervisory team. These key 
topics for discussion can be seen in section 7.2 Method. Questions and prompts were 
developed to ensure that they were not leading or biased and included in the topic guide 
(see Appendix 20). The terminology used was checked during the pilot interviews to 
ensure it was appropriate for the potential participants (see section 3.6.6 Phase 4 pilot). 
 
3.6.4.2 Procedure 
The interviews and focus groups were arranged for a mutually agreed time. To build a 
rapport with participants prior to the sessions any arrangements were conducted in a 
polite, friendly and efficient manner. Both the interviews and focus groups began with 
a verbatim introductory script, to ensure every participant was given the same 
information. This information included a reminder that the session would be recorded 
for analysis purposes prior to switching on the recorder (see Appendix 20). Consent 
forms were completed prior to the session beginning and collected by the researcher. 
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The sessions were broadly divided into two sections, following a workshop-style 
approach rather than the format of a traditional focus group. In the first section the 
researcher gave a verbal overview of the proposed model of care, supported by a 
printed copy of the flowchart describing the new model of care, which was developed 
in phase 3 (see Figure 6-2). The second section involved the researcher asking open 
questions exploring participants’ opinions about the new model of care (see Appendix 
20). Each step of the proposed new model of care was discussed with participants.  
Prompts were used by the researcher to probe participants for more information about 
different aspects of the new model.  
 
The topic guide served as a guide throughout, but the order and wording of the 
questions were modified based on the flow of each individual session. All questions were 
asked at some point during each interview and focus group. Any specific comments of 
interest or those unfamiliar to the researcher were explored further. Care and 
attentiveness was maintained by the researcher during questioning and listening to 
participant responses to ensure that all interviews and focus groups were conducted to 
a similar high standard. The researcher strived to conduct the interviews in an impartial 
manner regardless of participant response in order to reduce bias. The researcher’s 
experience and background knowledge could hinder this, however the researcher aimed 
to utilise her background knowledge to facilitate the discussions and encourage 
participants to expand on their responses to gain a well-rounded and rich dataset. 
 
The focus groups and interviews took place in private rooms in order to minimise 
distractions or interruptions during the process. The researcher’s role was essential to 
ensure that the interviews or focus groups were successful, without leading the 
participants and causing bias. The questions and prompts were properly explained to 
participants if required. Trustworthiness of data collected was aided by building rapport, 
trust and openness with participants and encouraging participants to give their honest 
opinions. It was made clear to participants that honest feedback was important, so that 
they did not feel obliged to give positive responses if they felt that the new model could 
be improved. Sufficient time was allowed to ensure all questions could be answered 
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completely. As the researcher progressed through the data collection and analysis 
process it was noted that no new topics or perspectives were emerging. It was clear that 
data saturation had been achieved. At this point, several more interviews with 
participants from diverse backgrounds were conducted to ensure that stakeholders with 
different experiences had been included and a range of responses were gathered. 
 
3.6.4.3 Safety issues 
Neither the researcher nor any of the participants were put at risk or under any duress 
during data collection. All interviews and focus groups were conducted in a safe work 
environment, in quiet, easily accessible rooms. Neither the researcher nor any of the 
participants were put at risk physically or emotionally during data collection. 
 
3.6.5 Phase 4 data analysis  
The previous section discussed how data collection took place for phase 4 of the PoW. 
This section will describe the data analysis used for phase 4. 
 
3.6.5.1 Transcription 
The digital audio recordings were transcribed in Microsoft Word immediately after each 
interview or focus group by the same researcher in order to reduce the risk of 
transcription errors and aid memory recall. All participant identifiable data was removed 
at this stage. Similarly to the method used for transcription in Phase 1 (see section 
3.3.5.1 Interview transcription), transcriptions were checked against the audio-
recording to ensure the content and meaning had been maintained. The supervisory 
team also checked a sample of the transcriptions to improve robustness of data. 
 
3.6.5.2 Coding and analysis 
For the purpose of analysis, interview data and focus group data were pooled and 
analysed together. Coding of the transcript data took place using the same process as in 
phase 1 of the PoW. See section 3.3.5.2 Coding and analysis for details of the process 
used. Using a coding process that involved attention to detail of the text itself helped to 
focus attention on the text rather than the researcher’s preconceptions. The supervisory 
66 
 
team were also involved in discussions around collation of data into themes. This was 
important when analysing the new model of care which was developed by the 
researcher to help reduce bias in the analysis. Once the themes were identified, the 
researcher went back to the original transcript data to check if any themes had been 
missed. This is known as thematic analysis by constant comparisons (see section 3.7 
Methodology for more detail). 
 
Two separate methods of qualitative analysis were performed on the data within this 
phase of the PoW. The qualitative analysis, as discussed above, to identify themes and 
review the proposed model of care holistically. A stepwise review of the new model of 
care was also performed. This qualitative analysis took on a more predictive approach, 
whereby nodes were arranged according to the individual stages of the proposed new 
model of care, to systematically analyse each step of the new model of care in detail. 
Using these two methods of analysis added to the robustness of the phase.   
 
3.6.6 Phase 4 pilot 
The first interview conducted was a pilot to determine if methods of recruitment were 
suitable and the topic guide yielded suitable data for analysis. The pilot also checked the 
recording equipment to ensure everything was in working order.  The first focus group 
conducted was also carried out as a pilot.  
 
3.7 Methodology  
Research paradigms are frameworks based on philosophical beliefs that are shared by 
groups of researchers.(146) Paradigms provide a basis for understanding the nature of 
reality, they guide how researchers approach research and will impact research 
design.(148) A variety of paradigms are discussed in the literature, each with differing 
viewpoints. It is important to state which paradigm individual research studies belong 
in, to acknowledge that the approach taken for the study is one of many and that there 
are other ways to carry out the research. 
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The pragmatic paradigm was the approach taken for the PoW as it is orientated toward 
solving practical problems in the ‘real world’(149,150) and endorses theory that informs 
practice.(143,150) Pragmatism lends itself well to this PoW and the personal views of the 
researcher. The research area was identified from known problems with the current 
discharge process, both anecdotal and from existing evidence. The pragmatic paradigm 
was appropriate to explore issues with the current discharge process and use this 
information to develop a new model of care to improve practice. It is important to note 
that the pragmatic approach views current knowledge as tentative and changing over 
time.(143) As systems and technologies develop with time, knowledge previously 
collected regarding the discharge process can become invalid and this was taken into 
account during the study. 
 
Another methodology important to this PoW is grounded theory. This qualitative 
methodology’s purpose is to construct theory grounded in data.(1) There are several 
unique features of grounded theory, namely that the concepts out of which the theory 
is constructed are derived from the data collected during the research process and not 
chosen prior to beginning the research. Secondly, in grounded theory, research analysis 
and data collection are interrelated. After initial data are collected, the researcher 
analyses that data and the concepts derived from the analysis form the basis of 
subsequent data collection.(1) Regardless of the type of data used, they are analysed by 
means of a process called constant comparisons. In doing constant comparisons, data 
are broken down into manageable pieces with each piece compared for similarities and 
differences. Similar data are grouped together under the same conceptual heading. 
Through further analysis, concepts are grouped together by the researcher to form 
themes. These themes are integrated around a core theme which provides the structure 
of the theory.  
 
Within the qualitative phases of this PoW the principles of grounded theory were 
utilised to carry out data analysis and develop themes based on the data. However for 
the purpose of this PoW a theory was not constructed as is usual for grounded theory. 
Within the qualitative phases of the PoW, topics discussed during data collection 
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developed based on the findings from the analysis of the initial data collected from 
participants. Analysis was also grounded in the data, using the principles of constant 
comparisons to establish emerging themes.  
 
Different methodologies exist for carrying out research. These broadly fall under either 
quantitative or qualitative approaches. Quantitative research is used to measure the 
research problem by generating accurate numerical data. Qualitative research is usually 
exploratory, involving in-depth discussions with participants leading to rich data sets. As 
such, qualitative data can be seen as more subjective than quantitative research. The 
qualitative approach is used to understand opinions and reasons and tends to address 
the questions what, why and how. The type of method chosen will depend on the 
research problem and what type of data would be most appropriate to address the 
problem.  
 
In some circumstances, a combination of both qualitative and quantitative would be the 
most appropriate approach. Mixed methods research is the use of quantitative and 
qualitative methods in a single study or series of studies.(151) This methodology is 
increasingly used by health researchers, especially within health services research.(151) 
The underlying assumption of mixed methods research is that it can address some 
research questions more comprehensively than by using either quantitative or 
qualitative methods alone.(150) Research questions that profit most from a mixed 
methods design tend to be broad and complex, with multiple facets that may each be 
best explored by quantitative or qualitative methods.(151)  The research problem of 
discharge from hospital is a broad and complex issue and requires a combination of 
quantitative and qualitative methods to resolve.  
 
Pragmatism, the paradigm adopted by the PoW, lends itself to mixed methods as it frees 
the researcher to use a range of approaches to best understand the research 
problem.(150) Mixed methods were appropriate to address the overall aim of the PoW, 
as each phase required different research strategies to enable a thorough understanding 
of the research problem from different perspectives, either confirming or providing an 
69 
 
alternative explanation, enhancing trustworthiness of the data. A range of methods 
were therefore employed to use the appropriate method for each individual phase, to 
meet the aim of each phase. The methods complemented each other and benefited 
from the strengths of each method whilst allowing the biases from individual methods 
to be overcome by the strengths of the other methods. The subjective bias of the 
researcher was a disadvantage, which cannot be removed. Reflexivity was adopted by 
the researcher to identify if her views influenced the research.  
 
The individual methods used throughout this PoW have been discussed within their 
respective sections in this chapter. Triangulation is a well-documented advantage to 
mixed methods research, whereby the same research problem is explored using 
different methods. The PoW followed a concurrent triangulation design whereby both 
exploratory qualitative and explanatory quantitative methods were used separately, 
independently and concurrently in different phases.(143) The findings were then 
compared to assess their convergence(143) to form a clearer picture of the research 
findings. 
 
3.8 Ethical Issues 
A researcher has a responsibility to work within a code of ethics. Different professionals 
will have their own code of ethics, but all should have common principles. For example, 
researchers must strive to protect subjects from undue harm arising as a consequence 
of their participation in research.(152) The researcher had a responsibility to complete the 
PoW with integrity and contribute to the knowledge base. The PoW was therefore 
designed to ensure the research was carried out ethically and appropriate ethical 
approval was sought for each phase of the PoW. 
 
Various potential ethical issues were considered during each phase of the PoW. One 
area that required ethical consideration was the participants. The researcher strived to 
develop an atmosphere of mutual trust with each of the participants. As part of this, the 
researcher was not judgemental and respected the beliefs and values of the individual 
participants, which may have differed from her own. The methods adopted to ensure 
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the research within each phase of this PoW was conducted ethically have been discussed 
throughout this chapter and two important aspects, informed consent, and 
confidentiality and anonymity are discussed in more detail below.  
 
3.8.1 Informed consent 
Informed consent is essential for research involving human participants. It is when 
permission is granted by the participant who has been fully informed of the research 
study and the possible consequences. Informed consent was obtained for all phases in 
the PoW involving data collection.  Participant information leaflets (PIL) were provided 
in each phase of the PoW to assist participants to make an informed choice about 
participation. Each PIL provided detailed information about the background to the 
specific study, information about the researcher, what participation involved, benefits 
and possible risks of participating, an invitation to take part, why they have been chosen 
to participate, confidentiality and the participant’s rights. The PILs were phrased in such 
a way that they were easy to read and if the participant had any questions they could 
contact the researcher for more information. In order to confirm that informed consent 
had taken place, consent forms were provided for all participants throughout the phases 
to complete, sign and return to the researcher before the research took place.  
 
The individual methods used to provide information and obtain informed consent for 
each phase of the PoW are detailed in the relevant individual sections for each phase. 
See sections 3.3 – 3.6 for further information. 
 
3.8.2 Confidentiality and anonymity 
Participant confidentiality and anonymity was maintained throughout all phases of the 
PoW. Personal information was not collected unless necessary and very few participant 
identifiable data were required for the purpose of the PoW.  
 
For qualitative phases 1 and 4 which involved audio-recorded interviews, the researcher 
anonymised all data at the transcription stage by removing any participant identifiable 
information and coding the transcripts to enable participant identification. For the 
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quantitative phase 2, no patient identifiable data was collected. To ensure 
confidentiality, only the researcher and supervisory team had access to the data 
including: interview audio-recordings, transcripts, questionnaires and consent forms.  
 
All forms of electronic data were stored on the researcher’s personal computer which 
was attached to the LJMU server and password protected in a locked office at LJMU. All 
paper copies of research data, for example questionnaires and consent forms, were kept 
in the same locked office in a locked cabinet which was only accessible to the researcher.  
 
3.9 Robustness of research across PoW 
The PoW was designed to ensure that the research carried out was robust. This was 
achieved in a variety of ways, including ensuring trustworthiness throughout the PoW. 
The specific means of ensuring trustworthiness in the design of each individual phase 
are discussed throughout this chapter. 
 
Triangulation of the data was an important aspect of ensuring robustness. The benefits 
of triangulation in a mixed methods study have previously been discussed in this chapter 
(3.5.1 Phase 3 rationale). This PoW used a variety of data collection methods: qualitative 
interviews, focus groups and questionnaires. All of these methods have both strengths 
and weaknesses which have been discussed within the appropriate individual section of 
this chapter. The benefit of using all of these methods within one study is that the 
strengths of each individual method will offset the weaknesses of the others. This is one 
way of ensuring methodological robustness. Another example of robustness 
incorporated into the PoW is the participant sample. Chief Pharmacists were 
interviewed to obtain their perspectives of the discharge process in phase 1 and patients 
were included in phase 2. Including different participant perspectives on the same 
research problem supports the robustness of the study. Finally, to ensure that the 
researcher did not limit the review of the new model of care to her own views, a range 
of stakeholders in the discharge process were approached to evaluate the new model.   
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3.10 Reflexivity 
In qualitative research, the researcher collects and interprets data, making the 
researcher as much a part of the research process as the participants and the data they 
provide.(1) Subsequently, as discussed throughout this chapter, there is a risk within 
qualitative research that the researcher’s beliefs, experience or values will influence the 
research (see also section 3.7 Methodology). This was a consideration during this PoW 
due to the researcher’s experience as a hospital pharmacist. The individual methods 
sections throughout this chapter discussed ways in which the researcher attempted to 
limit the bias in each phase. To remove this bias is impossible. One way to recognise that 
the researcher was not a neutral observer was by including reflexivity. Qualitative 
reflexivity is the process by which the researcher reflects upon and critically appraises 
the data collection and interpretation process.(142,153) It looks at the effect of the 
researcher on the research process. This self-reflection was important to identify all of 
the influences that may have inadvertently affected the research process. The 
researcher kept a research journal documenting her thoughts throughout the process 
and identified several preconceptions that could have influenced the qualitative analysis. 
By being aware of these, the researcher was less likely to inadvertently allow this to 
occur. By keeping this journal, the researcher was able to take a critical look at the 
research and take a step back from the intense process of qualitative research, which 
can occasionally be overwhelming. The findings chapters for each phase of the PoW 
contains a section on reflexivity within the individual phases.  
 
3.11 Methodological limitations of PoW 
The methodological limitations thought to affect each phase of the PoW are discussed. 
Each of the methods used within the individual phases have their own limitations. 
However as discussed in section 3.9 Robustness of research across PoW, the strengths 
of each phase offset the limitations of others, which is one of the benefits of using a 
mixed methods approach to research. Despite the strengths of the mixed methods 
approach, there are also challenges. Using a mixed methods approach meant that the 
researcher required training to learn a new set of skills for different methods both 
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qualitative and quantitative. This was time consuming, but necessary to ensure that 
each phase of the PoW was carried out correctly. 
 
There is an inherent risk of bias during qualitative interviews or focus groups. This was 
particularly relevant in phases 1 and 4 where qualitative interviewing techniques were 
used. The researcher has worked as a hospital pharmacist and having experience in the 
field under investigation, leads to the researcher having preconceptions. This was also a 
consideration in phase 4, due to the researcher’s involvement in the development of the 
new model of care. Although this bias can not be removed, numerous strategies were 
employed throughout the PoW to reduce the risk of bias. These have been discussed 
throughout this thesis. One particular strategy to reduce bias was the inclusion of the 
supervisory team throughout planning and data analysis. The team included three 
pharmacists from varied backgrounds, one with a background in psychology. This variety 
helped to provide differing viewpoints throughout the process.  
 
The interviews were conducted in a way to minimise bias from the interviewer which 
could adversely affect the study. The researcher kept an open manner throughout each 
interview, setting aside any preconceptions as much as possible. Questions were asked 
in an impartial manner and properly explained to all participants to avoid being 
misleading. The researcher’s background as a hospital pharmacist was beneficial to 
assist with understanding of any terminology used by the expert participants during the 
interviews.  
 
Reflexivity of the researcher was a key component of carrying out the qualitative phases 
of the research. This is introduced earlier in this chapter (see section 3.10 Reflexivity). A 
reflexive paragraph within the findings chapters for phases 1 and 4 will overview the 
specific impact of the researcher on the findings and vice versa within the individual 
phases.  
 
A common problem with research is that participants may be reluctant to discuss certain 
issues because they are concerned about confidentiality, causing problems or distress 
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for themselves or others. Equally, participants may want to give socially desirable 
responses to be viewed favourably by others. These types of responses from 
participants could lead to misrepresentative data being collected. This could apply to 
the interviews or focus groups, but also when respondents are completing 
questionnaires. This was not a serious threat to this study, as the topic was not 
considered sensitive. Nevertheless, during all correspondence and at the beginning of 
each interview, focus group or prior to respondents completing the questionnaire, the 
researcher ensured that participants knew information was confidential. During all 
phases, participants were informed how their responses may impact future models of 
discharge care to encourage honest responses. 
 
Response bias can also be an issue if questions are not carefully constructed. Care was 
taken when developing the questionnaire to avoid leading questions and minimise bias. 
Care was also taken by the researcher during the interviews and focus groups to follow 
the wording of questions on the interview schedule or topic guide to ensure all questions 
were asked clearly and consistently.  
 
Not all participants answered every question, which could lead to some response bias 
for individual questions. It is not possible to know whether all possible patients were 
approached to participate. This is due to the fact that individual ward gatekeepers 
directed the researcher to the appropriate patients. This may have affected the study 
response rate and contributed some response bias. However, a representative sample 
of patients awaiting discharge was thought to have been achieved. 
 
Achieving true integration of the different types of data, both qualitative and 
quantitative, can be difficult. It requires innovative thinking to move between different 
types of data and make meaningful links between them.(151) The findings from phases 1 
and 2 were from different sources and used different methods and therefore made 
comparisons challenging during triangulation. Reflecting on the PoW findings, the 
results complement each other enough to have informed the development of the new 
model of care and integration of data has therefore been achieved.  
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Finally, the PoW has addressed the overall aim of the study, which was to provide the 
evidence to develop an innovative model of care for patient discharge from hospital. 
This PoW was not the only way that the aim could have been achieved. The most 
appropriate and feasible methods were chosen by the researcher to carry out the study 
at the time. Other options were available, for example, further information could have 
been sought about the current discharge process from other stakeholders in the early 
phases of the PoW. This however would not have been manageable within the time 
constraints of this PhD. The researcher chose the participants from phases 1 and 2 as 
they were thought to provide the most important and useful information.  
 
 
Chapter summary 
This chapter gave an overview of the PoW, before describing how the individual phases 
within the PoW were undertaken and the rationale for each. This included ethical issues 
and limitations of the study. The following four chapters will discuss the four individual 
phases of the PoW, along with their findings in detail. This begins with phase 1 findings, 
which is described in chapter 4. 
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Chapter 4 – Phase 1: Evaluating the current discharge 
process from the Pharmacists’ perspective  
 
An overview of the methods and rationale for the design of the PoW was provided in 
chapter 3 (see section 3.3.3 Phase 1 research method). This chapter describes and 
discusses the findings for phase 1 of the PoW. This is the first of the four phases in the 
PoW, involving telephone interviews with Chief Pharmacists to identify and evaluate the 
discharge process. 
 
4.1 Introduction 
As previously discussed in chapter 2 – Introduction, hospital discharge can lead to a 
variety of problems including: medication errors, hospital readmissions and bed-
blocking. This has a negative impact both on patients, who are at risk of harm and poor 
experience, and on the hospital itself in terms of patient flow.  
 
As mentioned in the outline for the PoW (in section 3.2 Overview of programme of work) 
it is important to identify where and how problems at discharge arise to develop 
solutions. Despite common problems associated with discharge from hospital being 
well-documented in the literature (see 2.7 Current problems at discharge), the solutions 
developed by hospitals to address these problems are not widely published. 
Furthermore, it is unclear if the discharge process is similar across all acute NHS hospitals. 
This first phase of the PoW attempted to broaden the scope of ‘grey literature’ available 
on this topic, by investigating how the discharge process is carried out at a range of acute 
NHS hospitals. This involved an evaluation of the current discharge process and any 
innovative ideas in place to improve the discharge process at each hospital. 
 
The findings from this phase are important to the overall PoW to inform the design of a 
new model of care for patient discharge, which incorporates successful aspects of the 
current process(es) and removes common problems at discharge. 
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4.2 Method  
As previously discussed in section 3.3.1 Phase 1 research rationale, this first phase of the 
research was an exploratory study, investigating discharge care from the perspective of 
NHS hospital pharmacy staff. This involved qualitative telephone interviews with chief 
pharmacists or a nominated senior pharmacy staff member from acute NHS hospitals 
across North West England. The resulting interview recordings were transcribed and 
analysed by constant comparisons. This next section of the chapter will discuss the 
findings in detail. 
 
4.3 Aim and Objectives 
As discussed in section 3.3.2 Phase 1 aim and objectives, the aim of this phase of the 
PoW was to identify and evaluate the discharge process(es) used in a range of acute NHS 
hospitals across the North West of England. 
 
The objectives were to: 
• Identify the current discharge process(es) in acute NHS hospitals across 
North West England 
• Determine which members of staff are involved in the current discharge 
process(es) 
• Explore which parts of the current discharge process(es) are considered 
effective and ineffective 
• Investigate any innovative ways of working employed by hospitals in order to 
improve the discharge process 
• Identify staff suggestions for the development of the current discharge 
process(es) 
• Determine the current role of community pharmacists in the hospital 
discharge process 
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4.4 Findings 
The findings are presented within this section, including details of the pilot, participant 
demographics and the themes which emerged from the data collected during data 
analysis.   
 
4.4.1 Outcome of the pilot  
A pilot study was carried out using two participants from the same hospital site. The 
pilot demonstrated that the interview questions were unambiguous and yielded suitable, 
relevant data to meet the study objectives.  Minor rephrasing of some questions on the 
interview schedule took place after the pilot, to improve clarity of questions. The pilot 
confirmed that the recruitment procedure and methods for obtaining consent from 
participants were appropriate. The pilot allowed the researcher to develop transcribing 
and data analysis skills, including the use of NVivo software, prior to data collection 
commencing. The pilot also confirmed that the telephone interviews were feasible in 
the setting and time period.  
 
The researcher’s interview technique had improved by the second interview and as both 
participants were from the same hospital, only one of the two pilot interviews could be 
used as part of the main analysis. Subsequently, the second of the two pilot interviews 
conducted was used as part of the main analysis. 
 
4.4.2 Demographics 
Data collection took place between 21st January 2015 and 25th April 2015.  All twenty-
two potential participants that met the inclusion/exclusion criteria (see section 3.3.3.3 
Inclusion and exclusion criteria) for the study were contacted and invited to participate. 
All of those that responded were interviewed. A total of 13 participants took part in the 
study, giving a response rate of 59%. A further two potential participants responded late, 
however data saturation had already been achieved at this point and no further 
interviews were arranged. The average duration of interviews was 30 minutes (range 15 
to 50 minutes).  
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A range of staff members participated, including: Chief Pharmacists, Clinical Services 
Managers and the Lead Pharmacy Technician responsible for running the ward-based 
discharge service.  Few of the participants played an active role in discharging patients, 
but all were involved in overseeing and organising the process and were aware of the 
problems occurring within their hospitals. The participants were from a range of types 
of acute NHS hospitals to assess the discharge process from a variety of types of acute 
hospital. This included teaching hospitals, three of which were city-centre teaching 
hospitals, district general hospitals and one integrated care organisation, formally 
known as a district general hospital. A full list of participants and their hospital 
demographics can be seen in Table 4-1. 
 
Table 4-1 – Phase 1 participant and study setting demographics 
Participant 
Number 
Job role Type of acute hospital Hospital beds 
Patient 
discharges 
per day 
1 
Clinical Services 
Manager 
City centre teaching hospital 600 + 100 + 
2 Chief Pharmacist City centre teaching hospital 600 + 100 + 
3 Chief Pharmacist District general hospital 600 + < 50 
4 Chief Pharmacist District general hospital – split sites 600 + 100 + 
5 
Clinical Services 
Manager 
District general hospital – split sites 600 + 100 + 
6 Chief Pharmacist District general hospital 300 – 600 < 50 
7 Chief Pharmacist Teaching hospital 600 + 50 – 100 
8 Chief Pharmacist District general hospital 300 – 600 < 50 
9 
Technical Ward-
Based Services 
Manager 
City centre teaching hospital 600 + 100 + 
10 Chief Pharmacist Integrated care organisation  300 – 600 50 – 100 
11 Chief Pharmacist District general hospital 300 – 600 unknown 
12 
Clinical Services 
Manager 
Teaching hospital 600 + 50 – 100 
13 Chief Pharmacist Teaching hospital 600 + 50 - 100 
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After 13 interviews, no new topics or perspectives were found to emerge. It was 
therefore assumed that the goal of identifying all issues and perspectives on the topic 
was reached and sufficient detail obtained for qualitative analysis, i.e. data saturation 
was achieved. The participants all offered valid opinions about their hospital discharge 
processes and it was assumed that the data collected was representative of the 
discharge process in each hospital at that point in time. 
 
All participants’ hospital pharmacy departments were open seven days per week, 
although the working hours each day differed between hospitals, particularly at 
weekends. Some were open later during the week and one hospital had a pharmacist 
on site 24 hours per day. At the time of interviews taking place, it was coming to the end 
of the winter period and most of the departments had extended their working hours to 
cope with the increased demand on acute hospitals during the winter months. However, 
these extended hours were temporary – supported by ‘winter pressures’ funding – and 
not reflective of usual working schedules. Standard seven-day clinical pharmacy services 
were not in place as has been suggested in the Carter report.(14,68) For most hospitals, 
the clinical pharmacy service provided at weekends was limited in comparison to that 
provided throughout the week.  
 
4.4.3 Themes 
Coding the interview transcript data led to a total of 38 nodes being created, which were 
then combined and organised into themes and subthemes during the analysis process. 
Coding began using some a priori codes initially, which were based on the study aim and 
objectives and the questions asked of the participants. However mainly a structured, 
detailed approach to coding the data was taken, looking at each line and questioning 
the meaning of each, focussing the researcher on the data itself. Transcriptions were 
reviewed, looking for repetition, similarities and differences in the data. The nodes were 
compared and combined to establish subthemes and then broader themes.  
 
Eight themes emerged during analysis. The steps taken to ensure robustness of the 
analysis have been described in section 3.3.5 Phase 1 data analysis. The themes were 
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based around aspects of discharge highlighted by participants. This included: planning 
for discharge, discharge documentation, supply of medication for discharge, post-
discharge community pharmacy involvement, communication within the discharge 
process, factors affecting the discharge process, patient involvement and innovative 
discharge processes. These themes are listed along with their subthemes in Table 4-2.  
 
 
Table 4-2 – Phase 1 list of themes and subthemes 
Theme Subthemes 
Planning for discharge  
 
Coordination of the discharge process  
Discharge planning  
Decision to discharge  
Out of hours discharge  
 
Discharge documentation 
 
Content of the discharge documentation  
Writing the discharge documentation  
Verification of the discharge prescription  
 
Supply of medication for discharge 
 
Medication supplied at discharge  
Dispensing of medication for discharge  
Delivery of medication to the patient for 
discharge  
 
Post-discharge community pharmacy 
involvement 
 
Hospital referral of patients to community 
pharmacy  
 Medicines support after discharge  
 
Communication within the discharge process 
 
Communication within the multi-disciplinary 
team  
Using technology for communication  
 
Factors affecting the discharge process 
 
Hospital pressures  
Discharge training for staff  
 
Patient involvement 
 
Patient counselling  
Patient involvement  
 
Innovative discharge processes 
 
Current innovative solutions Suggestions for 
changes to the discharge process  
 
 
As already discussed, (see section 2.6 Discharge from hospital) discharge from hospital 
is a complex multi-stage process, involving a number of different people. Subsequently, 
analysis of the discharge process did not result in a linear set of themes. Whilst each of 
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the themes identified impact on the discharge process, thorough analysis revealed that 
each individual theme is interlinked and influences others.  
 
Each theme is presented including an overview and a description of the subthemes. To 
help present the themes and subthemes, quotes taken directly from the data have been 
used. These quotes have been anonymised and for context have been described 
according to job role and type of hospital for each participant.  
 
4.4.3.1 Planning for discharge 
The theme planning for discharge encompasses the aspects of preparing and planning 
for patient discharge from hospital to ensure that discharge is organised, timely and 
appropriate. This theme comprises the following four subthemes: coordination of the 
discharge process, discharge planning, the decision to discharge and out-of-hours 
discharge.  
 
4.4.3.1.1 Coordination of the discharge process 
Poor co-ordination of the process on the day of discharge was noted by the majority of 
participants. There did not appear to be a set person taking responsibility for ensuring 
that it ran smoothly. 
“So no-one coordinates it most of the time, although there’s lots of 
attempts to coordinate it.” Clinical Services Manager, District general 
hospital 
Discharge coordinators were discussed by the participants; however the job role was 
not consistent between hospitals. The role of the discharge coordinator ranged from 
overseeing discharge for all patients on a ward, to being involved in discharge planning 
for complex patient cases only. Junior doctors were not thought to play a role in the 
coordination of the discharge process. 
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“[Discharge coordinators] tend to be more involved in the complex 
discharges, but I think in general it’s the nursing staff who coordinate the 
discharges.”  Chief Pharmacist, City centre teaching hospital 
Even within the same hospital, quality of coordination can differ significantly as different 
members of staff take on that responsibility.  
“It is usually, it varies enormously on different wards to be quite honest. 
On some wards they have got a discharge coordinator. On some wards 
it’s the lead nurse, on some wards it’s pharmacy-based.”  Clinical Services 
Manager, Teaching hospital  
The findings of this study showed that nursing staff were most commonly cited as being 
responsible for coordinating the discharge process on the day of discharge.  
“[The nurses] manage the patient’s discharge, they will call on the 
doctors to generate a TTO if they’ve not done it, they’ll call upon us to do 
our bit if we haven’t done it.” Chief Pharmacist, City centre teaching 
hospital 
Several participants mentioned their hospitals trialling pharmacist-led discharge and 
had a small evidence base to say that the service was effective, based on pilot data. This 
involves pharmacists taking control of the discharge process once the decision to 
discharge the patient has been made. 
“We started in the medical wards a pharmacist-led discharge. So 
changing the process so the pharmacist actually writes the discharge 
instead of the medics. So we are informed that the patient is fit for 
discharge, the pharmacist takes over and we process.” Clinical Services 
Manager, Teaching hospital 
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4.4.3.1.2 Discharge planning 
Discharge planning was highlighted by the participants as taking place early in the 
inpatient stay. 
“The same as many other trusts out there, the discharge planning starts 
quite early in patient stay” Chief Pharmacist, City centre teaching hospital 
In practice, a predicted (or estimated) date of discharge can be given for each individual 
patient, based on their needs. This helps to plan for discharge. Predicting the date of 
discharge can pre-empt some of the tasks involved at discharge and reduce the lag time 
of patients waiting after they are told that they are due to be discharged. Despite 
planning for discharge occurring, participants admitted that predicting the date of 
hospital discharge did not always occur for their patients.  
“But getting [the medical staff] to predict the date of discharge 
accurately and then for the ward staff, whether it be doctors, nurses or 
us, to then meaningfully use that intelligence to plan for the discharge is 
very difficult.” Clinical Services Manager, District general hospital 
The findings from this phase suggest that participants would like to work towards using 
the estimated discharge date for all patients. 
“I think we need to work towards estimated date of discharge and better, 
I think that’s a problem for the organisation.” Chief Pharmacist, District 
General hospital 
 
4.4.3.1.3 Decision to discharge 
The decision to discharge a patient was usually made during the consultant ward round.  
“The decision to discharge is normally a consultant-led decision as are 
many decisions in terms of the next step in people’s care during the 
hospital [stay]. So I suppose that decision to discharge traditionally would 
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happen on a ward round or some other meeting between the consultant 
and the patient or appropriate review.” Clinical Services Manager, City 
centre teaching hospital 
In addition to consultant ward rounds, several of the hospitals ran morning ward-based 
meetings with medical staff to highlight patients that could be discharged that day. This 
was to make the MDT aware early on about any potential discharges to help prepare 
patients for discharge earlier in the day. 
“There is a daily what we call whiteboard round, where the consultants 
are supposed to just come to the ward at about 9 o’clock and identify if 
any patients can go that day depending on results and things. And 
that’s … in between formal ward rounds.” Chief Pharmacist, District 
General hospital 
 
4.4.3.1.4 Out of hours discharge 
This sub-theme focused on the discharge process out of pharmacy working hours. As 
previously mentioned (see section 4.4.2 Demographics), the pharmacy departments 
were open 9-5pm Monday to Friday, with some working extended hours throughout the 
week and at weekends, usually with skeleton staff. The larger hospitals were open later 
on weeknights and longer hours at the weekends. All hospitals had an on-call pharmacist 
(usually off-site) to deal with any emergencies out of hours. One of the large inner city 
teaching hospitals had a pharmacist on site 24 hours per day.  
 
In theory, good planning for discharge should ensure that most patients are discharged 
within pharmacy working hours. However, the findings from this phase revealed 
circumstances whereby patients needed to be discharged out of pharmacy working 
hours. Participants agreed that their off-site pharmacist on-call would not come in to 
dispense a discharge prescription for a patient out of hours, as it is not seen as an 
emergency. The only exceptions to this mentioned by participants were patients at the 
end-of-life stage who required controlled drugs dispensing to get them home and keep 
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them comfortable, or in an emergency situation where patients needed to be discharged 
to free up more hospital beds. 
“Every discharge will be taken into account on its own merit so if it's a 
standard one we would normally say wait until the next day, but of course 
there are exceptions. For example if it was a palliative discharge or if 
there was a significant bed crisis in the hospital, we may need to sort of 
review that on a case-by-case basis and make a decision. But strictly 
speaking our on-call service is for urgent advice and supply and not for 
discharges.” Clinical Services Manager, City centre teaching hospital 
If a discharge prescription was written and a pharmacist was not available to complete 
it, hospitals have made individual arrangements for obtaining any required medication 
through other routes. Examples of this include: pre-labelled stock on wards for nursing 
staff to give routine medication to patients as appropriate or an FP10 prescription – 
which can be dispensed by any community pharmacy – could be written to allow the 
patient to collect their medication from a community pharmacy.   
“There are policies to allow for patients to be discharged out of hours. If 
a patient has all the medication they need, two professionals can check 
the discharge. So a nurse and doctor could check the patient has 
everything they need, which would allow the patient to go home out of 
hours. We have the ability to write FP10 for any outstanding medication 
so they can actually collect that from a community pharmacy out of 
hours.” Clinical Services Manager, City centre teaching hospital 
Patients discharged from hospital out of hours, when a full pharmacy service is not 
available, would not receive the same thorough prescription check as when a pharmacist 
was available. Through analysis of the discussions with participants, it was inferred that 
for a quality, safe discharge for a patient, input from the pharmacy team is required.  
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Enabling the timely discharge or transfer of patient care improves both quality of care 
and the efficiency of services. It requires resources to be balanced and aligned so that 
they are available to meet patients’ needs at the earliest possible point, seven days a 
week.(154) Few hospitals were running a full pharmacy service seven days a week. 
Participants voiced the difficulties in providing a seven day service and cited funding as 
the main issue with this.  
 
4.4.3.2 Discharge documentation 
Discharge documentation is the handover document sent to the patient’s GP, which 
encompasses all of the information regarding the inpatient episode and medication. This 
theme covers the preparation of the discharge documentation, which comprises the 
discharge prescription (TTO) and the discharge summary containing details on the 
inpatient episode. The three subthemes under this umbrella theme include: the content 
of the discharge documentation, writing, and verifying the discharge prescription.  
 
The findings suggest that the process of creating the discharge prescription is similar at 
each hospital, with some hospitals providing an innovative approach to the preparation 
of the discharge prescription. These innovative approaches are discussed in more detail 
within the theme ‘innovative discharge processes’.  
 
4.4.3.2.1 Content of the discharge documentation 
The hospitals used a broad range of electronic systems for discharge. The software for 
discharge included: Sunquest ICE®, JAC®, Quadramed®, Advantis®, Ascribe®, Medisec® 
and Lorenzo®. Ascribe® was the most frequently used system out of the small number 
of participants interviewed.  
 
From the findings, the discharge prescription may be separate from the discharge 
summary of events during the inpatient episode depending on the electronic discharge 
systems used. However, the discharge summary and discharge prescription were 
combined prior to sending the information out to the GP. 
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“The discharge system is different to our electronic prescribing inpatient 
system. But you can pull the discharge medication from one system onto 
the other so there is an interface.” Chief Pharmacist, District general 
hospital 
All of the participants confirmed that their hospitals had progressed from the traditional, 
paper-based, handwritten discharge documentation and were using the preferred 
electronic discharge systems to write their discharge documentation.  
“It’s a lot better. The paper system was hopeless for us and for the GPs.” 
Chief Pharmacist, Teaching hospital 
Several of the participants felt that electronic discharge systems had been forced onto 
their hospitals in order to meet the targets for sending discharge summaries to GPs 
within the 24 hour target.  
“E-discharge has been sort of forced on us by the CQUIN requirement that 
the GPs need a discharge summary within 24 hours of the patient going 
home and the only way you can do that is electronically.” Chief 
Pharmacist, Integrated care organisation 
Despite problems occurring with individual prescribers, participants agreed that 
switching from the traditional paper-based system to the electronic discharge system 
had improved the information sent to the patients’ GPs. 
“I think it's improved the quality of the discharge summary greatly when 
it is done correctly. Obviously it's garbage in garbage out and you will find 
some of the individual doctors not doing a very good job on the discharge 
summary, but tends to be the minority and when it is done properly we 
had a lot of positive feedback from the GPs saying this is great” Chief 
Pharmacist, Integrated care organisation 
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The study found that the participants’ hospitals were compliant with current national 
standards by including all relevant discharge information in the discharge summary 
templates.(59,60) 
“It contains the narrative of the presenting complaint, investigations, 
diagnosis there is a section for medicines started, stopped and changed, 
as well as the medicines that the patient has to go home on.” Chief 
Pharmacist, City centre teaching hospital 
 
4.4.3.2.2 Writing the discharge documentation 
The findings suggested that discharge prescriptions were commonly written by a junior 
doctor from the team looking after the patient.   
“The discharge prescription needs to be written and that traditionally will 
be done by the most junior member of the medical team. So either an F1 
or an F2 depending on the structure of the team.” Clinical Services 
Manager, City centre teaching hospital 
All participants highlighted that the time spent waiting for the doctor to write the 
discharge prescription was inefficient. 
“It sort of jumps out that bit waiting for the medics to prescribe is totally 
ineffective.” Chief Pharmacist, City centre teaching hospital 
The junior doctor’s role includes completing a list of jobs generated during the 
consultant ward round. This included writing the discharge prescription for any patients 
going home, however discharge prescriptions were not always seen as a priority and 
were often written after their more urgent jobs are completed.  
“I think to be fair to the junior medical staff there is tremendous pressure 
to do other tasks first. That’s a problem as well … The problem is, or one 
of the problems is, that the doctors will do the ward round but the 
90 
 
discharges are not completed until after the ward round and then after 
the main tasks from the ward round are done.” Chief Pharmacist, District 
General hospital 
Having junior medical staff writing the discharge summary can be time consuming and 
inefficient and requires action in order to reduce the wait time for patients. Some 
hospitals have started to utilise their non-medical prescribing pharmacists to write 
discharge prescriptions as a way of reducing the wait time for patients. This will be 
discussed in more detail in theme eight (see section 4.4.3.8 Innovative discharge 
processes). 
 
Despite discharge summary templates including prompts for all mandatory information 
on discharge summaries, issues regarding incomplete writing of discharge summaries 
were highlighted by several of the participants during the interviews. Electronic 
discharge systems had mandatory boxes for completion, which theoretically should 
ensure the information is inputted into the discharge summary. However, one 
participant noted that doctors completing the electronic discharge summaries had 
managed to find ways of overriding the system so they did not have to complete all 
sections of the discharge summary.  
“Our doctors have worked out that if they just put a full-stop in there it 
will just let them go on.” Chief Pharmacist, Teaching hospital 
 
4.4.3.2.3 Verification of the discharge prescription 
The verification of the discharge prescription to ensure that the medication prescribed 
at discharge is accurate, safe and complete, was seen by all participants as an important 
stage in the discharge process. The pharmacist clinical check was thought to lead to a 
significant reduction in medication errors after any issues have been rectified.  
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“Unfortunately we know roughly one in two discharges we have that 
additional step of needing to go back to the prescriber for some form of 
amendment.” Clinical Services Manager, City centre teaching hospital 
Participants stated that a pharmacist’s verification of discharge prescriptions was 
standard for their hospitals. A potential patient safety issue was highlighted for 
discharge prescriptions that are sent out to GPs without verification. 
“I think I can name one trust where they only authorise a quarter of the 
discharge letters that leave the building. Now we know like 90% of things 
we need to change them in some way, some are minor, some are major. 
So if you’re only doing a quarter, then three quarters are going out with 
duff information on and that’s going to have impact on people’s lives.” 
Clinical Services Manager, District general hospital 
 
4.4.3.3 Supply of medication for discharge 
This theme relates directly to the supply of medication for discharge. The three 
subthemes within this theme included: medication supplied at discharge, dispensing of 
medication for discharge and delivery of medication to the patient for discharge. The 
findings identified that the supply of medication on discharge from hospital was carried 
out by the hospital pharmacy team.  
 
4.4.3.3.1 Medication supplied at discharge 
The supply of medication on discharge from hospital was highlighted as an area of waste 
in the process. Supplying all medication often leads to patients receiving medication on 
discharge from hospital that they could obtain from their GP.  
“Sadly we do [dispense all medication on discharge], and that means that 
we often dispense a lot of items for surgical patients that are nothing to 
do with the reason that they came into the hospital.” Chief Pharmacist, 
Teaching hospital 
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On discharge from hospital, enough medication was supplied to ensure that patients 
have time to obtain further supplies from their GP. Participants from different hospitals 
stated that they would supply a minimum of seven, ten or fourteen days’ supply of 
patient’s medication on discharge, depending on their agreements with local CCGs. This 
included both newly started medication and long-term medication that patients were 
taking prior to admission. Due to calendar pack sizes of most medication, patients often 
received one month’s supply at discharge. 
“We do a minimum of 7 days, but we would supply an original, like a 28 
day supply. But we make sure that the patients go home with a minimum 
of 7 days.” Technical Ward-Based Services Manager, City centre teaching 
hospital 
4.4.3.3.2 Dispensing of Medication 
Dispensing the required medication for discharge traditionally takes place in the 
pharmacy dispensary. The findings support that this was still normal practice. The 
majority of hospitals also had facilities on the wards for the ward-based pharmacy team 
to dispense and label medication for discharge on the ward.  
“We have ward-based access to the pharmacy dispensing system and 
labellers on the ward. So the pharmacist and technician can, if the drugs 
are available… they can do it on the ward.” Chief Pharmacist, District 
general hospital 
Participants had data to demonstrate that ward-based dispensing had reduced the wait 
time for the patient in comparison to dispensing the discharge prescription in the 
pharmacy dispensary.  
“We have KPIs for ward-based turnaround times and dispensary 
turnaround times, and it’s pretty clear that if the discharges are done on 
the wards they are done a lot quicker.” Chief Pharmacist, District general 
hospital 
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Participants were in agreement that one of the most time consuming processes in the 
dispensing of discharge prescriptions was the preparation of monitored dosage system 
(MDS) compliance aids. Whilst useful for some patients to manage their medication if 
prescribed multiple medicines, they require more resources to dispense in the pharmacy.  
“Least effective are when we get venalinks down in pharmacy … It’s just 
time, it’s just it takes two people to do it. One person to do it, one person 
to check and then you have to get the pharmacist to check the final thing. 
We have to do two weeks’ worth of venalinks because we give 14 days 
on discharge and that includes venalinks. So it’s just the usual time 
consuming process that it is.” Chief Pharmacist, District general hospital 
Participants highlighted that pharmacy was the perceived cause of delay for patients 
when they are going home. One participant had witnessed a doctor insinuating to a 
patient that pharmacy would take a long time to get their discharge medication.  
“[A doctor] said [to patient] you can go home, the only thing we're 
waiting for is your pain relief from pharmacy and they take ages to do 
that, do you want to be bothered waiting?… So I think we still have got 
the same perception, as we are an easy target unfortunately. ‘Oh it’s 
down in pharmacy they’ve had it for ages’.” Chief Pharmacist, Integrated 
Care Organisation 
 
4.4.3.3.3 Delivery of medication to patient for discharge 
One of the highlighted problems contributing to the patients’ wait at discharge was the 
wait for the arrival of discharge medication on the ward after being dispensed in the 
pharmacy dispensary. Participants overcame this issue by employing a designated 
pharmacy porter, which significantly reduced this wait time.   
“One of the things that we identified as a real problem was that the 
prescriptions could be done but our portering was ineffective. So we’ve 
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now got a band 2 pharmacy runner, who will take the discharges to the 
wards. So that’s resolved that problem.” Chief Pharmacist, District 
General hospital 
 
4.4.3.4 Post-discharge community pharmacy involvement 
After discharge, the patient crosses the interface between hospital and community. 
Maintaining continuity of care throughout this transfer relies on good communication 
of information. All hospitals complied with current guidelines by routinely transferring 
discharge information to the patient’s GP. However, communication with other 
community healthcare providers was not mandatory.  This theme covers the two 
subthemes: hospital referral of patients to community pharmacy, and medicines 
support after discharge. 
 
4.4.3.4.1 Hospital referral of patients to community pharmacy 
One participant found that not all patients use one regular community pharmacy. 
Instead it tended to be older patients who required delivery of their medication who 
were more likely to visit just one regular pharmacy. 
“In our meds rec document, one of the questions we’re going to ask is do 
you have a regular community pharmacist. So that we can begin to know 
who the community pharmacist is. But actually, when we started 
speaking to patients we find a lot of them don't have one set community 
pharmacy they always go to. The older patients tend to, but a lot of them 
are getting their medicines delivered.”  Chief Pharmacist, Teaching 
hospital 
From the findings, it is uncommon for any discharge information to be sent to the 
community pharmacy by the hospital after discharge. This usually only occurs if a patient 
has their medication in an MDS compliance aid from a regular community pharmacy. 
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“The common ones that pharmacy get involved in would be when a 
patient has a compliance aid so we need to convey information and 
arrange ongoing supply and that the turnaround is often reduced, we will 
fax community pharmacies with the discharge information to make sure 
that they can liaise with primary care colleagues and arrange for further 
supplies for compliance aids.” Clinical Services Manager, City centre 
teaching hospital 
One area’s local CCGs were investigating the possibility of implementing a CQUIN 
(Commissioning for Quality and Innovation) target around sending information to the 
community pharmacy, as current performance was poor and this would provide staff 
with an incentive to send this information.  
“I know there’s quite a few schemes going on around the region to try 
and have that information sent to the local, their pharmacy to make sure 
that that information is carried through. So we’re certainly interested in 
looking in that and I think our local commissioners are thinking about a 
CQUIN around the communication to community pharmacies.” Chief 
Pharmacist, District general hospital 
The most commonly used method of transfer of discharge information was by fax, 
however participants had varying views on the confidentiality of faxes and as a result, 
some hospitals have stopped using this method. 
 “We used to fax copies of the prescription if we felt community 
pharmacists needed to see the copies. But I think sending faxes is quite 
hazardous from a confidentiality point of view. So we didn’t feel 
comfortable with that.” Chief Pharmacist, District general hospital 
An application had been developed to attempt to improve this referral process called 
‘Refer to Pharmacy’, see subtheme below, medicines support after discharge, for further 
details. 
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4.4.3.4.2 Medicines support after discharge 
A major role for community pharmacists after patient discharge from hospital is to carry 
out MURs or the NMS with patients when they are back home from hospital, to ensure 
that there are no problems or confusion with any of the new medication. It is 
recommended that hospital pharmacists refer patients to their community pharmacy 
for this purpose.(7) It is clear from the findings that very few of the hospitals were 
referring patients regularly for this additional support.  
“We’re not very good at that. I think the infrastructure locally isn't great 
for doing it. We do some certainly. I wouldn't like to give you a proportion 
it will probably be quite low.” Chief Pharmacist, Integrated Care 
Organisation 
Some hospitals had their own community interface teams that carry out similar services 
to the MUR and NMS services offered by community pharmacies. Subsequently there 
may not be the same need to refer to a community pharmacy. 
“We’ve got our own community service team linked in with the hospital. 
They tend to pick up, in community any issues that they might want to 
follow up with the patient.” Technical Ward-Based Services Manager, 
City centre teaching hospital 
One hospital that had undertaken research around community pharmacy involvement 
after discharge stated that even if the patient had been made aware of the services 
offered by community pharmacists, unless prompted, they would be unlikely to utilise 
them.  
“The evidence is that very few people actually follow through in that and 
I think it’s because they just don’t get it. And, when we’re talking to them 
about it, they go home, relax, they’re home from hospital and then they 
forget about it.” Clinical Services Manager, District general hospital 
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This led to the development of an application that allows easy identification of the 
patient’s local community pharmacy and sends a referral, including the patient’s 
discharge information, to that pharmacy. The onus will then be on the pharmacy to 
contact the patient to carry out the services and hopefully increase the uptake.  
“Refer to pharmacy application, it’s got a link with the PAS system so all 
the patient demographics are instantly sucked in just by putting the 
patient’s hospital number into the search engine… We can either if you 
know the name of the pharmacy just type it in or type the telephone 
number or the postcode, some kind of recognisable thing from the label 
or what they’ve told you and that rapidly finds the… pharmacy. But if 
they’re kind of descriptively telling you where it is, there’s an interactive 
map, google maps, which has flags to show you where the patient lives 
and where the community pharmacies are. And you can use that to help 
them navigate.” Clinical Services Manager, District general hospital 
4.4.3.5 Communication within the discharge process  
A recurrent finding was that all stages of the discharge process are heavily reliant on 
communication. Two main subthemes emerged: communication within the multi-
disciplinary team, and using technology for communication. 
  
4.4.3.5.1 Communication within the multi-disciplinary team 
Communication within the MDT was important in delivering good patient care. Each 
step in the discharge process relied on communication between different members of 
the MDT. Any miscommunication in the process could lead to errors or delays. 
“There is no direct mechanism of informing the pharmacist that it is ready 
so it needs to be some sort of physical communication… so the pharmacy 
team, either the technician or the pharmacist will either rely on the 
prescribing doctor or the ward team to alert them that the discharge for 
a specific patient needs to be processed.” Clinical Services Manager, City 
centre teaching hospital 
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One participant thought that at their hospital, the pharmacist needed to play a more 
integrated role in the team, in order to improve communication, add to the skill mix of 
professionals and improve patient care.  
“So the way I see the pharmacy profession at the moment we work in 
isolation a bit too much, and I suppose some of the senior members of 
the team, although they have fantastic relationships and links with 
consultants, they may not be embedded into the medical teams….there 
is a role for non-medical prescribers to be part of the team so you'd have 
that continuity and responsibility for the patient… you may be able to get 
the best bit of the pharmacists in terms of their attention to detail and 
accuracy and really understand the discharge process from the pharmacy 
perspective.” Clinical Services Manager, City centre teaching hospital 
Communication between members of the MDT is not only important in direct patient 
care, but also in the planning and development of care systems used. One example 
highlighted problems a pharmacy team were experiencing with their electronic 
discharge system. This system had been implemented without seeking pharmacy input 
and had led to unforeseen difficulties for the pharmacy team when using the system.  
“It was implemented by a consultant and pharmacy weren’t really 
involved in it. And this is the problem with it really the medicines and all 
the patient information that needs to be relayed back to the GP.” 
Technical Ward-Based Services Manager, City centre teaching hospital 
4.4.3.5.2 Using technology for communication on discharge 
Overall, despite some inherent difficulties, many positives were highlighted by the 
participants regarding the use of technology in the discharge process. There was 
variation between the hospitals in the extent of technology used for communication. 
One participant highlighted that because of the technology available, communication 
between hospital and community should be good quality in order to ensure transfer of 
care for every patient is safe.  
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“I think there’s a greater need for clarity of information. I think primary 
care are now very specific of what the expectation is in terms of the whole 
discharge letter or clinical summary and we need to make sure that we 
aspire to give that on every patient basis. With all the communication 
tools that we've got, not to have the accurate communication I think we 
recognise that is detrimental.” Clinical Services Manager, City centre 
teaching hospital 
A large proportion of hospitals used both electronic prescribing systems, for inpatient 
prescribing and electronic discharge systems for writing and sending discharge 
prescriptions to the GP. As already discussed, a range of different electronic discharge 
systems were used in hospitals. The same issue applied for electronic prescribing 
systems. In several hospitals, one programme was used for both inpatient prescribing 
and electronic discharge, which was thought to make writing the discharge prescription 
a straight forward process.  
“We have electronic prescribing across the whole hospital and so 
basically when somebody is ready to go home, to prepare the discharge 
the doctor can then just choose which of the prescriptions that are 
currently active, and then it goes into the electronic document. And then 
there's a flowsheet to fill in, of different sections about the patient about 
why they have been in and all those things.” Chief Pharmacist, Teaching 
hospital 
Three of the hospitals used separate electronic systems for inpatient prescribing and 
discharge. For the hospitals that had different electronic prescribing and electronic 
discharge systems, an electronic link between the two had been developed, so that no 
transcription was required. 
“The discharge system is different to our electronic prescribing inpatient 
system. But you can pull the discharge medication from one system onto 
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the other so there is an interface.” Chief Pharmacist, District general 
hospital 
Conversely, several hospitals did not use an electronic prescribing system, but did have 
an electronic discharge system. A highlighted issue with this method of writing discharge 
prescriptions is that the prescriber had to manually transcribe the medication from a 
paper medication chart, onto the electronic prescribing system, increasing the risk of 
transcription error.  
“I think what doesn’t help for us is that we haven’t got electronic 
prescribing. So the junior doctors or whoever when they write the take 
home prescription they have to manually go in and type them all in as 
opposed to just choosing what’s on the screen and what they’ve had as 
an inpatient. So I think that’s laborious and that’s where errors happen.” 
Chief Pharmacist, District general hospital 
There were a variety of mechanisms for sending the completed discharge summary to 
the GP, including: direct electronic transfer, by email (via NHS.net email address) or by 
post. Not all GP practices were able to use the electronic discharge systems and the 
mechanism of choice was dependent on the capabilities of the GP practice.  
“There’s some GPs that are not on that system and if they’re in our health 
economy what we do is print a copy off for the GP and that goes on the 
path lab mail run the following morning. And for those GPs outside of the 
area, we post them to them…If they’ve got the necessary software or 
they’ve agreed to whatever they need to agree with they’ll be on it. Most 
GPs are but for some reason some of them aren’t.” Clinical Services 
Manager, District general hospital 
The consensus from participants was that an electronic system for transfer of patient 
information, accessible to all relevant healthcare professionals would be a solution to 
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ensuring seamless communication between hospital and community. This system does 
not currently exist in practice. 
“Having a technical solution that aids the two-way communication 
between primary and secondary, you know truly interfacing, not 
automatically having it populate, but truly having the capability to review 
and accept changes made by hospital into the primary care record and 
vice versa... Removes transcription errors and enhances seamless 
communication” Clinical Services Manager, City centre teaching hospital 
The closest system to this ‘ideal’ electronic system that was mentioned was an 
‘Integrated Care Record’, which is discussed within theme eight (4.4.3.8 Innovative 
discharge processes). The electronic systems available have helped to improve the 
discharge process. 
“But the pharmacy bit is getting more and more efficient because the 
technology is being used to help us instead of prevent us working.” Chief 
Pharmacist, Teaching hospital 
 
4.4.3.6 Factors affecting the discharge process 
This theme provides an insight into the factors affecting the discharge process. Two main 
factors were identified and are discussed under the following subthemes: hospital 
pressures and discharge training for staff 
 
4.4.3.6.1 Hospital Pressures 
Throughout discussions with each of the participants, the topic of hospital pressures 
impacting on the discharge process came up repeatedly. This was often cited as a reason 
for failings within the discharge process. 
 
Hospitals and hospital staff are under pressure from a variety of sources. For example, 
some of the sources of pressure are from the hospital to meet targets and from patients 
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to meet their expectations of service and ensure quality patient care in a short space of 
time.  
“In the organisation for the last 6-9 months we’ve had tremendous 
pressures from Monitor… regarding our performance in our ED targets 
(95% target) and we’ve had people who’ve come in to review our 
processes and things.” Chief Pharmacist, District General hospital 
All of the pressures appear heightened if the hospital is understaffed. Participants 
highlighted that there was a deficit of staff, particularly junior doctors.  
“Because of the reconfiguration of some of the doctor training, we are 
going to be looking at a deficit of junior doctors.” Clinical Services 
Manager, City centre teaching hospital 
Due to pressures on healthcare staff, tasks often need to be prioritised in order to cope 
with the workload. As a result, patient discharge is not always a high priority. 
“I also think there is something about the culture… if you’ve got nurses 
who are very busy, and new patients create more work, pushing patients 
quickly through the discharge process means that they’ve got to see 
patients more quickly. And therefore it’s when they’re already busy, and 
I do think sometimes the process could be faster from that perspective.” 
Chief Pharmacist, District General hospital 
 
4.4.3.6.2 Discharge training for staff 
Another factor highlighted as having an impact on the discharge process was staff 
training.  This included educating prescribers to prescribe earlier and complete 
discharge summaries appropriately.  
“So we have been looking at having training sessions with junior doctors.” 
Chief Pharmacist, Teaching hospital 
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The importance of training staff to use newly implemented systems effectively was 
identified as a finding. One example of where this would have improved practice was 
given by a participant whose hospital had piloted a pharmacist-led discharge service. 
Despite the pilot ensuring medication was supplied faster, time until the patient was 
discharged was not reduced. This was due to other healthcare professionals being 
unprepared for their role in the new service. 
 “What we did see in the sort of post intervention data is that time from 
when the medicines are all on the ward to the patient actually leaving 
got longer. And we think that’s just due to the nurses not being used to 
having the drugs ready so early. So we’ve caught them by surprise and 
they’re not getting the patients ready quick enough. So I think there’s 
some inefficiencies there that we will have to work through as well.” Chief 
Pharmacist, City centre teaching hospital 
 
4.4.3.7 Patient Involvement 
The theme of patient involvement included the two subthemes: patient counselling, and 
involving the patient at discharge. The findings suggest that patient involvement in their 
own discharge from hospital was limited. This was noted throughout all interviews.  
 
4.4.3.7.1 Patient Counselling 
Policies at most hospitals recommended that counselling should take place at the point 
of discharge when the nurse is giving the patient their medication. 
“The process is that the nurse will sit down with the patient and go 
through all of the medicines almost as their last job prior to the patient 
being discharged. The idea is they go through each and every medicine 
with them and offer them counselling around the medicines at that time.” 
Chief Pharmacist, City centre teaching hospital 
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Participants agreed that ideally, patient counselling should take place throughout the 
patient’s admission, whenever any new medication is prescribed.  
“What we try to encourage is counselling throughout the process rather 
than at discharge. So we are trying to encourage the pharmacists [for any] 
new items being prescribed, have a conversation with the patient at that 
point rather than leave it all to the end of the process.” Clinical Services 
Manager, Teaching hospital 
Participants agreed that patients are not always counselled before discharge. One 
participant in particular mentioned several serious incidents that had occurred in their 
hospital as a result of this.  
 “We've not been great at getting involved in counselling on discharge. 
Although that might change because there have been quite a few 
incidents where it hasn't been done properly or it hasn't been done at all 
and patients have ended up with drugs missing. Or in one or two cases 
patients getting somebody else's medications, so quite serious incidents.” 
Chief Pharmacist, Integrated care organisation 
In addition to participants admitting that counselling was not routinely taking place, a 
lack of ownership of patient counselling was highlighted. No specific healthcare 
professional appeared to be responsible for ensuring that counselling was taking place 
before discharge. 
“Who counsels? That's a very good question there. The answer is 
probably we don't, nobody does it well enough I would say. It is an area I 
think which is in relative terms poorly managed. So I think doctors think 
nurses do it, nurses think pharmacists do it and pharmacists think 
everybody else does it apart from them. I think that pharmacists do it to 
a certain extent, but they don't do it universally and comprehensively. I 
think we've got a big gap and that comes up regularly in inpatient surveys 
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and things where patients say that they don't get enough information 
about their medicine. I would say it is an area for development still.” Chief 
Pharmacist, District general hospital 
In some cases, pharmacy had no contact with the patient prior to discharge, these 
patients were given labelled pre-packed medication stocked on the wards for routine 
surgery. The nurses were responsible for counselling the patient at discharge.  
“Surgery is an interesting model because quite a lot of surgical discharges 
are done by pre-packs and nurse-led discharge…. the nurses would have 
to do the counselling.” Chief Pharmacist, District General hospital 
Several participants reflected that during discharge may not be the most appropriate 
time to discuss the patient’s medication with them as they receive a lot of information 
at discharge. 
“You know we're trying to give them all the pharmacy information and 
the number of changes that could be upwards of five or six pieces of 
information and that could be the same time as their next clinic 
appointment, person coming out to see them, everything else … I'm not 
sure that we are targeting the best time to actually get salient points of 
information across” Clinical Services Manager, City centre teaching 
hospital 
 
4.4.3.7.2 Involving the patient at discharge 
The findings suggest that when a patient was considered medically fit for discharge, 
doctors would tell the patient that they could go home, without a realistic timescale of 
how long the discharge process would take. This leads to the unrealistic expectation that 
patients can leave straight away and impacts on their experience.   
“I think the least effective thing is a consultant telling a patient at 9 
o’clock in the morning that they can go home without explaining to them 
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there is a process that has to be followed.” Chief Pharmacist, Teaching 
hospital 
Participants mentioned patient involvement during a review of their medication and 
discussions about any supplies they may have had at home. Other patient involvement 
was limited to the few instances when a visit to their community pharmacist was 
recommended to discuss their medication after discharge from hospital.  
 
4.4.3.8 Innovative discharge processes 
The discharge process has evolved dramatically over the years. One participant 
discussed how the introduction of a clinical pharmacy service within hospitals changed 
the system from a supply only service, to clinical involvement in patient care to ensure 
that treatment is optimal.  
“So clinical pharmacy now is well established within the hospital 
environment and we're not just talking about an accuracy based system 
where a drug is prescribed and we dispense based off that prescription. 
We're taking a much more holistic view of the patient and the clinical 
pharmacists are experts in their area or the rotational pharmacist is an 
aspiring expert in the area and they're aware of relevant guidelines and 
recommendations and what is gold standard or best care for any given 
patient”  Clinical Services Manager, City centre teaching hospital 
Patients have high expectations of the services provided to them by the NHS. One issue 
noted was that it is important to manage patient expectations to avoid disappointment 
and frustration. 
“So patient's ready to go home, fundamentally there you have got a 
customer service issue where a patient has been told they are fit and well 
to go and you are then in the business of managing their expectations 
when the discharge prescription may or may not have even been written” 
Clinical Services Manager, City centre teaching hospital 
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To address the issues of high pressures and meeting patient expectations, several 
hospitals had trialled some innovative solutions to the issues with the discharge process 
with the limited resources at their disposal. Several of the innovative ideas have been 
mentioned throughout other themes. 
 
4.4.3.8.1 Current innovative solutions 
In a bid to reduce the delay whilst waiting for doctors to write the discharge summary, 
several participants discussed pilot studies where their non-medical prescribing 
pharmacists wrote the discharge prescriptions instead of junior doctors on some of the 
hospital wards. This both reduced the time involved obtaining a written discharge 
prescription and also improved the accuracy of the written prescriptions. 
 “The whole process took … 8 hours 37 minutes from the point the patient 
was told they could go home ‘til them actually leaving the ward. And 
when we looked at a breakdown of that time, close to 3 hours was for 
doctors to generate the prescription … we got a prescribing pharmacist 
to generate all the TTOs on the medicines admissions unit and what we 
found straight away was … for the whole process, it went from just over 
8 and a half hours to just over 5 hours.” Chief Pharmacist, City centre 
teaching hospital 
“What we found is the error rates have gone down to just about 0. The 
baseline was when we did an intervention audit, 1 in 5 prescribed had 
errors.” Chief Pharmacist, District General hospital 
Conversely, one participant argued that pharmacists writing discharge prescriptions was 
not an appropriate use of non-medical prescribing pharmacists.  
“We have pharmacists who can prescribe but we don’t have them writing 
TTOs…We used to, but then when the law became a bit clearer we took a 
very strong view about what non-medical prescribing is and isn’t and we 
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don’t think it’s writing TTOs for a patient we’ve never seen before.” Chief 
Pharmacist, Teaching hospital 
A number of the hospitals had links with community interface teams, either their own 
hospital staff who work with patients out in the community, or links with a community-
based service who visit patients. Patients could be referred to the teams after discharge 
for follow-up if they required help with their medication, or were thought to be high risk 
for readmission.  
“Follow up once they have been discharged back home just to make sure 
they are settled ok with their new medicines… So it’s really if we suspect 
that there’s going to be some concordance issues, either through the lack 
of understanding of complex medicines or just through sheer numbers of 
medicines that they are getting discharged home on.” Chief Pharmacist, 
City centre teaching hospital 
There was anecdotal evidence that this service was beneficial for patients. 
“So we’ve got pharmacy involvement in that so we would refer for 
medicines usage reviews, review medication for pills and spills if they’re 
falling over or if they are a falls risk. So that’s fairly recently set up but 
working really well. And it also enables us to keep patients at home who 
might otherwise have been admitted to hospital.” Chief Pharmacist, 
District general hospital 
Several of the hospitals had a medicines hotline, which patients could ring after they had 
been discharged to ask any questions. One hospital was in the process of setting up 
email access to their medicines hotline to provide easier access for a wider patient 
audience.  
“We are looking at maybe doing beyond just a patient helpline. Because 
a lot of patients are working and unable to ring so we are thinking about 
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trying to have a patient portal so you could email in a question as well as 
ring.” Chief Pharmacist, Teaching hospital 
One technology solution was in use in one hospital, called an ‘Integrated Care Record’, 
which allowed healthcare professionals to input and obtain patient information from 
both sides of the interface, hospital and community.  
“See the GP’s record so we can see the patient's allergies, all the 
prescriptions they've had recently and any visits they've had... In the same 
way… the GPs in [the area] can see our hospital blood results and they 
can see all the outpatient letters and all the discharge letters there.” Chief 
Pharmacist, Teaching hospital 
 
4.4.3.8.2 Suggestions for changes to the discharge process 
When asked about any changes that they would like to make to their discharge process, 
participants were varied in what they thought would improve the system. Some of the 
suggestions included:  
• Having a van to deliver medication to patients after discharge instead of 
having the patient wait 
• Providing pre-recorded counselling tools to patients which are accessible 
electronically so that they could be watched at a time appropriate for the 
patient  
• Having an all-encompassing technology solution, which would allow 
read/write access to patient discharge information for all relevant healthcare 
professionals  
• Having pharmacist-led discharge as standard around the hospital 
• Discharge prescriptions to be written during consultant ward rounds 
• More investment in pharmacy to enable the pharmacy teams to manage all 
medication related tasks on the wards 
• Having community pharmacists dispense the discharge prescriptions and 
patient collect from them/ have it delivered 
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• Employing a ward-based pharmacy technician, based in the discharge 
lounge. So that they would manage the discharge prescriptions, ensure the 
correct people were contacted and counsel the patients prior to discharge 
 
4.5 Generalised discharge process mapping 
During the interviews, participants were asked to describe the discharge process at their 
hospital. This alongside prompts from the researcher elicited a discussion of a step-by-
step discharge process at each hospital. From gathering and analysing the data, it was 
found that the general discharge process was similar in all hospitals. Minor differences 
were found in the members of staff who undertook each step in the process, or in those 
hospitals who had implemented innovative discharge processes to improve discharge as 
discussed within the individual themes.  
 
This phase of the PoW aimed to identify the current discharge process and evaluate it. 
It was important to get to the root of the problems at discharge and one way of helping 
to do this was to map the process out. Not only does mapping out the process help to 
clarify a complicated multistage process, it also helps to identify areas where 
improvements can be made. The steps involved in the discharge process are mapped in 
the form of a flowchart (see Figure 4-1), based on the standard discharge processes for 
all hospitals that participated in the study. This is a generic process that could be applied 
to each hospital that participated in the interviews, and therefore does not take into 
account any innovative schemes, any steps in the process from hospitals that did not 
take part, or any emergency situations. Subsequently, this model is applicable to the 
hospitals that participated in this phase, however individual hospitals across the UK may 
show minor variance from this generalised model.  
 
The stages where issues were identified within the discharge process have been 
highlighted on this generalised model, using the findings discussed throughout this 
chapter. The shaded areas on the flowchart represent the stages in the discharge 
process where problems were identified in the findings. 
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This map of the discharge process in combination with the findings around where issues 
arise in the process will provide the foundation for the development of the new model 
of care. 
 
  
112 
 
Figure 4-1 – Generalised discharge process in acute hospitals across North West England 
showing issues identified by pharmacists 
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A stepwise discussion of the generalised discharge process is detailed below. The 
labelled roman numerals refer to the individual steps of the discharge process, as seen 
in Figure 4-1. 
 
(i) After a medical review, when a patient is deemed medically fit, a 
consultant or other senior medic will make the decision to discharge the 
patient. The patient is told at this point that they can be discharged. 
(ii) After the decision to discharge has been made, a discharge prescription 
(TTO) and summary of the inpatient episode are written. This is 
traditionally carried out by a doctor involved in the patient’s care during 
the admission. This may also be carried out by a non-medical prescribing 
pharmacist.  
(iii) The ward based pharmacy team are made aware that the discharge 
prescription is written. If there is no ward based pharmacy team, this 
communication will be with the pharmacist in the pharmacy dispensary. 
(iv) The next stage is the verification of the discharge prescription by a 
pharmacist, to ensure that the medication prescribed at discharge is 
complete, safe and all required information is included. The pharmacist 
identifies if there are any issues with the discharge prescription and 
contacts the prescriber to rectify them if applicable. 
(v) A full list of the patient’s medication is documented on the discharge 
prescription, but only those required will be supplied. The patient’s 
medication on the ward is compared with the medication listed on the 
discharge prescription. The patient will usually then be asked what 
medication they have at home and the discharge prescription will be 
annotated to say which, if any of the medications need supplying on 
discharge. This role is usually by the ward pharmacy team, i.e. the 
technician, or pharmacist if a technician is not available. In some cases, 
nursing staff will be involved in asking the patients about their 
medication supplies at home, or they may send any medication to the 
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pharmacy dispensary for checking there. This would only be if the ward 
based pharmacy team was not available.   
(vi) Dispensing the required medication for discharge is traditionally done in 
the pharmacy dispensary, although if the facilities are available, it can be 
done on the ward. Regardless of where the prescription is dispensed, a 
member of the pharmacy team, usually pharmacy assistant or technician, 
will label and dispense the required medication on the discharge 
prescription.  
(vii) A suitably qualified member of the pharmacy team will then perform an 
accuracy check to ensure that the correct medication, quantities and 
directions for use have been supplied for the patient.  
(viii) For discharge prescriptions dispensed in the pharmacy dispensary, the 
completed discharge prescription is delivered to the ward by the 
pharmacy team, a porter or collected by nursing staff from the ward. For 
those dispensed on the wards, no delivery is required as the medication 
will be ready on the ward.  
(ix) Once the medication and completed discharge summary is ready on the 
ward, and any other arrangements have been put in place, the patient 
can then be prepared for discharge. The discharge medications are 
checked against the prescription and the patient is counselled, usually by 
the nurse. 
(x) The patient is then discharged with a copy of the discharge summary and 
medication. 
(xi) The completed summary including the prescription is sent to the 
patient’s GP and the community pharmacy if appropriate. Other 
healthcare professionals may also be sent a copy on an individual patient 
need basis, for example a district nurse or the care home. 
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4.6 Discussion 
Through analysis of the interview data, the current discharge process at each hospital 
was identified, and a generic discharge process mapped. This generic discharge process 
includes a stepwise description, for reference as can be seen in Figure 4-1. An evaluation 
of each stage of the current discharge process was achieved, which allowed conclusions 
to be drawn as to the effective and ineffective parts of the current discharge process. 
 
The findings determined that the discharge process was similar at each hospital and the 
issues highlighted by participants appeared to be common across the range of acute 
hospitals that participated.   
 
The separate themes are discussed, followed by a discussion of the findings overall, 
considering the themes collectively 
 
4.6.1 Planning for discharge 
Discharge is known to be a complex intervention, with multiple obstacles within and 
outside of the hospital setting.(155) It involves a range of different services and requires 
planning and coordination to ensure that quality patient care is not compromised. The 
consequences of not doing this can have a negative effect on patients, their family and 
carers, the hospital itself and people needing hospital treatment.(53) 
 
Currently, the discharge process is poorly coordinated in most of the participating 
hospitals. There are too many different members of staff involved with no-one 
overseeing the process. As mentioned in the findings, several hospitals are looking to 
integrate a pharmacist prescriber into the medical team. This could ensure the 
pharmacist is aware of any upcoming patient discharges and transfer the responsibility 
of coordinating patient discharge to the pharmacist.  
 
Making a single health or social care practitioner responsible for coordinating the 
person's discharge from hospital is clearly beneficial and fits in with current NICE 
guidance.(56) As pharmacy is heavily involved on the day of discharge, it would appear a 
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logical step to for them to oversee the process. The idea of pharmacist-led discharge 
was trialled in one hospital as discussed in the findings. An adaptation of this should be 
considered in the new model of care. 
 
From the findings, it would appear that discharge planning was occurring early in the 
inpatient stay, demonstrating that hospitals in this phase were working towards current 
national guidance.(51,55,156) However discharge planning was not used to its full 
advantage. Current literature suggests that focusing on a predicted date of discharge 
increases the likelihood of discharge by this date and may reduce the length of stay in 
hospital.(157) Using a predicted date of discharge in combination with one person 
coordinating discharge could improve preparation for patient discharge. 
 
Linking the findings that patients discharged out of hours are unlikely to be seen by a 
pharmacist and the risks associated with not having a pharmacist verify a discharge 
prescription, clearly not having a 24/7 clinical pharmacy service is a problem. When 
developing new models of care, out of hours discharge needs to be considered so 
patients can be discharged safely at any time of day. With the push towards seven day 
working within the NHS,(14,154) working patterns may change and this may no longer be 
an issue. Until those changes are made however, mechanisms of ensuring safety for 
patients discharged out of hours need to be put in place. Developing a new model of 
care that improves efficiency at discharge may limit the need for patients to be 
discharged out of working hours. 
 
4.6.2 Discharge documentation 
The handover of patients when discharged from hospital to community is a complicated 
and multifactorial process. According to a 2014 patient safety alert, poor 
communication during transfer of care is identified as a particular area of risk and 
accounted for approximately 33% of the 10,000 patient safety incidents reported to the 
National Reporting and Learning System between October 2012 and September 
2013.(158) This highlights just how important it is to send a complete and accurate 
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summary of events and medication over to the patient’s GP, to allow them to provide 
appropriate ongoing care.  
 
From October 2015, transfer of discharge information had to be by either secure email, 
or direct electronic transfer.(159) In addition to preparing hospitals for this change from 
the paper-based system, electronic discharge systems facilitate the transfer of 
information to the GP within the 24-hour target. The vast number of electronic discharge 
systems available was highlighted as an issue. One common platform would reduce the 
risk of confusion for all electronic system users. 
 
Problems associated with incomplete information regarding medication on discharge 
are well-documented.(51) The study findings support the current literature that these 
problems are still common. The pharmacist could be a safety net to add any relevant 
medication information and prevent incomplete discharge documentation getting sent 
to the GP.  
 
Preparation of the discharge prescription and discharge summary for an inpatient 
episode is traditionally carried out by a junior doctor involved in the patient’s care during 
the admission.(160) The findings suggest that this is occurring in most hospitals. Within 
the findings, there was a general consensus that waiting for junior doctors to write 
discharge prescriptions is an inefficient use of time and a major cause of delay in the 
discharge process. This is an important step in the discharge process that will require 
amendment in the new model of care. 
 
As highlighted, the verification of the discharge summary by a pharmacist was deemed 
important to prevent medication incidents from occurring on discharge. While it is not 
always possible to provide a clinical check of every prescription, it is important to ensure 
that procedures enforce this for discharge summaries and this will be incorporated as 
standard in the new model of care. 
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4.6.3 Supply of medication for discharge 
The findings from this theme suggest that participants felt that they are providing 
unnecessary medication to the patient and this is an area that needs to be addressed 
when developing a new model of care. This stage of the discharge process is time 
consuming, especially for those discharge prescriptions that require dispensing in the 
pharmacy dispensary. This impacts on the patient who has to wait for the medication to 
be supplied, but equally is a waste of resources in terms of staff labour and cost of 
supplying unnecessary medication.  
 
The findings suggested that patients are often told by ward staff that waiting for their 
medicines in pharmacy is the cause of their hospital delay. Phase 2 of the PoW will 
address the issue from the patient perspective to determine their opinion. Regardless 
of the cause, the wait for medicines needs to be reduced to improve the process. Several 
mechanisms were in place to try to reduce the time taken for pharmacy to dispense 
medication. Ward based dispensing is becoming common, which has proved to be 
quicker. For prescriptions dispensed in pharmacy, porters have been employed to speed 
up delivery of medication to the wards. 
 
4.6.4 Post-discharge community pharmacy involvement  
One important finding was the lack of community pharmacy involvement after discharge. 
Currently literature suggests that community pharmacists are not well utilised after 
discharge and this phase demonstrated that few hospitals refer their patients for 
services provided by community pharmacies. Patients may have a long-standing 
relationship with their community pharmacist and encouraging them to visit post-
discharge can raise patient awareness of the support that is available to them at their 
community pharmacy. 
 
The findings from this study support previous studies suggesting there is a lack of 
communication between the hospital and the patients’ community pharmacist(54) and 
that there are very few discharge medication reviews undertaken.(87) Community 
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pharmacy services after discharge are an underused resource that should be 
incorporated when developing new models of care for patient discharge. 
 
4.6.5 Communication within the discharge process 
MDTs can bring benefits to patient care when communication is timely and relevant, but 
problems can arise when communication is poor or responsibilities are unclear.(161) A 
lack of communication within the MDT causes issues not only from a clinical perspective, 
but also in planning future services. Using the example discussed in the findings (see 
section 4.4.3.5.1 Communication within the multi-disciplinary team), if valuable input 
from different healthcare professionals had been sought, the electronic discharge 
system would have been user friendly for all healthcare professionals needing to use the 
system. This example demonstrates that a range of stakeholders should be involved in 
the development of a new model of care to take into account different roles and 
requirements of the new model.  
 
As discussed in section 4.4.3.5.2 Using technology for communication on discharge, not 
all hospitals use the same system for electronic prescribing and electronic discharge. The 
electronic link between electronic prescribing and electronic discharge systems appears 
to be a solution for the issue of using two separate systems, however since the 
interviews took place, an audit in one of the hospitals found that over half of 
electronically generated discharge letters (n=25, 53.2%) did not contain a complete list 
of medicines.(162) This would require further information to determine whether this was 
due to human error or the electronic interface itself, but this could potentially lead to 
problems with transfer of information and therefore continuity of care.  
 
A vast number of different electronic discharge systems were in use. Within the thirteen 
hospitals, seven different systems were used. This can cause confusion for healthcare 
professionals, who may need to be familiar with a number of systems within their job 
role. GP practices may not have the technology available to integrate a variety of 
systems. This also applies to the different electronic prescribing systems. Although each 
individual hospital has chosen the systems suitable for their specific needs, this limits 
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the possibility of connecting systems used in different care settings. This strengthens the 
argument that a solution for many of the issues on discharge would be a single electronic 
system, where each care setting has read/write access to the same patient information, 
for a smooth transfer of care for patients. Despite the progress in technology, good 
communication between healthcare providers is essential to ensure that the discharge 
process runs smoothly.  
 
The different systems will also be confusing for patients. They may have to follow 
different processes depending on the systems and it may also not be easy for them to 
understand the information or layout of different summaries. Although outside the 
scope of this study, further work needs to be done to determine if the electronic 
discharge summary has had an effect on patient understanding of discharge instructions. 
 
4.6.6 Factors affecting the discharge process 
As long-term and complex conditions become increasingly common in an ageing 
population,(163) pressures on the NHS are more evident than ever. The demand for 
hospital resources is increasing, without the financial support to provide them. It is 
difficult to meet demands with limited resources. The limited funding available is a well-
publicised problem for the NHS. Subsequently, there is a greater need to ensure work is 
streamlined and efficient. Having an inefficient discharge process not only prevents 
patients being discharged in a safe and timely manner, but also impacts on patient flow 
through the hospital and therefore patients waiting in the emergency department. 
Quality of patient care will also be affected by an inefficient and time consuming 
discharge system. Lack of funding for the NHS is not a short term issue and new more 
efficient models of care need to be developed to work around the lack of resources 
available to NHS hospitals. For the reasons discussed, it is important that any new 
models of care that are developed take into account the hospital pressures. A process is 
required that will ease the burden on the hospital staff instead of add to it. 
 
Many of the issues within the discharge process highlighted by participants could be 
improved by providing training. Certain areas are lacking when it comes to staff training. 
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It is important to note that any lack of staff training highlighted, is likely as a result of 
the pressures on NHS hospitals.  
 
Junior doctors do not receive formal training for writing discharge prescriptions. One 
study highlighted that over a third of junior doctors felt inadequately prepared for 
writing discharge summaries.(160) Training packages led by pharmacists or another 
suitably experienced member of staff should be developed for junior doctors or medical 
students to improve the quality of the discharge summaries produced.   
 
4.6.7 Patient Involvement  
The involvement of patients, carers, and families is crucial to successful and timely 
discharge planning(54) From analysis of the data, the extent of patient involvement in the 
process appeared minimal, although this may be due to the pharmacists discussing the 
discharge process from an operational point of view. Consequently, in the latter 
interviews, questions were asked around the perspective of the patient. In light of the 
recent patient and public involvement agenda within health and social care research, 
there is an emphasis on involving the patient in decision making. This too should be true 
for service development and this will be included in the development of a new model of 
care for discharge from hospital.  
 
Patient counselling improves medication compliance and reduces hospital 
readmissions.(164) Standards published by the Royal Pharmaceutical Society recommend 
that the pharmacy team provides information about medicines to patients and their 
carers before discharge.(165) From the literature, patients commonly state that they do 
not receive enough information about their medicines before discharge from hospital.(93) 
The findings from this phase support this as patient counselling was highlighted as an 
area for improvement by participants.  
 
The point of discharge may not be the most appropriate time to discuss medication with 
the patient, and the new model of care should include counselling so that patients are 
discharged safely from hospital whilst getting the most from their medication. One 
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suggestion would be that for patients who are unable to take in the information, follow 
up by a community pharmacist may be an opportunity to provide additional counselling 
to a when the patient is settled at home. 
 
Mechanisms to involve patients in their own care need developing, as self-care is 
important. One small study demonstrated that educating patients about self-care after 
discharge and through facilitation of patient self-care throughout their stay, led to a 
reduction in readmission or emergency department visits at 30 days post discharge.(166) 
It would appear from the findings that this is not being encouraged currently by hospitals 
across the North West. One important aspect of self-care is being able to get reliable 
information about the medication that they are taking. Enabling patient access to care 
through easy and accessible methods could improve the use of services and lead to an 
increase in adherence with medication through thorough understanding. Community 
pharmacies are an under-used resource, as they could provide help after discharge for 
patients as previously discussed. In addition, having access to a medicines helpline, a 
pharmacist at the hospital or an interface team could help patients become more 
informed and therefore involved in their own care. 
 
4.6.8 Innovative discharge processes 
Due to the shortfalls in the current discharge process, patients’ expectations and 
hospital demands are not always met. Hospitals have therefore attempted to improve 
discharge by piloting innovative solutions. Utilising the clinical pharmacy service is 
important to improve the process, and the phase found several innovative examples of 
this happening across the North West. Many of the solutions to improve the discharge 
process could be adapted and used nationally. 
 
One interesting finding was the common use of pharmacists writing the discharge 
prescription. All of the hospitals had at least considered doing so and most had piloted 
this new model of care. Participants cited preliminary data demonstrating the benefits 
of having a pharmacist write the discharge prescriptions instead of the medics. One 
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reservation with this is the risk of deskilling junior doctors, as these prescribing 
opportunities are when the junior doctors will learn to prescribe appropriately. 
 
One development issue for pharmacists writing discharge prescriptions is that there will 
be occasions when pharmacists have to write discharge prescriptions for patients when 
they have not been involved with their care, or perhaps in an area of medicine with 
which they are not familiar. Although this may be unavoidable in certain circumstances, 
the new model of care should be developed to reduce this risk. Ensuring that the 
pharmacist prescriber is an integrated member of the medical team, involved in ward 
rounds and therefore more likely to have met the patient is one way to reduce the risk.   
 
Many of the innovative solutions aim to encourage patients to participate in self-care, 
which is beneficial for patients and can help with the medicines optimisation agenda. 
Unfortunately, many of these innovative ideas have not become standard practice. The 
highlighted lack of current solutions to issues with the discharge process demonstrates 
a need for the development of new solutions to overcome issues that occur at discharge.  
 
4.7 Conclusion 
To summarise this phase, a variety of themes emerged from subjects that were 
important to the participants, who were professionals familiar with the problems faced 
when discharging patients from hospital. The themes discussed individually provide 
detailed evidence of the areas that impact – both positively and negatively – on the 
discharge process. All of the themes are useful in describing individual areas that are 
important in ensuring the discharge process is safe, effective and efficient. Many of the 
themes discussed contain overlapping information as for the discharge process to 
function effectively, each individual component has to occur. Breaking down the 
information gathered during the study is important to elicit the details of where 
problems and examples of good practice arise during discharge, which was undertaken 
during the discussion of each of the eight themes. This highlighted a number of 
important findings, such as lack of staff training on patient discharge, lack of patient 
involvement in the discharge process and poor communication between hospital and 
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community pharmacists. Many of the problems highlighted by the study are 
longstanding and attempts have been made to overcome them. Most of the innovative 
solutions to these problems suggested by the participants were based on small-scale 
pilots and have not become part of routine practice.  
 
It is equally important however, to step back and look at the bigger picture, especially 
whilst developing ideas for a new model of care. By combining the eight themes into 
broader organisational categories, it becomes easier to view the overall study findings. 
These broader themes can be seen in Table 4-3. 
 
Table 4-3  List of phase 1 organisational categories 
Organisational category Theme 
Stages of the discharge process Planning for discharge  
Discharge documentation 
Supply of medication for discharge 
 
Collaboration at discharge 
 
Post-discharge community pharmacy involvement 
Communication within the discharge process 
Patient involvement 
 
Factors affecting the discharge process Factors affecting the discharge process 
 
Innovative discharge processes 
 
 
Innovative discharge processes 
 
The themes relating to the ‘stages’ within the discharge process – planning for discharge, 
discharge documentation and supply of medication for discharge – were combined. By 
doing this, it became clear that the problems at discharge are not caused by one 
particular stage that could easily be addressed, but are occurring as a result of different 
stages of discharge and are caused by many factors. The discharge process does not just 
need improvement in one particular area or stage, but in all areas. The new model of 
care for discharge will be developed based on the positive and negative findings and will 
focus on improving patient discharge as a whole addressing all of the highlighted issues. 
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The themes: patient involvement, communication within the discharge process and 
post-discharge community pharmacy involvement all highlight the need for improved 
communication and collaboration at discharge, with different healthcare professionals 
and the patient themselves. Collectively, these themes can be captured by an 
organisational category relating to collaboration within the discharge process. 
Improving collaboration is another overarching issue that needs to be addressed when 
developing the new model of care. Designing an improved model of care will not provide 
a better discharge service without communication and involvement of all relevant 
parties.  
 
Importantly, some of the factors affecting the discharge process will still be a problem 
even in the new model of care. Resources and staff are limited within the NHS and the 
new model of care should be designed in a manner that does not disadvantage the 
already overburdened system. Working to produce a streamlined system that runs 
within the limited resources is key. The innovative discharge ideas implemented by 
different hospitals as pilots are a useful tool to start developing ideas and determine 
what works well. 
 
The research method has successfully met the study aim by identifying and evaluating 
the current discharge process used at acute NHS hospitals across North West England. 
This phase of the PoW was the first study to identify and evaluate the discharge process 
in acute NHS hospitals across North West England. This research identified that 
participating hospitals operated similar discharge processes. Furthermore, each of the 
objectives for this phase were met. The current discharge process was identified and 
mapped, this included which member of staff was responsible for each stage of the 
discharge process. The findings established which stages of the process work well and 
where problems exist along with reasons for the issues. The issues highlighted were 
similar across the acute NHS hospitals. The study also identified a range of innovative 
solutions and ideas or suggestions that participants had to improve patient discharge 
from hospital. Finally, the community pharmacists’ role at discharge was investigated 
from the perspective of hospital pharmacists. The findings from this phase support 
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existing evidence around issues with the discharge process and demonstrate that the 
current discharge process has many issues and is substandard.  
 
A number of recommendations resulted from these findings were taken forward in the 
development of the new model of care. The examples of good practice will be 
incorporated and areas causing common problems at discharge will be removed where 
possible. A range of healthcare professionals need to be involved in the design of the 
new model of care, both hospital and community based. Equally, patients – as service 
users – should be involved in the development of care provision services where possible, 
in order to improve patient experience when the service has been implemented. 
Although outside the scope of this study, further work could involve development of a 
formal discharge training programme for junior medical staff. 
 
This chapter has discussed in detail the findings from phase 1 (Evaluating the current 
discharge process from the pharmacists’ perspective) of the PoW and highlighted areas 
that will be taken forward to develop a new model of care in phase 3. The results of this 
phase were published in the European Journal of Hospital Pharmacy.(167) See Appendix 
21 – Published journal article ‘Hospital patient discharge process: an evaluation’. Having 
achieved all that was set out in phase 1, the next chapter will present the findings from 
phase 2 of the PoW (Evaluating the current discharge process from the patients’ 
perspective) Phase 1 has given an indication of what is happening in practice from an 
operational and managerial perspective. Due to the highlighted lack of patient 
involvement in the findings, phase 2 addresses the patients’ perspective of the current 
discharge process. 
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Chapter 5 – Phase 2: Evaluating the current discharge 
process from the patients’ perspective  
 
Having described and discussed the findings from phase 1 (Evaluating the current 
discharge process from the pharmacists’ perspective) of the PoW in the previous 
chapter (Chapter 4), this chapter will review and discuss the findings from phase 2. This 
second of four phases within the PoW, involved a questionnaire survey to determine 
patient perceptions of the current discharge process. 
 
5.1 Introduction 
As mentioned in the outline for the PoW (section 3.2 Overview of programme of work), 
to address the problems at discharge, it is important to determine where and how the 
problems arise. Whereas phase 1 of the PoW identified problems and examples of good 
practice within the discharge process from an operational and managerial perspective, 
phase 2 assessed the same process from the patient’s perspective. This was to provide 
a clearer picture of where good and poor practice exists at discharge. As discussed in 
chapter 2 (see section 2.7.4 Patient perspectives of discharge), evidence in the literature 
regarding patient perspectives of hospital discharge is limited and conflicting. This phase 
adds rigour to the PoW by exploring the patient-facing themes identified in phase 1 from 
the patient perspective. This allows the opinions and experiences of patients to be 
compared and contrasted with those of the pharmacists in phase 1 during triangulation 
of data in phase 3 (see Chapter 6 – Phase 3: Developing a new model of care for patient 
discharge from hospital ).  
 
The findings of this phase are important to the overall PoW to inform the design of a 
new model of care for patient discharge which incorporates successful aspects of 
current systems and removes any steps that commonly lead to problems. Chapter 2 (see 
section 2.9 Developing new models of care) discusses the importance of taking into 
account patient experience during development of a new model of care. Developing a 
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new model of care that is based around patient priorities and needs should lead to a 
positive patient experience when it is implemented. 
 
5.2 Method  
As detailed earlier (see section 3.4.3 Phase 2 research method) this phase of the 
research was a questionnaire-based survey completed by inpatients at the RLBUHT to 
explore the current discharge process from the perspective of NHS patients. As 
previously discussed (section 3.4.4.1 Questionnaire development), questions were 
developed based on the issues identified in the patient-facing themes from phase 1 of 
the PoW (see section 4.4.3 Themes). These four themes include: planning for discharge, 
medication supply for discharge, post-discharge community pharmacy involvement and 
patient involvement. In addition to exploring the phase 1 themes, patients were asked 
about their overall opinion of the discharge process and if they had any suggestions for 
improvement.  
 
The data collected were entered into an SPSS database and descriptive statistics were 
used to analyse the data (see section 3.4.5 Phase 2 data entry and analysis for further 
detail). 
 
5.3 Aim and Objectives 
As mentioned in section 3.4.2 Phase 2 aim and objectives, the aim of this phase was to 
explore patient perceptions and experiences of the current discharge process at RLBUHT.  
 
The objectives were to: 
• Investigate patients’ views of their discharge from hospital 
• Explore issues identified in the phase 1 findings from the patients’ 
perspective  
• Identify patients’ suggestions for improving the current discharge process 
• Explore current relationships between patients and community pharmacists 
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5.4 Findings  
The findings are presented in this chapter under the following subheadings: 
• Demographics 
• Patient experience of discharge and suggestions for improvement 
• Patient involvement 
• Post-discharge community pharmacy involvement 
Response rates to individual questions are indicated throughout the tables in the 
findings section within the response column.  Responses to each question are reported 
by the percentage (%), followed by the number of respondents selecting each answer 
(n) and the response rate for the question (N). The response rates differ between 
individual questions due to not all respondents answering every question. 
 
5.4.1 Outcome of the pilot  
A pilot study was carried out with four patients from the RLBUHT. The pilot highlighted 
an important issue with the procedure. Many of the questions in the questionnaire only 
applied to patients who had been told that they could go home. This was highlighted by 
one case where the nurse knew that a patient was due for discharge that day, but the 
medical team had not yet informed the patient. This was taken on board during data 
collection and gatekeepers were asked to recommend patients that had been informed 
about their discharge. The pilot demonstrated that other aspects of the research process, 
the recruitment process and obtaining consent were successful. It also found that the 
questionnaire yielded suitable relevant data and no amendments to the questionnaire 
were necessary.  
 
5.4.2 Demographics 
Data collection took place on different days of the week during the period 30th 
November 2015 and 7th February 2016. A total of 104 patients were approached at their 
bedside on wards to participate. The full range of wards are shown in Table 5-1. All of 
those approached agreed to participate (100% return rate), although response rates to 
individual questions varied as not every respondent answered all questions.  
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Respondents were all patients, no family members or carers completed the 
questionnaire on behalf of a patient. In some circumstances (for example poor eyesight 
with no glasses, patient unable to write) the patient requested that the researcher 
complete the questionnaire on their behalf. In these cases, the researcher read the 
questions out verbatim and did not elaborate so as not to lead the respondent’s answers. 
The demographic characteristics of the study respondent in phase 2 are shown in Table 
5-1. 
 
Table 5-1– Demographic characteristics of phase 2 respondents 
 Response   
Age in years   mean (SD) 55 (18) 
  
Age group  %      (n/N) 
18-35 17% (18/104)  
36-55 34% (35/104) 
56-75 37% (38/104) 
76+ 12% (13/104) 
  
Gender    
Male    60% (62/104) 
Female    40% (42/104) 
  
Inpatient ward   
Medical ward 38% (37/96) 
Surgical ward 22% (21/96) 
ESAU 21% (20/96) 
AMU 19% (18/96) 
 
The average age of respondents was 55 years with an age range of 19 to 93 years. The 
majority, (37%, 38/104), of respondents fell into the age group 5675. More males (60%, 
62/104) than females (40%, 42/104) completed the questionnaire. 
 
Patients were recruited from a range of admissions, medical and surgical wards, the 
acute medical unit (AMU) and the emergency surgical admissions unit (ESAU). The 
majority of respondents were from medical wards (38%, 37/96), with a relatively even 
distribution of respondents from the other three ward areas.  
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One question asked if patients took regular medication prior to admission to hospital 
and if so, the number of daily medicines that they took. A breakdown of the findings is 
shown in Table 5-2. 
 
Table 5-2 – Patients taking regular medicines before hospital admission 
Question Response  
% (n/N) 
Did patient take regular medicines   
Yes    71% (74/104) 
No    29% (30/104) 
  
Number of regular medicines taken daily   
1-4    32% (24/74) 
5-9    43% (32/74) 
10 +    22% (16/74) 
Don’t know    3% (2/74) 
 
The study findings indicate that the majority of respondents (71%, 74/104) were taking 
regular medication prior to admission to hospital. Of these patients taking regular 
medication, the majority were taking five or more medications daily as can be seen in 
Table 5-2.   
 
5.4.3 Overall patient experience and suggestions for improvement  
Patients were asked about their opinions and experiences of hospital discharge, along 
with any suggestions for improvement of the process. The findings will be discussed 
within the section and have been broken down into the following subheadings: patient 
experience of their discharge from hospital, perceived reasons for delay to patient 
discharge, suggestions for improvement of hospital discharge. 
 
5.4.3.1 Patient experience of their discharge from hospital 
Patients were asked to rate their experience of discharge from hospital. Overall, the 
majority of patients found that their discharge experience was either good (57%, 56/98) 
or satisfactory (32%, 31/98). 11% (11/98) of patients rated their discharge as poor.  The 
results are displayed in Table 5-3.  
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Table 5-3 – Patient experience of discharge 
 Response 
% (n/N) 
Patient rating of discharge experience   
Good    57% (56/98) 
Satisfactory   32% (31/98) 
Poor    11% (11/98) 
 
Respondents were asked if there were any positive or negative aspects about their 
discharge. Common themes within the positive comments related to being able to go 
home and the good, caring staff. For negative aspects, patients commonly referred to 
the long wait for their medicines. The specific positive and negative comments are 
discussed within the relevant findings sections throughout this chapter. 
 
5.4.3.2 Perceived reasons for delay to patient discharge 
Determining a true representation of how long the patient waited for their discharge in 
total would not be possible, as the patient had not left the hospital at the time they 
completed the questionnaire. Patients were therefore not asked how long their wait had 
been. However, several patients commented that a negative aspect of their discharge 
was the long wait to be discharged. 
 
Patients were asked which tasks they were waiting for to be carried out before they 
could go home. The perceived reasons for delay to patient discharge are shown in Table 
5-4. As patients could select more than one option, the results are therefore not 
mutually exclusive. 
 
Waiting to receive discharge medicines was the most commonly cited reason for 
patients’ perceived delay to their discharge (70%, 64/92). For those that selected ‘other’, 
the reason given was waiting on a review by another healthcare professional before they 
could be discharged, this included specialist nurses or another medical team within the 
hospital.  
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Table 5-4 – Patients’ perceived reasons for delay to discharge 
 Response  
% (n/N)* 
Factors causing delay to patient discharge   
Waiting for discharge medicines 70% (64/92) 
Waiting for test results 14% (13/92) 
Waiting for further tests 10% (9/92) 
Waiting for transport home 10% (9/92) 
Unsure  7% (6/92) 
Other 7% (6/92) 
Waiting for social care arrangements 2% (2/92) 
*categories not mutually exclusive  
 
 
5.4.3.3 Suggestions for improvement of hospital discharge 
Respondents were asked if the process of supplying discharge medicines could be 
improved. Responses are given in Table 5-5.  
 
Table 5-5 – Patient suggestions for improvement of discharge 
 Response  
% (n/N) 
Could the supply of discharge medicines be improved?    
No 45% (41/91) 
Don’t know 32% (29/91) 
Yes 23% (21/91) 
 
Almost one quarter (23%, 21/91) of respondents felt that the service of supplying their 
discharge medicines could be improved. These respondents made suggestions for 
improvement of the service in a free text answer box in the questionnaire. Their 
responses included improving speed and communication, and having the option of 
collecting discharge medicines from an outside pharmacy to save time. One respondent 
who was clearly familiar with the technology available in the community suggested that 
a community-based electronic system to collaborate and organise the prescription could 
be helpful. EMIS Web was the example given, which is an integrated healthcare record 
system that allows patients to order repeat prescriptions from their GP. Two 
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respondents thought that prescriptions should be organised and completed the day 
before discharge.  
 
Patients were then asked if the hospital could help them with their medicines after 
discharge. Table 5-6 presents respondents’ views on whether hospital staff could help 
patients with their medicines after discharge. 
 
Table 5-6 – Hospital assistance with medicines after discharge 
 Response 
% (n/N) 
Could the hospital help patients with their medicines after discharge?  
No 72% (69/96) 
Don’t know 21% (20/96) 
Yes 7% (7/96) 
 
Most respondents (72%, 69/96) did not think that hospital staff could support them with 
their medicines after discharge, with one respondent commenting ‘people in the 
community should help me, it should be my GP in charge’.  
 
Only 7% (7/96) of respondents felt that hospital staff could support them with their 
medicines once they had been discharged home.  Patient suggestions for this support 
included: delivery of medicines to the patient, ability to contact or see patient again if 
they need help after discharge. One patient commented that a nurse would be visiting 
them at home daily to administer injections that they were not able to do themselves.  
To add to this, patients were also asked where they would prefer to collect the discharge 
medicines from, if they had a choice. These results are presented in 
Table 5-7. 
 
More patients would prefer to collect their medicines from a community pharmacy of 
their choice (52%, 47/91) than wait to collect their medicines in hospital (39%, 36/91). 
A small proportion (9%, 8/91) would like to go through their GP surgery to collect. 
Additionally, two of the respondents that chose community pharmacy as an option 
added that they would like a delivery service alongside this. 
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Table 5-7 – Patients preferred place to collect discharge medicines 
 Response 
% (n/N) 
Where would patients prefer to collect discharge medicines from?   
Community pharmacy of patient’s choice 52% (47/91) 
Hospital 39% (36/91) 
GP surgery 9% (8/91) 
 
5.4.4 Patient involvement 
Phase 1 found that patient involvement in the discharge process was limited (see section 
4.4.3.7 Patient Involvement). The findings within this section explore whether patients 
feel that they are involved in the discharge process. This section encompasses patient 
involvement during different stages of the discharge process, as well as communication 
and patient counselling. 
 
5.4.4.1 Planning for discharge 
Patients were asked if they felt that they had been involved in their own discharge 
planning. Their responses can be seen in Table 5-8. 
 
Table 5-8 – Patient involvement in discharge planning 
 
 
 
 
 
 
 
A combined total of 63% of respondents either agreed (41%, 38/92) or strongly agreed 
(22%, 20/92) that they were involved in planning their discharge. Whereas a combined 
total of 24% disagreed (11%, 10/92) or strongly disagreed (13%, 12/92) that they had 
been involved and 13% (12/92) were neutral. 
 
 Response 
% (n/N) 
Patient involvement in discharge process  
Strongly agree 22% (20/92) 
Agree 41% (38/92) 
Neutral 13% (12/92) 
Disagree 11% (10/92) 
Strongly disagree 13% (12/92) 
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When asked if there were any positive or negative aspects about their discharge 
experience, several of the responses were related to planning for discharge. When asked 
if there were any positive aspects about their discharge, patients commented that 
getting to go home and free a bed was a positive. Several patients also mentioned that 
the process appeared well organised. Conversely, one patient felt that they were getting 
sent home too early and another was made anxious by mixed messages from different 
doctors about whether they were ready to be discharged or not. Another patient 
commented that they would have liked more notice before going home to make 
arrangements with family members. 
 
One particularly surprising example of poor discharge planning was documented by one 
patient. Whilst waiting for test results and then discharge, their bed was given to 
another patient whilst they were still on the ward. This was extremely embarrassing for 
the staff and patients involved. This is an unfortunate example of what can happen when 
multiple people are involved in coordinating patient discharge and patient flow 
throughout the hospital. 
 
5.4.4.2 Communication with patients throughout the discharge process 
Patients were asked about the communication they had received during the discharge 
process. The findings are shown in Table 5-9. 
 
The study found that a combined total of 74% of patients strongly agreed (25%, 24/95) 
or agreed (49%, 46/95) that the discharge process was explained to them. Similarly, 79% 
of respondents strongly agreed (34%, 32/94) or agreed (45%, 42/94) that they 
understood the discharge process.  One patient commented that having prior 
experience of discharge meant that they were more aware of what was likely to happen 
this time round at discharge. 
 
Only 57% of patients either strongly agreed (21%, 20/94) or agreed (36%, 34/94) that 
they were kept updated with the progress of their discharge.  
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Table 5-9 – Communication with patient throughout their discharge 
 Response 
% (n/N) 
Was the discharge process explained to patients?   
Strongly agree 25% (24/95) 
Agree 49% (46/95) 
Neutral 18% (17/95) 
Disagree 6% (6/95) 
Strongly disagree 2% (2/95) 
  
Did patients understand the discharge process?  
Strongly agree 34% (32/94) 
Agree 45% (42/94) 
Neutral 15% (14/94) 
Disagree 2% (2/94) 
Strongly disagree 4% (4/94) 
  
Was patient updated on progress of discharge?  
Strongly agree 21% (20/94) 
Agree 36% (34/94)  
Neutral 32% (30/94) 
Disagree 9% (8/94) 
Strongly disagree 2% (2/94) 
 
 
Messages were mixed regarding communication of information. When asked if there 
were any positive aspects of their discharge, some respondents commented on the 
helpful, caring staff and good communication between staff and themselves. Conversely, 
one patient commented that they were given misinformation. A further example of poor 
communication was a patient who had been sent to another ward from the admissions 
unit after being told that they could go home, with no explanation as to why. At the time 
of completing the questionnaire, they were still waiting for their medicines and to go 
home.  
 
5.4.4.3 Patient counselling 
Patients were asked if any changes made to their regular medicines during their hospital 
admission were verbally discussed with them. If changes had been discussed, 
respondents were then asked if they understood what medicines they should be taking 
after discharge. The responses given are shown in Table 5-10. 
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Table 5-10 – Counselling on any changes to patients’ regular medicines 
 Response 
% (n/N) 
Changes to medicines during admission  
No changes to medicines 56% (56/100) 
Changes to medicines 32% (32/100) 
Patient didn’t know 12% (12/100) 
  
Was patient clear about what medicines to take after discharge?   
Fully 63% (20/32) 
Partly 31% (10/32) 
Not at all 6% (2/32) 
 
The majority (88%) of respondents knew if any changes had been made to their 
medicines during their hospital admission. Of those 88%, (56%, 56/100) had no changes 
to their medicines. Those patients with changes to their regular medicines (32%, 32/100) 
were asked if they had received any counselling about their medicines and which 
member of staff had discussed their medicines with them. Not all 32 responded to every 
question, responses can be seen in Table 5-11 along with the number of respondents.   
 
Table 5-11 – Verbal patient counselling provided for new medicines 
 Response 
% (n/N) 
Patient received counselling on the following points:  
How to use the medicine(s)   93% (25/27) 
What new medicine(s) are for  89% (24/27) 
Benefits of new medicine(s)  88% (23/26) 
When to use the medicine(s)  85% (22/26) 
Whether further supplies are needed 73% (19/26) 
How to obtain further supplies 58% (15/26) 
Side effects of medicine(s)  58% (15/26) 
  
Healthcare professional patient was counselled by  
Consultant 47% (15/32)* 
Nurse 34% (11/32)* 
Other doctor  28% (9/32)* 
Pharmacist  13% (4/32)* 
No-one 6% (2/32)* 
Don’t know 3% (1/32)* 
*categories not mutually exclusive  
 
Of the patients with changes to their medicines, the majority were told what their new 
medicine was for (89%, 24/27) and how to use their medicines (93%, 25/27). An 
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important finding is that not all of the counselling points listed in were routinely covered 
with patients. Interestingly, according to respondents only 13% (4/32) of patient 
counselling was by a pharmacist.  
 
5.4.5 Post-discharge community pharmacy involvement 
This section builds on the phase 1 findings that despite evidence suggesting community 
pharmacy involvement after discharge is beneficial for patients, communication 
between hospital and community pharmacy is limited. This section aimed to establish 
any pre-existing relationships between patients and their community pharmacies.  
Patients were asked if they usually collected their medicines from the same community 
pharmacy and reasons for choosing that particular pharmacy. Table 5-12 shows patient 
responses to these questions.   
 
Table 5-12 – Patient use of regular community pharmacies 
 Response 
% (n/N) 
Does patient use regular community pharmacy?   
Yes 84% (82/98) 
No 13% (13/98) 
Don’t know 3% (3/98) 
  
Reason for use of particular pharmacy  
Close to patient’s home 73% (60/82)* 
Close to patient’s GP surgery 54% (44/82)* 
Pharmacist knows patient and their needs 32% (26/82)* 
Delivery service provided 26% (21/82)* 
Pharmacy orders patient’s repeat medication 23% (19/82)* 
Other reason 7% (6/82)* 
*Categories not mutually exclusive  
 
The majority (84%, 82/98) said that they did use one regular pharmacy, whilst 13% 
(13/98) did not use the same pharmacy each time. Proximity to the patients’ home was 
the main reason for choosing their particular pharmacy (73%, 60/82), followed by 
proximity to their GP surgery (54%, 44/82). Those who selected ‘other’ as a reason for 
choosing a regular community pharmacy (7%, 6/82) cited the following: pharmacy 
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provides multi-compartment compliance aids (MCA), helpful staff, good service and 
ability to order prescriptions electronically.  
 
Patients were asked if they would be visiting a community pharmacist after discharge 
and if so, their reasons for doing so. Table 5-13 breaks down the responses to these 
questions.  
 
Table 5-13 – Intended community pharmacy visits after patient has been discharged 
 Response 
% (n/N) 
Will patient be visiting a community pharmacy after discharge   
No 46% (45/99) 
Yes 28% (28/99) 
Don’t know 26% (26/99) 
  
Reason for community pharmacy visit   
Obtain further supplies of new medicines 71% (20/28)* 
Order next repeat prescription 64% (18/28)* 
Discuss any problems with medicines 29% (8/28)* 
Discuss newly started medicines 14% (4/28)* 
*categories not mutually exclusive  
 
A greater proportion of respondents (46%, 45/99) did not plan to visit a community 
pharmacy after discharge, or were unsure if they would need to (26%, 26/99). For those 
that did plan to visit a pharmacy (28%, 28/99), this was mainly to collect (71%, 20/28) or 
order (64%, 18/28) their medicines. Very few of the patients intended to see the 
community pharmacist for advice about their medicines. 
 
5.5 Discussion 
As discussed in chapter 1, current evidence suggests that many problems can occur with 
patients’ regular medicines after hospital discharge.(75,76,168) The survey found that a high 
number of patients took regular medicines. This suggests that the risk of medication 
problems applies to the majority of inpatients and is therefore an important issue to 
resolve. This highlights the importance of having a robust service in place at discharge 
to reduce the risk of problems occurring with medication after discharge. 
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The patients who participated in this study were from a variety of wards, were a 
relatively even split of male and females and had a wide age range. Including a diverse 
range of patients in the study, captured views from different patient groups. This 
improved the likelihood of the study findings being generalisable to other acute NHS 
hospitals with similar populations.  
 
5.5.1 Overall patient experience and suggestions for improvement 
The findings from section 5.4.3 Overall patient experience and suggestions for 
improvement are discussed below.  
 
Patient experience of their discharge from hospital 
The findings indicate that a large number of patients were satisfied with their experience, 
whilst still encountering issues during discharge. This study supports previous research 
whereby patients have reported a high level of satisfaction with discharge (see section 
2.7.4 Patient perspectives of discharge). There could be many reasons for this. It could 
be argued that patients’ low expectations of hospital discharge are responsible for them 
reporting a high level of satisfaction with the discharge process despite known problems. 
Equally, that the patient is being discharged could have resulted in a more positive 
response. Despite the majority of patients finding their discharge experience at least 
satisfactory, there is much room for improvement at discharge.  
 
Perceived reasons for delay to patient discharge 
Respondents commonly felt that discharge from hospital took too long. The majority of 
patients (70%) perceived that waiting for their discharge medicines was the main cause 
of delay to their discharge. This result is higher than in the National Inpatient Survey 
2014 results, where 61% of delayed discharges were perceived to be caused by patients 
waiting for their medication.(93) It was not possible to determine if this was the true 
cause of delays to discharge as this was outside the scope of the study. Unfortunately, 
waiting for pharmacy to supply discharge medicines is known to be commonly perceived 
by hospital staff as the main delay to discharge,(169) and the findings from this study 
suggest that patients also hold this view. This belief may stem from either real or 
142 
 
perceived pharmacy-related delays. An example of a real issue is when pharmacists are 
unavailable to authorise discharge prescriptions, or discharge medicines take a long time 
to arrive from pharmacy. An example of a perceived pharmacy-related delay could be 
through misinformation supplied by ward staff, or because the discharge process and its 
expected duration is not explained to patients. Previous research has shown that 
discharge delays are a much wider issue and pharmacy is not the only cause.(167,169) 
Regardless of where the responsibility lies, delays at discharge need to be addressed to 
improve patient experience.   
 
Suggestions for improvement of hospital discharge 
Only 23% of patients felt that their discharge could be improved. This builds on the 
findings that the majority of patients were satisfied with their discharge. Providing a 
faster service was a common theme highlighted by patients throughout the study as well 
as some reasonable suggestions for future developments to the discharge service. 
 
The findings suggest that community healthcare professionals should support patients 
with their medicines after discharge, rather than hospital staff. It is interesting that 
patients see their GP as the main source of help with medicines after discharge. This 
could be due to a lack of awareness of the support available from community 
pharmacies who offer the NMS and MURs to support patients recently discharged from 
hospital. Hospital pharmacists have an important role in signposting or referring patients 
to community pharmacies for support with their medicines. Encouraging 
communication between patients and their community pharmacist could prevent any 
issues that may arise in the future. Of the small proportion of patients who would like 
support after discharge from hospital, they requested delivery of their medicines and 
the option to be contacted or seen again if help was required after discharge. It may be 
possible that both of these services could be carried out by community pharmacists. 
 
A larger proportion of patients preferred to leave the hospital and collect their 
medicines from a community pharmacy than remain in hospital to wait for them. This is 
a similar idea to the model of care used by an increasing number of hospitals who have 
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now outsourced their hospital outpatient prescriptions to community pharmacy 
chains.(19)  
 
5.5.2 Patient involvement 
The findings from section 5.4.4 Patient involvement are discussed below. 
 
Planning for discharge 
Phase 1 found that although discharge planning was seen to be happening, it was not 
very well coordinated. Planning a patient’s discharge from hospital should include the 
patient as well as their family members or carer as appropriate.(54,55,170) There was no 
mention of patient involvement in this planning process by the participants from phase 
1. The questionnaire therefore asked patients if they felt that they were involved in the 
discharge process.  
 
Whilst the findings suggest that the majority of patients felt that they had been involved 
in their discharge planning to some extent, these were lower than national figures. The 
National Inpatient Survey 2014 found that 54% of patients strongly agreed that they 
were involved in decisions about their discharge(93) compared to only 22% in this study, 
demonstrating room for improvement. Although respondents were similar in age and 
gender, the variation could be due to the slight difference in how the questions were 
asked in both questionnaires and the much larger sample size in the national survey.  
 
Communication with patients throughout the discharge process 
In phase 1, patient involvement and patient counselling during the discharge process 
was found to be limited.  
 
Discharge from hospital can be complex, depending on individual patient needs and 
without explanation, patients will not be aware of the reasons for any hold-ups at 
discharge. Findings from phase 1 identified that hospitals experienced issues because 
doctors often told patients that they could go home without sufficient explanation 
about the process, leading to unrealistic expectations from patients about when they 
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could leave hospital (see section 4.4.3.7.2 Involving the patient at discharge). From the 
findings of this phase, it appears that the majority of patients felt that the process had 
been sufficiently explained to them.  This study did not ask which member of the 
multidisciplinary team explained the discharge process to patients and it would 
therefore be difficult to determine if it was in fact the doctors that were providing this 
information at the appropriate time. 
 
As previously discussed in Chapter 2, providing patients with the information required 
to enable involvement in their care is a Government priority.(38) The findings indicate 
that information about discharge was given to most patients. Nonetheless, all patients 
should be involved in their care and should therefore receive information about 
discharge. Explaining the complexities of the discharge process so that patients 
understand the numerous steps that need to take place before they are discharged 
would empower the patient and improve their experience. This includes regular and 
accurate information about the duration of any delays during episodes of care.(171) 
Owing to the discharge process being a time consuming and complex one, inevitably 
delays can occur. Providing updates if discharge is delayed or if any changes occur will 
help the patient to understand what is happening and improve their overall experience.  
 
Patient counselling 
As discussed in Chapter 2, a component of the medicines optimisation programme is to 
support medicines adherence(40) by providing patients with information about their 
medicines. As it is estimated that between 30-50% of patients do not take their 
medicines as intended,(40) improving medicines adherence is vital. Counselling patients 
on their medicines prior to hospital discharge is therefore encouraged. The majority of 
patients in the study stated that they were aware of whether or not changes were made 
to their medicines during their admission. However, over a third of patients were 
unclear about what medicines they should be taking after discharge. This could be due 
to a lack of patient counselling, poor understanding of information or the patient not 
remembering information. It does highlight that improved communication of 
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information is required and calls into question the quality of information given to 
patients and whether it is provided at an appropriate time.  
 
Interestingly, findings from this phase indicate that pharmacists are the least likely 
healthcare professional to provide patient counselling, despite being the most 
appropriately trained in medicines use. This supports the findings from phase 1 that 
hospital pharmacists are unlikely to be providing adequate patient counselling (see 
section 4.4.3.7.1 Patient Counselling). During the development of a new model of care, 
medicines counselling involving trained pharmacy staff should be incorporated as 
standard. 
 
5.5.3 Post discharge community pharmacy involvement 
According to the literature, community pharmacists can play an important role in patient 
care after discharge (see section 2.6.3 Community pharmacy involvement at discharge). 
Phase 1 identified that although considered beneficial, communication between 
hospital pharmacists and community pharmacists was limited and for most hospitals, 
not a straightforward process due to the methods of communication available. This 
phase therefore tried to ascertain whether patients have an established relationship 
with a particular community pharmacist and whether they intended to visit a community 
pharmacist to assist them after discharge. 
 
The majority of patients in this study appeared to use a regular community pharmacy, 
which can help build relationships and improve continuity of care. However, although 
the majority of patients may use a regular community pharmacy, not many would think 
to visit after discharge. For those patients that would visit, this would tend to be to order 
and collect their medicines rather than seek any advice or counselling. When developing 
a new model of care, this pre-existing relationship between patients and their 
community pharmacy needs to be built upon. In particular, patients should be 
encouraged to seek support and advice after discharge from hospital. 
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5.5.4 Limitations 
Recruitment for this study proved more difficult than anticipated, mainly because junior 
doctors were threatening to strike during the data collection period. The hospital altered 
its standard processes in response to this threat to ensure patient safety was not 
compromised. As a result of the temporary change to normal procedure, this was not a 
true representation of the current discharge process and therefore data collection was 
interrupted. Additionally, although preliminary discussions with the research site 
established that on average approximately 100-120 patients were discharged daily, the 
actual number of patients that met the phase 2 inclusion criteria was much lower, which 
meant that data collection took longer than anticipated. 
 
As this study was specific to one hospital, the findings are only relevant to the RLBUHT 
and are not necessarily generalisable across other hospitals. The reasons for conducting 
the study at this one particular site are discussed within section 3.4.3.1 Research site. 
However if the research were to be conducted again, extending the study to recruit 
patients from other hospitals would improve generalisability of the findings.  
 
5.7 Generalised discharge process with problem areas 
highlighted 
A generalised hospital discharge process was mapped by the researcher in phase 1. This 
can be seen in Figure 4-1. In phase 1, the stages of the discharge process where 
pharmacists identified problems were highlighted in yellow on the flowchart. The image 
in Figure 5-1 shows the same discharge process developed in phase 1 – containing the 
pharmacists’ perspective – with the issues identified from the patient’s perspective 
overlaid. The areas highlighted orange on the flowchart represent those stages in the 
discharge process where problems were identified by patients.  
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Figure 5-1 – Generalised discharge process in acute hospitals across North West 
England showing issues identified by patients  
  
  
KEY 
148 
 
5.9 Conclusion 
To summarise this second phase, questionnaires elicited a range of responses from 
patients which enabled their perspectives of the discharge process to be captured. This 
phase highlighted a range of interesting findings detailing what is important to patients, 
which have been discussed throughout section 5.4 Findings.  
 
The findings highlighted several areas for improvement at discharge. Most importantly 
that despite most patients feeling satisfied at discharge they found that the discharge 
process takes too long, with the wait for medicines perceived by patients to be the main 
cause. It is important that the new model of care reduces the delays to patient discharge. 
Additionally, the misconception that waiting for pharmacy to supply discharge 
medication is the cause of delays to discharge needs to be addressed in the new model 
of care. 
 
The findings from this phase and from the National Inpatient Survey(93) demonstrate that 
patients should be more involved in their discharge from hospital, this would support 
the Government’s agenda (see section 2.4 Patient involvement). Ensuring the patient is 
involved in decisions around their medicines for discharge including the supply is an 
important consideration and extends beyond the scope of pharmacy. However, the new 
model of care should provide adequate opportunity for patients to be involved during 
planning for discharge.  
 
Communication with patients at discharge appears to be extremely varied. There are 
examples of good communication, with many patients appearing satisfied, whereas 
some patients found communication poor. Improved communication with patients is 
required as standard, so all are receiving the same high standard service. Existing 
evidence demonstrates the failings that result from poor communication with patients 
(see section 2.7.2 Medication errors at discharge from hospital). Opportunities need to 
be created within the discharge process to allow and encourage good communication 
to happen. This applies to both communicating general discharge information to 
patients and counselling patients on their medication. A trained member of the 
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pharmacy team would be an ideal person to provide counselling to patients, equally 
however, one person should be given overall responsibility for providing all information 
about the progress and expected duration of the patients discharge. Providing this 
information is likely to improve the patient experience. 
 
Throughout the findings, utilising community pharmacy services after discharge was 
mentioned. The findings suggest that in the new model of care, there is scope for 
community pharmacy involvement to increase after discharge. This could improve 
patient care at discharge and help to forge relationships between the patient and their 
community pharmacist to encourage future support with medicines. Raising patient 
awareness of the services provided by community pharmacists is important to increase 
likelihood that patients will make use of the available services.  
 
This second phase of the PoW has successfully met the study aim by exploring patient 
perceptions and experiences of the current discharge process at RLBUHT. Furthermore, 
this phase met the study objectives by investigating patients’ views of their discharge 
from hospital, exploring the issues identified in the phase 1 findings from the patients’ 
perspective and identifying patients’ suggestions for improving the current discharge 
process. The current relationships between patients and their community pharmacists 
were also investigated.  
 
Phase 2 builds on phase 1 findings and addresses those issues highlighted by 
pharmacists, but from the patients’ perspective. This phase has identified that despite 
the majority of patients feeling satisfied with their hospital discharge, issues commonly 
arise. The study has highlighted several areas that require improvement to provide safe, 
quality care for patients and improve patient experience at discharge. In particular, the 
findings support phase 1 findings which suggested that both patient counselling by 
pharmacists and patient involvement in discharge are limited. Findings also show that 
patients perceive their discharge to take too long and is largely due to the wait for 
discharge medicines. 
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This phase builds on the existing knowledge of problems at discharge by adding the 
patients’ perspective to issues commonly highlighted by healthcare staff. Patient 
experience is important to determine if services are providing high quality care. From 
the results of this phase there is much room for improvement. This supports findings 
from phase 1 which suggest that an improved discharge process is required. The findings 
from phase 2 will be combined with those from phase 1, and used to inform the 
development of the new model of care for patient discharge.  
 
This second phase produced important findings that will be used to inform the 
development of the new model of care in the next phase of the PoW. Several major 
issues emerged from this phase that will be taken into account. The new model will 
include medication counselling provided by trained pharmacy staff as standard, support 
with medicines after discharge by community pharmacists and communication of 
information during discharge to all patients. Patients, as service users, should not only 
be involved during their discharge from hospital, but should also be involved in the 
development of the new model of care, to improve patient experience whilst using the 
services. Finally, it is essential that the new model of care will speed up patient discharge.  
 
The study was designed to establish the patient perspective of discharge prior to leaving 
hospital. This was to ensure an accurate recollection of the process and to help with 
recruitment of patients. However, although outside the scope of the PoW, further 
research could involve patient follow up after discharge to determine if their opinions 
differ after leaving the hospital.   
 
This chapter has discussed in detail the findings from phase 2 of the PoW (Evaluating the 
current discharge process from the patients’ perspective) and highlighted areas that will 
be taken forward to develop a new model of care. The results of this phase were 
published in the European Journal of Hospital Pharmacy.(172) See Appendix 22. Having 
achieved the aim and objectives set out for phase 2, the following chapter will present 
phase 3 of the PoW in which the new model of care for patient discharge from hospital 
was developed based on phase 1 and 2 findings.  
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Chapter 6 – Phase 3: Developing a new model of care for 
patient discharge from hospital  
 
Having overviewed the findings for phases 1 and 2 of the PoW in the previous two 
chapters, this chapter discusses the third phase of the PoW in which a new model of 
care for discharge was developed. This chapter includes an overview of the current 
discharge process, the proposed new model of care along with a rationale, concluding 
with a discussion. 
 
6.1 Introduction 
As previously discussed, the current hospital discharge process tends to be fragmented 
and of varying quality between individual patients. This can lead to a variety of problems 
including: medication errors, hospital readmissions and bed-blocking. This has a 
negative impact on both patients and the hospital itself. This PoW looked to resolve the 
issues occurring at patient discharge. In order to do so, the overall PoW aimed to 
develop a new model of care for patient discharge that will provide safe, quality and 
effective transfer for patients from hospital to community care (see section 3.1 Aim and 
Objectives of PoW). 
 
A model of care outlines best practice services. It aims to ensure people get the right 
care, at the right time, by the right team in the right place.(107) (see section 2.9 
Developing new models of care) A model of care should be based on the best available 
evidence, which is why the PoW was developed to identify and evaluate the current 
discharge process and use the evidence collected to inform the development of the new 
model of care for discharge. Chapters 4 and 5 discussed the current discharge process 
from a pharmacist and a patient perspective, respectively. This third phase involved 
triangulation of the data from both of these earlier two phases, to gain a multi-
perspective evaluation of the current discharge process (see 3.5.3 Phase 3 method for 
more detail). An explanation is given (in section 6.3 Problem areas within the current 
discharge process) of how the findings from the evaluation of the current discharge 
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process, discussed in detail throughout chapters 4 and 5, were combined to generate a 
useful basis to begin the development of a new model of care for patient discharge. The 
findings from the triangulation were used in addition to evidence in the literature to 
develop the new model of care. As mentioned in the overview of the PoW (see section 
3.5.3 Phase 3 method), development of the new model of care incorporated the 
successful aspects of the current process and removed any stages that commonly cause 
problems at discharge. 
 
This chapter then moves on to introduce the new model of care, along with a discussion 
of the rationale for the new model. As the new model was informed by the earlier 
findings, these will be referred to throughout the rationale. 
 
6.2 Aim and Objectives 
The aim of this third phase was to develop an innovative model of care for patient 
discharge from hospital that provides safe, quality care in a timely manner and improves 
patient experience. 
 
The objectives were to: 
• Explore and triangulate the findings from phases 1 and 2, to determine the 
issues that require solutions and the examples of good practice at discharge 
• Use the triangulated findings and current literature to generate a new model 
of care for discharge 
• Define and map out the new model of care for patient discharge 
• Explain how the new model of care for patient discharge overcomes the 
issues identified in phases 1 and 2  
• Explain how the new model of care for patient discharge encompasses the 
good practice identified in phases 1 and 2 
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6.3 Problem areas within the current discharge process 
The common issues with the current discharge process identified by both pharmacists 
and patients were discussed within chapters 4 and 5. These issues were highlighted on 
two generic discharge process flowcharts, to help visualise where issues commonly 
arose in the current discharge process. The two flowcharts showing the stages where 
issues were identified by pharmacists and patients can be seen in Figure 4-1 and Figure 
5-1 respectively. To ascertain whether the problems were similar for patients and 
pharmacists, i.e. from an operational or managerial perspective and a service user 
perspective, the two flowcharts were merged. Figure 6-1 contains the combined 
flowchart, illustrating the stages of the discharge process where issues commonly arose 
from a pharmacist and patient perspective. As indicated by the key, stages in the process 
where issues arise from the pharmacists’ perspective are highlighted in yellow, those 
from the patients’ perspective are highlighted in orange and the areas where both found 
issues arise are highlighted in red.  
 
Three stages within the current discharge process were identified as problem areas by 
both pharmacists and patients, these can be seen highlighted in red on Figure 6-1 and 
for the purpose of discussion, are labelled A, B and C. The first stage highlighted as an 
issue from both perspectives was when the patient is informed about their discharge 
(see A in Figure 6-1). The problem was related to the delay from when the time patient 
is told by the medical team that they can go home and the actual time that the patient 
is discharged from hospital. That patients are informed they can go home without a clear 
explanation of how long the process will take, leads to unmanageable patient 
expectations as it is not possible to discharge patients instantly. This not only impacts 
on the patient experience, but puts more pressure on staff trying to arrange the 
discharge.  
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Figure 6-1 – Generalised discharge process in acute hospitals across North West England 
highlighting pharmacist and patient identified issues 
KEY 
 Pharmacist identified issues (P1) Patient identified issues (P2) Issues identified by pharmacists and patients (P1&2) 
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The next stage of the discharge process that both pharmacists and patients deemed a 
problem area was during dispensing of discharge medication (see B in Figure 6-1). 
Patients thought that discharge from hospital took too long and that the wait for 
medicines was a main cause of this delay. Pharmacists also felt that the process of 
waiting for medicines at discharge took too long and despite a variety of reasons for this, 
accepted that dispensing discharge medication is one of the causes of delay. Whilst 
some hospitals attempted to dispense medication on the wards to speed up the process, 
this facility was not widely available (see section 4.4.3.3.2 Dispensing of Medication).  
 
The final stage of the process highlighted by both pharmacists and patients as an issue 
was at the point of preparing the patient for discharge (see C in Figure 6-1). Patient 
counselling was an important aspect of this, but unfortunately the content of 
counselling was mixed and was rarely carried out by a pharmacist.  
 
Other problem areas highlighted from phases 1 and 2 that are important to take into 
consideration during the development of the new model of care include:  
• Poor coordination of the discharge process 
• The length of time it takes for doctors to write discharge prescriptions 
• Pharmacy relying on ward staff to inform them when a discharge prescription 
has been written 
• Many medications supplied to the patient that could otherwise be obtained 
from their GP, leading to waste 
• Completed discharge information is not always sent to patients’ GP 
• Limited communication between hospital and community pharmacy  
• Patient involvement in their discharge is limited  
 
It is essential that the new model of care for discharge addresses these issues and 
identifies ways of overcoming them. 
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6.4 Positive aspects of the current discharge process 
Whilst for this PoW it was important to identify the stages of the discharge process 
which often lead to problems and delays at discharge, it was equally important to 
ascertain the stages that work well. Participants from both phases 1 and 2 highlighted a 
variety of examples of good practice in the current discharge process. Having 
pharmacists write discharge prescriptions instead of junior doctors was shown to speed 
up the discharge process and improve accuracy of discharge prescriptions (see section 
4.4.3.8.1 Current innovative solutions). The verification and clinical check of discharge 
prescriptions by a pharmacist was also seen as an important step for patient safety in 
the discharge process (see section 4.4.3.2.3 Verification of the discharge prescription). 
The introduction of electronic discharge systems have improved the quality of discharge 
information and enabled fast transmission of information to GPs (see section 4.4.3.2.1 
Content of the discharge documentation).  
 
From a patient perspective, the positives mentioned related to having good, caring staff 
looking after them, and being able to go home. It is important that the new model of 
care allows staff to prioritise patient care to provide a positive patient experience. All of 
this information gathered was taken into account during the development of the new 
model of care for discharge, along with the suggestions for improvement of the 
discharge process discussed in chapters 4 and 5. 
 
6.5 Proposed new model of care for patient discharge from 
hospital 
As previously discussed, the new model of care was developed based on the earlier 
findings and information from the literature. This new model of care was based on the 
suggestions and requirements of the participants within phases 1 and 2 of the PoW and 
is therefore appropriate for these patients and pharmacists. The new model of care was 
discussed with the supervisory team and the agreed model of care is depicted in a 
flowchart, outlining the stages of the proposed new model of care. The proposed new 
model of care for patient discharge flowchart can be seen in Figure 6-2.  
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Figure 6-2 – Proposed new model of care for patient discharge flowchart 
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6.5.1 Rationale for new model of care for patient discharge from hospital 
It is important to improve the discharge process and there are many potential 
beneficiaries to having a safe, efficient patient discharge system (see section 1.3 
Significance of the research). As has already been discussed, there are many potential 
sources of error and delay within the discharge process. Subsequently, there are many 
areas of the discharge process that need to be improved. For this reason, the proposed 
new model of care for discharge differs from the current discharge process in a number 
of ways.  
 
A recurring theme within the findings from both pharmacist and patient perspectives 
was to speed up patient discharge. The wait for discharge medicines was perceived as 
the main cause of delay to current discharge (see section 5.4.3.2 Perceived reasons for 
delay to patient discharge). If a patient is left waiting for their discharge medication, 
they are effectively ‘blocking’ a hospital bed by preventing a new patient from being 
admitted into it. By increasing the speed at which discharge medications are provided 
to patients, this will improve the efficiency of the discharge process overall. This should 
impact positively on both patient flow through the hospital and patient experience. This 
model of care has therefore been designed with a view to speed up the supply of 
medication at discharge. 
 
Each stage of the new model of care for patient discharge has been numbered in Figure 
6-2 – Proposed new model of care for patient discharge flowchart. The individual stages 
within the new model of care for patient discharge are described in detail, along with a 
discussion of the rationale for each, in the following sections.  
 
 
Stage 1: Prescribing pharmacist fully integrated into ward team 
For a prescribing pharmacist to be able to successfully write discharge prescriptions it is 
important for them to be fully integrated into the ward-based team. This will improve 
communication and team working between the MDT (see section 4.4.3.5.1 
Communication within the multi-disciplinary team). For the new model to function, it 
relies on the pharmacy team including pharmacists and pharmacy technicians to be 
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ward-based. This may involve redistribution of pharmacy staff, which will be feasible 
due to the shifting of roles as discharge dispensing is outsourced. 
 
Stage 2:  Decision to discharge 
The pharmacist as an integral member of the ward-based MDT, will ideally be on the 
ward round with the senior medical team and therefore present when the decision to 
discharge is made for each patient. The decision to discharge should remain the 
responsibility of the senior doctor looking after the patient, no evidence to the contrary 
was collected around this. 
 
This new model of care encourages pharmacy ownership of the medication supply 
aspect of discharge. Once the decision to discharge a patient has been made, the 
pharmacy team should take responsibility for the process, from the initial writing of the 
discharge prescription, to the patient receiving their medication for discharge. This will 
encourage improved coordination of patient discharge which was found to be lacking 
according to the pharmacists interviewed (see section 4.4.3.1.1 Coordination of the 
discharge process). 
 
In the current discharge process, when patients are declared medically fit for discharge 
they are told at this point that they can go home and this is usually when the process of 
medication supply at discharge begins. The process is known to be a lengthy, complex 
one with the potential for delays and error as previously discussed. Patients are often 
misinformed at this point as they mistakenly think that they can go home straight away, 
when in fact they often have to wait (see section 4.4.3.7.2 Involving the patient at 
discharge). Having a pharmacist present who is aware of the likely duration of the 
discharge process can ensure that patients are given the correct information and that 
patient expectations are appropriately managed. 
 
 
Stage 3: Writing the discharge prescription and patient consultation 
Whilst there are numerous reasons for the long wait in the current discharge process, 
the initial delay is the time lag between the decision to discharge and the doctor writing 
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the discharge prescription (see section 4.4.3.2.2 Writing the discharge documentation). 
Attempts have been made by hospitals to overcome this delay, for example: 
transcription of medication onto TTOs, pharmacists writing TTOs and writing TTOs 
earlier in the patient's stay. Those solutions that are working well, particularly 
pharmacists writing discharge prescriptions, appear to still be in the pilot phase or have 
not been rolled out across all hospital wards. Most hospitals were positive about 
pharmacists writing discharge prescriptions. It is for this reason that the new model of 
care will utilise a prescribing pharmacist on the ward to write the discharge prescriptions.  
 
Provided there are no social issues that need resolving prior to discharge, a pharmacist 
prescriber can begin writing the discharge prescription. The discharge prescription 
should be written during the ward round, to start the process at the point the patient is 
told they can go home. This should speed up patient discharge as delays currently arise 
when waiting for a doctor to write the discharge prescription once their competing 
interests have been addressed.  Having the pharmacist present when the decision to 
discharge is made provides the opportunity to clarify any medication queries or issues 
with the medical team immediately, which should speed up the writing process. Delays 
in the current process occur if pharmacists need to contact the medical team to address 
any queries or errors on discharge prescriptions written by doctors.  
 
The pharmacist should ensure that any additional information required is included on 
the discharge prescription. For example, reasons for any changes to medication, any 
monitoring requirements or future changes to medication. This is to improve 
communication across the interface. 
 
An important aspect of the new model of care is that as much of the discharge 
prescription as possible should be written at the patient's bedside. This provides an 
opportunity to discuss any changes to medication with the patient and give any 
counselling required. This stems from the findings in phases 1 and 2 that patient 
counselling is limited and unlikely to be carried out by a pharmacist. This is also an ideal 
opportunity for pharmacists to inform the patient about the discharge process, how long 
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they are likely to wait and what they need to do to get their medicines. Improving 
communication around the process of patient discharge is essential at this early stage, 
so the patient is fully informed.  
 
 
Stage 4: Communication with pharmacy team 
As in the current discharge process, the new model of care is heavily reliant on good 
communication to work efficiently. Within this new model, pharmacy will not be waiting 
for the medical team or nursing staff to let them know a discharge prescription has been 
written, which again, is often not a priority for them. This is an important step in the 
discharge process and could potentially lead to delays if not carried out.  
 
In stage 4 of the new model of care, the ward-based pharmacy team need to 
communicate this information between themselves. This is likely to be easier to do, as 
the pharmacy team’s priorities will be aligned and making contact within the team 
should be easier than attempting to contact a junior doctor. This is another area where 
the pharmacy team ownership of the supply of medication at discharge can help to 
smooth patient discharge. Once the discharge prescription is written by the pharmacist 
prescriber it is important that the pharmacy team is made aware of this so that they can 
carry out the rest of the process. Any delays informing the team will inevitably delay the 
rest of the discharge process. 
 
Stage 5: Verification of discharge prescription 
The discharge prescription, which has been written by a prescribing pharmacist, should 
receive a clinical check and be verified by a second pharmacist. From the phase 1 
findings, the verification by a pharmacist for patient safety in the current discharge 
process was seen as an example of good practice (see section 4.4.3.2.3 Verification of 
the discharge prescription). There have been a number of studies which demonstrate 
that discharge prescriptions written by hospital doctors commonly contain errors and 
omissions. Despite findings suggesting that prescriptions written by pharmacists are less 
likely to have errors than those written by doctors (see section 4.4.3.8.1 Current 
innovative solutions), in the interest of patient safety verification by a pharmacist is still 
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necessary within the new model of care due to the risk of human error. The second 
pharmacist checking the discharge prescription does not necessarily have to have been 
involved in the patient’s care. The second pharmacist should be able to clinically check 
the prescription and identify if there are any issues with its content. Communication 
between pharmacists to rectify any issues should be easier within a small team. 
Contacting the doctor to rectify issues was shown in phase 1 to be an additional rate-
limiting step at discharge.   
 
Stage 6: Assessment of patients’ own medication for discharge 
The next stage of the proposed model of care is to assess the patient's own medication 
for discharge. This should be carried out by the pharmacy team as it is in the current 
discharge process. Patient’s own medication should be checked for suitability for 
discharge, including asking the patient when they have any supplies of their medicines 
at home. It should then be documented on the discharge prescription which – if any – 
medication the patient requires a supply of for discharge. This stage is important to 
reduce medication waste.  
 
Stage 7: Does patient have all medication required for discharge 
This stage of the new model of care is based on the question ‘does patient have all the 
medication that they require for discharge?’ Two options now exist depending on the 
answer to that question, which can be seen on the flowchart in stage 7 of Figure 6-2. If 
patients have all of their medication for discharge, or have sufficient supplies at home, 
they will skip the supply stage of the new model and be prepared for discharge (stage 
10). This is similar to what currently happens in practice. Alternatively, for patients who 
require a supply of medication at discharge, they will move on to stage 8 ‘discharge 
prescription sent electronically to community pharmacy’. 
 
Stage 8: Discharge prescription sent electronically to community pharmacy 
If the patient does not have all of their regular medication in the current discharge 
process they are supplied with a minimum of seven days’ worth of medication. This wait 
for medication to be dispensed adds to the delay for the patient waiting to go home and 
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can lead to ‘bed blocking’. Hospitals are under a lot of pressure to improve patient flow. 
One idea that some hospitals have had to increase patient turnaround time is to move 
medically fit patients from their bed on the ward, to a discharge lounge where they can 
wait for their medication and free up their hospital bed (see section 4.4.3.8.2 
Suggestions for changes to the discharge process). Whilst this does in theory free up a 
hospital bed, problems can still arise here and it does not necessarily improve the 
patient experience as they are still left waiting for their discharge medicines in hospital. 
 
In the new model of care, patients who require a supply of medication will have their 
discharge prescriptions sent electronically to a community pharmacy of their choice to 
be dispensed. There are several reasons for this stage. There is a drive for moving care 
back into the community (see section 2.2 The changing care environment) and 
community pharmacies are ideally placed to dispense medicines close to the patient’s 
home. Patients often have a regular community pharmacy and communicating the 
patient’s discharge information to their community pharmacy will not only improve 
continuity of care, but will enable community pharmacists to support patients with their 
medicines after discharge. Having the community pharmacy aware of any changes to 
the patient's medication that took place during the hospital admission is likely to be 
beneficial to patient care. When asked for suggestions for improvement to discharge, a 
larger proportion of patients preferred to collect their medicines from a community 
pharmacy than wait for them in the hospital (see section 5.4.3.3 Suggestions for 
improvement of hospital discharge) and one Chief Pharmacist suggested that 
community pharmacies could supply discharge medication (see section 4.4.3.8.2 
Suggestions for changes to the discharge process).  
 
Clearly, visiting a community pharmacy after discharge is not feasible for every patient. 
However, the majority of community pharmacies offer a delivery service, which could 
be arranged for the patient when they are back at home. This should help improve the 
patient experience as their wait in hospital is reduced and support with their medicines 
after discharge is encouraged. This stage also benefits the hospital by speeding up 
discharge turnaround times and therefore improving patient flow through the hospital.  
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Many hospitals have chosen to outsource their outpatient prescription dispensing. This 
involves community pharmacy companies running outpatient pharmacies within a 
hospital where all outpatient prescriptions are dispensed. This has been shown to 
improve efficiency, reduce patient wait for their outpatient medication, and has had a 
cost saving impact for many hospitals.(19) With the success of outsourced outpatient 
pharmacies, it would be remiss to not utilise similar resources for the dispensing of 
discharge medication. Although utilising these outpatient pharmacies to dispense 
discharge prescriptions was considered, sending the discharge prescription to the 
patient’s regular community pharmacy was chosen. Firstly, because not all hospitals 
have an outsourced outpatient dispensing facility and secondly, the link with the 
patient’s community pharmacy at discharge was thought to be beneficial for continuity 
of care. 
 
 
Stage 9: Communication with community pharmacy 
In order to ensure the new model of care is robust, there needs to be some mechanism 
of communication with the community pharmacy that the prescription as has been 
electronically sent to. This would ideally be an electronic form of communication to 
improve efficiency. This communication would be a two-way system where the 
community pharmacy could confirm that they have received the prescription, that they 
are able to supply that medication within a particular time frame, and to confirm a time 
for delivery or a time the patient can expect to collect the medication. This information 
should then be relayed to the patient to confirm the arrangements. With the 
appropriate technology, a message could also be sent to the patient confirming the 
arrangements. Once arrangements are organised with the community pharmacy, the 
patient can then move to the next stage of the new model where they are prepared for 
discharge.  
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Stage 10: Patient prepared for discharge 
In the current discharge process, discharge medications are checked and handed to the 
patient, along with the discharge prescription, by the nurse looking after them. Patients 
should at this point be counselled on their medication before they go home. The extent 
to which this was thought to take place was limited (see section 4.4.3.7.1 Patient 
Counselling). This is an essential stage in the process, however in the new model of care, 
a member of the pharmacy team should oversee that final check of the patient’s own 
medication given to the patient at discharge. The pharmacy team will have just checked 
the patient’s own medication for discharge (see Stage 6: Assessment of patients’ own 
medication for discharge) so going through the medication with the patient and 
providing any last minute counselling can be seen as an extension of this task. The 
addition of the pharmacy team at the last stage should ensure that the patient receives 
only the correct medicine at discharge. This concludes the pharmacy ownership of the 
discharge process and ensures everything is carried out as intended. The patient will 
have the process of either collecting or receiving their discharge medication from the 
community pharmacy explained to them at this point. 
 
 
Stage 11: Transfer of care 
All discharge information is automatically sent electronically to the patient’s GP, as this 
is essential for continuity of care to allow the GP to continue to provide the necessary 
follow-up care. Stage 11 should already be occurring in practice, to transfer patient care 
from the hospital back to their community provider. Appropriate technology should be 
utilised to ensure that the electronic information arrives with the GP completed, and in 
a timely manner.  
 
As indicated in stage 11 of Figure 6-2, the patient then crosses the interface as they are 
discharged from hospital. Stage 11a involves the GP practice receiving this electronic 
discharge information from hospital, across the interface. This is an automatic stage 
once stage 11 is carried out by hospital staff. 
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Stage 12: GP-based clinical pharmacist involvement 
Alongside the patient arriving home and receiving their medication, the discharge 
information is sent and now received by the GP surgery. Currently, any changes to 
patients’ medication are usually actioned by their GP. One important change in the new 
model of care is the involvement of a clinical GP pharmacist at discharge, which is not 
currently standard practice (see section 2.2.1 Changes in pharmacy services). By 
including a clinical pharmacist in the GP setting, this closes the loop and improves 
continuity of care. The GP-based clinical pharmacist can review the discharge 
medication, perform medicines reconciliation and update the patient's medical record 
to ensure that all medication is accurate and up-to-date. Having the ability to quickly 
contact the hospital pharmacist prescriber will allow GP staff to rectify any queries (see 
Stage 14: Ability to contact the hospital prescribing pharmacist). 
 
 
Stage 13: Community pharmacy supply patient with medication 
After discharge from hospital, the patient arrives home. The final stage involves the 
patient receiving their medication from the community pharmacy. This may be by 
delivery from the community pharmacy, or it may be that an arrangement has been 
made for the patient or their representatives to collect from the community pharmacy 
as appropriate. This is another opportunity for the community pharmacy to ensure the 
patient has been counselled on any new medication and is clear what exactly they 
should be taking. By having access to the discharge prescription, they should have the 
necessary information to enable them to do this. 
 
 
Stage 14: Ability to contact the hospital prescribing pharmacist 
The discharge prescription will contain the contact details of the prescribing pharmacist. 
This means that if there are any issues with medication in the community there is a 
contact for them to get in touch with the pharmacist prescriber to rectify this. 
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6.6 Discussion 
Overall, the pharmacy team ownership of the medicines aspect of the discharge process 
is important to ensure that the process is completed as safely and efficiently as possible. 
Phase 1 findings demonstrated poor coordination of the discharge process and that no 
one was taking ownership of the discharge process overall (see section 4.4.3.1.1 
Coordination of the discharge process). Having the pharmacy team responsible for all 
aspects relating to patients’ medication is important, from prescribing, counselling, 
organising the supply and handing out medicines to the patient ready for them to go 
home. This is likely to increases efficiencies in the process and avoid omitting important 
stages. Whilst pharmacy ownership of the medicines aspect of discharge is important, it 
is essential to note that there are other aspects of discharge that will be occurring 
simultaneously (as discussed in section 2.6 Discharge from hospital). Links between the 
pharmacy team and those carrying out other aspects of patient discharge need to be 
maintained. The impact of this will be investigated through feasibility testing of the 
proposed new model of care in phase 4.  
 
The model of care follows the guiding principles in developing new models of care 
discussed in the introduction (see section 2.9 Developing new models of care). The new 
model of care is patient-centred and aims to improve patient experience as well as 
patient care. It was developed based around the participants from phases 1 and 2 of the 
PoW and takes into account their views and needs. The new model of care for patient 
discharge has localised flexibility to consider equity of access for all patients. Flexibility 
of the new model of care is key to its success. As with all ‘real world’ scenarios, there 
may be instances whereby the model of care is not suitable. A degree of flexibility will 
be necessary to allow for safe, appropriate patient care. As individual cases arise, these 
would have to be addressed. Good communication between patients and healthcare 
professionals throughout the process will facilitate this and avoid any issues. Suitable 
arrangements could be made for individual patients based on their needs, for example 
delivery or collection of medication as appropriate. This new model supports integrated 
care by encouraging communication between hospital and community pharmacy, 
improving continuity of care across the interface. It supports efficient use of resources, 
both in hospital and community whilst ensuring safe quality care for patients. The new 
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model of care is innovative, involving new ways of organising and delivering patient care, 
setting the vision for pharmacy services in the future. 
 
The new model of care draws on the earlier findings from this PoW and proposes 
solutions to overcome the issues highlighted, whilst keeping successful aspects of the 
current discharge process. Whilst the new model is an improvement on the current 
discharge process, in order to identify any issues with the new model of care feasibility 
testing is needed to refine the model and ensure its suitability for implementation. By 
undertaking feasibility testing, any issues that may arise on implementation of the new 
model of care for discharge can be identified, considered and resolved as appropriate. 
 
6.6.1 Limitations 
The main limitation for this phase is that the new model of care was developed based 
on the findings of phases 1 and 2, along with evidence from the literature. Although this 
has many positives, which is why the PoW followed this route, there is a risk of bias. 
Relying on the findings from these phases may have led to important aspects or 
viewpoints being missed. This is particularly the case with subjective qualitative data, 
other potential participants who did not participate in the earlier phases may have had 
differing opinions from those that did participate. 
 
 
6.7 Conclusion 
This phase of the PoW has successfully met the phase aim, which was to develop an 
innovative model of care for patient discharge from hospital that provides safe, quality 
care in a timely manner and improves patient experience. 
 
The phase 3 objectives were also met. The findings from phases 1 and 2 were 
triangulated, highlighting the issues that require solutions and the examples of good 
practice at discharge, from the perspective of pharmacists and patients (see section 6.3 
Problem areas within the current discharge process). The triangulated findings and 
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evidence from the literature were then used to generate a new model of care for 
discharge, which was mapped out and defined (see section 6.5 Proposed new model of 
care for patient discharge from hospital). Section 6.5.1 Rationale for new model of care 
for patient discharge from hospital, explains how the new model of care for patient 
discharge overcomes the issues and encompasses the good practice identified in phases 
1 and 2.  
 
The proposed new model of care has been designed as a result of existing evidence in 
the literature and discussions with patients and pharmacists about their expectations 
and requirements during hospital discharge. Evaluation of the model is required to 
determine its potential impact.  
 
So far, this thesis has described phases 1 and 2 which identified and evaluated the 
current discharge process from the pharmacists’ and the patients’ perspective. This 
chapter has presented phase 3 which triangulated these findings and used the results to 
develop a new model of care. This chapter introduced the proposed new model of care 
and detailed the rationale behind it. The following chapter will discuss the findings from 
phase 4 of the PoW, feasibility testing of the proposed model of care. 
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Chapter 7 – Phase 4: Evaluating the new model of care 
 
Having introduced the proposed new model of care in Chapter 6, this chapter describes 
and discusses the findings for phase 4 of the PoW, which involved feasibility testing of 
the proposed model of care. This final phase of the PoW involved interviews and focus 
groups with a variety of people involved in patient discharge from hospital (hereafter 
referred to as stakeholders) to evaluate the proposed model of care. 
 
7.1 Introduction 
To overcome the issues associated with hospital discharge previously discussed, the 
PoW was designed to facilitate the development of a new model of care. This new model 
was described in chapter 6. It is important to set this new model of care up to succeed. 
To facilitate this, the final phase of the PoW involved feasibility testing of the new model 
of care. This looked to identify any potential issues and establish the views of relevant 
stakeholders involved in the new model of care. This phase is important to the overall 
PoW as the findings are used to refine the proposed model to improve and increase the 
likelihood of a successful implementation. 
 
7.2 Method  
The method utilised in this phase of the PoW has been fully described in section 3.6.3 
Phase 4 research method. This qualitative phase involved both semi-structured 
interviews and focus groups with relevant stakeholders in patient discharge from 
hospital. The recordings resulting from the interviews and focus groups were 
transcribed and thematic analysis by constant comparisons was used.  
 
As discussed in section 3.6.4.1 Topic guide development, the general topics for 
discussion were based on the findings from earlier phases of the PoW. These key topics 
for discussion during the interviews and focus groups were as follows: 
• General feedback on new model 
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• Where any improvements could be made 
• Any practical issues with new model 
• What resources would be required to provide new model – is this feasible?  
• What knowledge/skills would be required for those providing the new model 
of care 
 
7.3 Aim and Objectives 
The aim of this final phase of the PoW was to explore stakeholder views of the proposed 
new model of care for patient discharge from hospital.  
 
The objectives were to: 
• Explore perceptions of the proposed model of care with relevant 
stakeholders in the new model including patients and healthcare 
professionals from hospital and community settings 
• Identify any potential issues with the new model of care 
• Identify the knowledge and skills required to deliver the new model of care 
to establish future training needs 
• Identify the resources required to deliver the new model of care 
• Refine the new model of care based on stakeholder feedback 
 
7.4 Findings  
This section will present and the discuss the findings from this phase of the PoW, 
including the pilot, participant demographics, a stepwise review of the new model of 
care and the themes generated. 
 
The transcripts were coded into nodes as described in section 3.6.5.2 Coding and 
analysis. Coding the interview transcript data led to a total of 81 nodes created. Coding 
began using some a priori nodes to code data into initially, which were based on the 
study objectives, the stages of the new model of care and the questions asked of the 
participants. In addition to the a priori nodes, a grounded approach to coding the data 
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was taken, looking at each line and questioning the meaning of each, focussing the 
researcher on the data itself. This led to the creation of many nodes based on the 
content of the data itself.  
 
Once the data had been coded, the nodes specifically relating to the logistics of each 
individual stage of the new model of care were taken and used to perform a detailed 
stepwise analysis of the new model of care to establish what participants thought of 
each stage of the new model of care. This can be seen in section 7.4.3 Stepwise review 
of new model of care. The remaining 28 nodes were thoroughly checked, looking for 
repetition, similarities and differences in the data to develop relevant subthemes then 
organised into broader themes during the analysis process. Both routes of analysis were 
thought to be important – to analyse in detail the steps and refine individual stages of 
the process to improve the new model of care as much as possible. A holistic view of the 
process is equally important and allowed other aspects to be discussed and reviewed 
that would not be possible in the detail.  
 
 
7.4.1 Pilot outcome 
The first interview conducted was undertaken as a pilot to determine if recruitment 
methods were suitable and the questions in the topic guide yielded suitable data for 
analysis. Similarly, the first focus group conducted was carried out as a pilot. This was to 
determine if the topic guide was as suitable for promoting discussion during the focus 
groups, as it was for the interviews. The pilot demonstrated that the questions elicited 
appropriate discussion around the topic in both the interviews and focus groups. The 
questions were unambiguous and yielded suitable, relevant data to meet the study 
objectives. Minor rephrasing of some questions took place after the pilot to improve 
their clarity. No significant changes were made to the topic guide or procedure following 
the pilot and the findings from both the first interview and the first focus group were 
included in data analysis. Data collected during both the pilot interview and focus group 
were included in the main analysis.  
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7.4.2 Demographics 
Data collection for this phase took place between 16th September 2016 and 6th 
December 2016. Potential participants (see section 3.6.3.2 Participants for details of 
how participants were selected) were approached in succession either in person or via 
email. All of those approached agreed to participate in either an interview or a focus 
group, depending on their availability.  
 
A total of 37 people participated in this phase, 23 of which participated in interviews. 
The average duration of the interviews was 32 minutes (range 19 to 60 minutes). The 
remaining 14 participants were involved in two focus groups. Both focus groups 
contained 7 participants each from a similar background, but with differing levels of 
experience. The two focus groups lasted 29 and 28 minutes respectively. 
 
All participants met the inclusion criteria and none of the exclusion criteria and 
therefore allowed the most representative data to be captured. A range of stakeholders 
participated, including: hospital pharmacists with differing levels of experience and from 
different hospitals, community and primary care pharmacists, nurses, hospital doctors 
and GPs, pharmacy technicians as well as patient and carer representatives. Participants 
were recruited from a range of hospitals, GP practices, community pharmacies and CCGs 
across North West England. A full list of participants and their backgrounds can be seen 
in Table 7-1.  
 
Data collected from all interviews and the two focus groups conducted were analysed 
together. To differentiate between the interview participants and the focus group 
participants, interview participants have been numbered 1 – 23 and focus group 
participants have been allocated a letter, A – N. Participants A – G were in one focus 
group and participants H – N were in the second focus group. This coding can be seen in 
Table 7-1. Each stage and theme throughout this findings section is presented including 
an overview of the topic and a description relevant information. Similarly to phase 1 
findings (see section 4.4.3 Themes) to help present the data, quotes taken directly from 
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the data have been used. These quotes have been anonymised and for context have 
been described according to job role or status of each participant.  
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Table 7-1 – Phase 4 participant demographics 
Participant  Job role Place of work 
Interviews 
1 Clinical Pharmacy Services Manager City centre teaching hospital 
2 General Practitioner GP practice 
3 Consultant Pharmacist City centre teaching hospital 
4 Independent prescriber Hospital 
Pharmacist 
City centre teaching hospital 
5 Medicines Management Pharmacist City centre teaching hospital 
6 Pharmacist Teacher Practitioner  University/ City centre teaching hospital 
7 Community Pharmacist City centre community pharmacy 
8 Community Pharmacist Suburban community pharmacy 
9 Medicines Safety and Care of the Elderly 
Pharmacist 
City centre teaching hospital 
10 Rotational Hospital Pharmacist City centre teaching hospital 
11 Band 7 Haematology Pharmacist City centre teaching hospital 
12 Nurse Ward Manager City centre teaching hospital 
13 Senior Hospital Pharmacist Large district general hospital 
14 Lead Pharmacist for Medicine City centre teaching hospital 
15 Primary Care Prescribing Pharmacist Clinical commissioning group 
16 Outpatient dispensing pharmacist Large teaching hospital 
17 Specialist Paediatric Pharmacist Children’s hospital 
18 Medical Education Pharmacist University/ City centre teaching hospital 
19 Junior doctor, medical specialities City centre teaching hospital 
20 Junior doctor, surgical trainee Teaching hospital 
21 Consultant, Acute Medicine City centre teaching hospital 
22 General Practitioner GP practice 
23 Clinical Pharmacy Operations for 
community pharmacy chain 
Large UK community pharmacy chain 
Focus group 1  
A Medicines management technician City centre teaching hospital 
B AMU medicines management technician City centre teaching hospital 
C Lead medicines management technician City centre teaching hospital 
D Medicines management technician City centre teaching hospital 
E Renal medicines management technician City centre teaching hospital 
F Medicines management technician City centre teaching hospital 
G Medicines management technician City centre teaching hospital 
Focus group 2 
H Patient representative Patient and public involvement group North West 
I Dementia nurse lead Patient and public involvement group North West 
J 
 
Learning disabilities nurse/carer   
representative 
Patient and public involvement group North West 
K Patient representative Patient and public involvement group North West 
L Patient representative Patient and public involvement group North West 
M Carer representative Patient and public involvement group North West 
N Patient representative Patient and public involvement group North West 
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7.4.3 Stepwise review of new model of care 
A detailed description of the stages of the new model of care was given in chapter 6 and 
can be seen in Figure 6-2. This section details the findings of a review of the stages within 
the new model of care, from the perspective of the stakeholders. The stages have been 
grouped together as discussed by the participants. In addition to any comments, positive 
or negative, suggestions for improvement have been included. Any refinements made 
to the new model of care based on participant suggestions have also been included 
within the relevant stages. 
 
Stages 1 and 2: Prescribing pharmacist fully integrated into the ward team and 
decision to discharge 
The participants’ thoughts on stages 1 and 2 of the new model of care have been 
discussed together below.  
 
Integrated ward team 
Having the pharmacist fully integrated to the ward team was seen as beneficial to write 
discharge prescriptions.  
“Pharmacists being the member of the team who’d write the discharge 
medications, factoring in anything that’s happened in that ward round or 
pre-planned in the notes. To me it makes a lot of sense.” Clinical 
Pharmacy Services Manager 
In addition to a pharmacist, it was suggested that it may also be beneficial to have a 
pharmacy technician integrated into the team and involved in the ward round, to 
support the logistics of the supply of medication. 
“Maybe they could have a technician attached the ward round as well. 
Because they are really knowledgeable. If a TTO goes missing they can 
find it, they know exactly where it is. I don't know how they do it but they 
just do.” Nurse Ward Manager 
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Before the decision to discharge 
Steps could be taken during admission to help the new model of care run smoothly. 
Participants highlighted the importance of ensuring the patient is prescribed the correct 
medication during their admission, by performing medicines reconciliation on admission. 
This should assist the reconciliation of discharge medications.  
“Obviously the big part now is the medicines reconciliation to make sure 
that information is flowing through. So it's important that we move to 
making sure that we document what everyone has come in on and we 
can then reconcile at the point of discharge all changes and make sure 
that does get communicated which is the big problem.” Lead Pharmacist 
for Medicine 
Another suggestion was that for certain patients, the pharmacist could begin writing the 
discharge prescription before the ward round and make any final adjustments after the 
decision to discharge has been made. This will help to speed up the process during the 
ward round and manage the pharmacists’ workload.  
“Often the decision can be taken before, the ward round could be a 
confirmatory thing so you could start the planning beforehand … So that 
if they know say three of the patients that they are going to see are 99% 
certain to go home they could have those TTOs written before the ward 
round, and then when the consultant says yes this patient can go home it 
is a case of just ‘is anything changing from what I have done?’ No, fine 
hit the button, move on.” Medicines Management Pharmacist 
Decision to discharge 
The actual decision to discharge should remain with the consultant responsible for the 
patient.  The new model of care should not affect this.  
“The decision to discharge, that’s kind of outside of our scope isn’t it? So 
there’s social issues etc.” Clinical Pharmacy Services Manager 
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Stage 3: Writing the discharge prescription and patient consultation 
As described in chapter 6 (see Stage 3: Writing the discharge prescription and patient 
consultation) in the new model of care, writing the discharge prescription and the 
consultation with the patient should occur simultaneously during the ward round. Both 
tasks are carried out by the pharmacist, resulting in an increase in pharmacist visibility 
to patients on the ward in comparison with the current discharge process. Patients 
should benefit from this increased interaction with the pharmacy team.  
“What I like about it is this idea that the pharmacist is more involved in 
the process, so there you are able to communicate any changes. It’s the 
stuff that we should be doing, but in a busy hospital we might not get the 
time to do.” Medical Education Pharmacist 
Pharmacists writing the discharge prescription 
Hospital pharmacists were considered an appropriate healthcare professional to write 
discharge prescriptions. Pharmacists were thought to produce quality discharge 
prescriptions and speed up the process. Pharmacists were seen by participants as able 
to understand a variety of perspectives and therefore generate an accurate and 
complete discharge prescription. 
“I think having pharmacists write the discharge again can make a lot of 
sense because we almost have that foot in both camps, you know. We’re 
clinically minded enough and part of that ward based team to know 
what’s going on with the care, but we’re functionally minded to know 
what it takes to create an accurate discharge prescription that a 
pharmacist can process.” Clinical Pharmacy Services Manager 
Junior doctors thought pharmacists writing discharge prescriptions would improve 
quality of discharge prescriptions, was an appropriate change in role and they were 
happy for them to do so.  
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“I have no problem with [pharmacists writing TTOs] it’s one less thing for 
doctors to do. We had a teaching session with a pharmacist and I was 
amazed at how many TTO scripts have errors on them that have to have 
a phone call. So you would hope that pharmacists writing the TTO would 
reduce that risk. So it probably will reduce time overall.” Junior doctor, 
medical specialities 
Logistics of writing discharge prescriptions during the ward round  
Writing discharge prescriptions on the ward round alongside the medical team on the 
ward round was thought to complement shared decision making policies.  
“The new prescribing competencies emphasise the point of shared 
decision-making. You do need to have close involvement with the team 
because you are available to them and they are available to you.” Senior 
Hospital Pharmacist 
This stage of the new model of care was thought by many participants to be feasible and 
work well. However, participants did note that there may be certain issues that could 
slow down the process. The following issues were highlighted. If the inpatient prescribed 
medication was not correct at the time of writing the discharge prescription. The 
pharmacist would have to take the time to rectify any issues before starting the 
discharge prescription.  
“So I think that it is a good model. I can see that that there are potentials 
for slowing down if you have to do the meds rec at the same time. And 
often you can do it easier if you've got the patient in front of you. If you're 
doing a TTO at the bedside you can go through the medications there and 
then. You can quite quickly know what is right and what is wrong, it is 
just sorting it that takes a bit of time, are mistakes intentional or not?” 
Senior Hospital Pharmacist 
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The timing of the ward round itself could also impede the process. If ward rounds or 
decisions about patient care are occurring later in the day, this will impact the time in 
which the discharge prescriptions can be written. Participants suggested that to 
overcome this, straight-forward discharge prescriptions should be completed as early as 
possible, to reduce the number remaining later in the day. 
 “If it’s done in the morning then they can all be done early on in the day. 
If my ward round was at 3 o'clock in the afternoon I’d be in a difficult 
position. There will be some situations where you can't make the 
decisions, for example you’re waiting for the INR to come back before you 
dose the warfarin. I think the key to this is getting the quick ones done 
and then the ones with problems you accept that there may be a decision 
late in the day but that's alright we can manage that because we’ve got 
less of them. And it's meeting the patient expectation, let them know 
what else needs doing.” Lead Pharmacist for Medicine 
A further obstacle highlighted was around logistics. If the ward round team move on to 
the next patient whilst the pharmacist is still writing the discharge prescription, or 
talking to the patient, they could miss information about the next patient.  
“But I think there is a downside though, to what you have described. 
Because if you have someone on a ward round, say the first patient you 
start the TTO for discharge and you then leave the ward round. We don’t 
stop, we carry on and the second person may also be going home and 
then you’re playing catch up then and you become independent from that 
team.” Junior doctor, medical specialities 
There is then a risk that pharmacists will rush discharge prescriptions, reducing their 
quality, to keep up with the pace of the ward round. One suggestion included waiting 
until after the ward round to write the discharge prescriptions if this became a problem.  
This would ensure that the pharmacist would be fully informed. However it could delay 
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all of the discharge prescriptions, depending on the length of time the ward round takes. 
This could result in a similar situation to what happens currently. 
“I do worry that you as a pharmacist will miss a lot of the ward round and 
you might end up rushing the TTO to get the next patient, so you wouldn't 
miss if someone with a massive medication list is going to go home. So 
might be better to do the ward rounds, take notes and then go to a room 
away from bleeps and work your way through them. You could ask which 
are the priority as well, annotate which ones are palliative ones or blister 
packs or ambulances and then after you've written them all liaise with 
the nurses” Band 7 Haematology Pharmacist 
Having to miss part of the ward round appears to be commonplace and from a 
consultant’s perspective, it is better to follow this model and hear the majority of 
relevant information than to not attend the ward round and potentially miss all relevant 
information. 
“If the next person is discharged, you’re going to miss it. But then still, 
you have picked up on the first one. Unless you’re going to have 100 
pharmacists which I doubt, that’s always going to be a problem. And I 
think it’s still better to do some, even if you can’t catch all of them. 
Because really for a pharmacist it’s crucial that they are there, because 
they’re picking up why these medicines are [prescribed].” Consultant, 
Acute Medicine 
By having the appropriate information technology (IT) infrastructure in place, this should 
allow the pharmacist to write discharge prescriptions without having to move away from 
the ward round.  
“Now that we are using more IT based things, if you’re the pharmacist on 
the round and it’s a simple TTO, there’s nothing to stop you having a 
notebook or a tablet and doing it on that. But you don’t have to physically 
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leave the ward round. There may be lots of patients where you are not 
physically needed for every single patient, but you are in the room. But 
that’s about the available technology rather than anything else.” Junior 
doctor, medical specialities 
Another logistical issue highlighted was the difficulty attending the ward rounds.  
Potentially trying to organise attending more than one ward round could be difficult. 
Particularly if they are running at the same time.  
“If you are just covering a ward and so if you are covering and you have 
got another ward and the ward rounds are at the same time, how would 
the pharmacist know what needs to go on the TTO?” Independent 
prescriber Hospital Pharmacist 
Patient consultation 
The patient consultation involves two aspects: medication counselling and an 
explanation of the discharge process and what the patient will need to do to obtain their 
discharge medication.  
 
The benefits of patient counselling by a pharmacist are discussed throughout this thesis. 
Despite the majority of participants agreeing that the new model of care provides an 
ideal opportunity to counsel patients, one participant raised the issue that some 
patients may be preoccupied and not take in the information.  
“If you’ve just been told you can go home, is that the right time to counsel 
a patient? Or is there another time they are going to be more receptive 
to information? I think it’s a tricky one because you have got the 
opportunity to counsel them and once they are out of the system you may 
find that they are not engaging with the system. Equally I think at the 
point that you are being discharged, there is a reasonable subset of 
patients whose focus is then going to be on the process of going home 
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and their attention is going to be reduced.” Clinical Pharmacy Services 
Manager 
This same participant suggested that technology could be used to provide patient 
counselling. Patients could be given electronic access to counselling points about 
medication that could be read at a time convenient for a patient.  
“I don’t really understand why you don’t have a QR code, or a website on 
a discharge summary then you’ve got a video repository that you could 
add. So you can always get your counselling and people could see, and 
pick and choose their drugs.” Clinical Pharmacy Services Manager 
As discussed in phases 1 and 2, patient counselling is not occurring routinely. It is unclear 
exactly when the most appropriate time to counsel patients is. Every patient is different 
and many factors will affect attention span, for example: the stage of discharge they are 
at, other personal issues and the amount of information they are given.  From the 
responses of participants, there does not appear to be a clear time to counsel patients. 
Counselling throughout admission if any changes are made would be beneficial, 
however from the generally positive responses from stakeholders, where possible 
counselling should take place with the pharmacist at the point that the discharge 
prescription is written. If further counselling can take place as a reminder, this will 
reinforce the information and should be encouraged.  
 
As previously mentioned, in the current discharge process patients are often 
misinformed when they are told that they can be discharged. Patients think that they 
can go home straight away and are often left frustrated when the process takes much 
longer than expected.  
“From personal experience I know that many patients and their relatives 
get really irate and upset when they are told that they can go and are 
then left waiting. I always think, why are they told they can go if they 
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don’t have the medicines? Because actually you can’t go. It’s being told 
to patients wrong.” Patient representative 
Participants saw the benefits of having a pharmacist present at this point to ensure that 
the patient is fully informed of the process and the likely duration. 
“If the pharmacists are there prescribing, you can eradicate any of that 
misinformation. You would be able to clarify it on that earlier 
intervention.” Dementia nurse lead 
 
Stages 4 and 5: Communication between pharmacy team and verification of the 
discharge process 
 The next two stages of the new model of care involve the prescribing pharmacist 
communicating to the pharmacy technician and the second pharmacist that a discharge 
prescription is ready and needs to be clinically checked and verified.  
 
Communication between the pharmacy team was thought to be easier than 
communication with the doctors who may not be on the ward when required.  
“It is easier for a pharmacist to contact a pharmacist rather than the 
doctors who may have a million other places that they need to be.” 
Independent prescriber Hospital Pharmacist 
Verification of the discharge prescription by a second pharmacist was thought to be an 
important stage in the process, as pharmacists are still at risk of making prescribing 
errors.  
“And then there’s a bit in there that I really strongly agree with and that’s 
that you are going to get someone verifying the pharmacists’ work. 
Because we always feel much safer when a pharmacist has reviewed our 
work. A lot of it is because you are going to make mistakes as human 
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error. We have a natural safety check when a doctor prescribes and a 
pharmacist checks it and I think you need to keep that safety check there. 
Show me someone who has done 100 prescriptions and not made a 
mistake on any of them. Especially when it’s busy.” Consultant, Acute 
Medicine 
Although it is not mandatory to clinically check a pharmacist’s prescribing, those 
pharmacists who are likely to carry out the role agreed that they would prefer to have 
their prescribing checked by another pharmacist. 
“Yes definitely. As someone who is just going through my non-medical 
prescribing training now and potentially working as a prescriber rather 
than a pharmacist I wouldn't want to be doing both sets myself. I don't 
think the RPS or the GPhC are explicit about that at the moment, beyond 
controlled drugs. But I do think that it is good practice to have someone 
doing the clinical check. Separate the tasks out.” Medicines Management 
Pharmacist 
One participant suggested that the community pharmacist could verify the discharge 
prescription, to reduce duplication of stages in the new model of care.  
“I think [the verification of TTO by a second pharmacist] is an additional 
step that may not be necessary. Could this not be done by the community 
pharmacist rather than the hospital pharmacist? The term ‘clinical 
pharmacist’ is often talked about in relation to hospital pharmacists, but 
all pharmacists are clinical pharmacists. The community pharmacist will 
be doing their own clinical check when they receive the TTO, as they 
would with any other type of prescription that they receive. So having the 
hospital pharmacist do a clinical check and then a community pharmacist 
do a check … Basically you are duplicating work here and adding a rate-
limiting step.” Head of Clinical Pharmacy Operations for community 
pharmacy 
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Stages 6 and 7: Assessment of patients’ own medication for discharge and does 
patient have all medication required for discharge 
Patients’ own medication will be assessed by the pharmacy team to establish what 
medication needs supplying on the discharge prescription. This happens in the current 
discharge process. Participants suggested that few items would need to be dispensed 
for the discharge prescription if the patient’s medication had been appropriately 
managed during their inpatient stay.  
“Hopefully they would have [all their medication] anyway. We manage 
our ward really well. Our TTOs hardly ever need dispensing. The 
technician manages it completely and pre-emptively. She looks at the 
notes and she listens on the ward rounds as well, she's in the background 
to see what might be happening. What drugs might be coming up.” Band 
7 Haematology Pharmacist 
Stages 8 and 9: Prescription sent electronically to community pharmacy and 
communication with community pharmacy 
As discussed in section 6.5.1 Rationale for new model of care for patient discharge from 
hospital, the discharge prescription will be sent to the patients’ community pharmacy 
to be dispensed in stage 8 of the new model of care. Stage 9 involves communication 
between the pharmacy team in the hospital and the community pharmacist to ensure 
that the community pharmacy can provide the medicines required on the discharge 
prescription for the patient.  
 
Following a detailed discussion with participants around stages 8 and 9, more steps are 
involved within these two stages than simply sending the prescription to the community 
pharmacy and communicating with the community pharmacy. As a result, the proposed 
model of care has been refined to expand on stages 8 and 9 to capture each element 
discussed by participants.  
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“You’ve got information that needs to go to the community pharmacy, 
community pharmacy needs to acknowledge that information, decide 
whether they can act on it, physically supply a patient, then there’s got 
to be some sort of feedback if they can’t.” Clinical Pharmacy Services 
Manager 
 
Sending the prescription electronically to the community pharmacy 
Participants were in agreement that a single electronic system should be used, rather 
than having different methods of sending over the discharge prescription.  
“If you're using a system which involves every single community 
pharmacy it is better to use a system which is consistent. Rather than 
saying one trust will fax them down, we’ll email them down, we'll scan a 
copy on and then email that. At least then it is electronically signed the 
doctor has to go dink it’s signed and then it goes to the spine.” 
Community pharmacist 
Participants thought that to improve continuity of care, regardless of whether patients 
need their discharge prescription sending to their community pharmacy to be dispensed, 
they should still be given the option of sending it to the community pharmacy for 
information purposes. 
“Potentially you should be asking the patient if they want us to send their 
information to the community pharmacy whether they are waiting for a 
supply or not of their medicines. This is for continuity of care and to help 
prevent problems.” Independent prescriber Hospital Pharmacist 
Patients should be given the choice as to whether they would like their discharge 
information to be sent over to their community pharmacy even if a supply of medicines 
is not required. For this reason, in the refined model of care, during stage 10 when the 
patient is prepared for discharge, they will also be asked if they would like their 
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discharge prescription to be sent to the community pharmacy if this has not already 
been done. Then as part of the transfer of care across the interface in stage 11, the 
discharge information can be sent to the community pharmacy as well as the GP if 
appropriate. This alteration can be seen in the refined model of care in Figure 7-1. 
 
Communication between hospital and community pharmacy 
Participants agreed that communication between hospital pharmacists and community 
pharmacists is important.  
 “Opening up that communication with community pharmacy, it’s 
definitely the way we need to be moving forward. In the last MDT I was 
at, they really appreciate how important it is for communication between 
different levels of care and not just hospital doing everything and then in 
community they haven’t got a clue what’s been going on.” Medical 
Education Pharmacist 
Respondents highlighted several projects beginning across the UK, looking at sending 
patients’ discharge information to their community pharmacy for information. This has 
not expanded to involving community pharmacies in dispensing medication for 
discharge. The response had been positive to the idea of hospitals sending over 
discharge information to the community pharmacy, with talks around how it can link 
into providing MURs and the NMS for patients after discharge. 
“Yeah everybody was really keen. It was like yeah, that makes so much 
sense.  We were talking around linking it in with the MURs and the New 
Medicines Service as well.” Primary Care Prescribing Pharmacist 
Participants raised concerns around an increase in the volume of telephone calls from 
community pharmacies as a result of outsourcing dispensing of discharge prescriptions 
to community pharmacies. Without adequate communication, community pharmacists 
may need to repeatedly contact the prescriber if there is anything that they are unsure 
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of. This could hinder the process and increase the workload for both community and 
hospital pharmacists.  
“We don’t really communicate that well with community pharmacists. I 
think that has to change fundamentally. We do have to be more proactive 
at communicating any changes, almost pre-empting if it is something 
unusual maybe to let them know in advance. Just in case they query it. 
Otherwise you might be having calls all of the time.” Pharmacist Teacher 
Practitioner 
An issue raised by one participant was that to ensure that the community pharmacist is 
able to supply the correct medication for each patient, it is important for them to 
understand the format of the discharge prescription and the endorsements made by 
hospital pharmacy staff indicating which medications need to be supplied.  
 “We need to be very clear with the community pharmacist what they 
actually need to dispense, because some of the items will have been 
dispensed as an inpatient. Sometimes you may not want anything 
supplying, so we need some way in the system of letting them know what 
the endorsements are.” Lead Pharmacist for Medicine 
For the purpose of the new model of care, the discharge prescription form to be sent to 
community pharmacies could be designed to provide clear, easy to follow information. 
This would assist the community pharmacy to dispense the correct medication.  
“If you are developing your own [form], you could have a column on there 
that was pre-populated. So all items could go on the discharge 
prescription to let them know what the hospital was treating the patient 
with, but you could have a box saying community pharmacy not to 
supply.” Medicines Management Pharmacist 
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It is important to note that there would be issues around legality for the community 
pharmacist dispensing medication off a discharge prescription form. These would have 
to be clarified before a pilot of the new model of care. 
 
Continued communication between the hospital and the community pharmacy was 
considered important, to update them on any changes that would affect the supply of 
discharge medication. The community pharmacy should be kept fully informed 
throughout the discharge process, despite this adding to the hospital pharmacy team’s 
workload. 
“But then what happens if they don’t send [the patient] home and the 
pharmacy is waiting with all these meds and they can’t send them? We 
would obviously have to communicate that they are actually not going 
home, but that might be an extra step.” Band 7 Haematology Pharmacist 
For example, whereas pre-empting patient discharge and early organisation can help 
smooth the discharge process, if there were last minute changes to the discharge 
prescription or the number of days required for short courses had altered since the 
community pharmacy had received the discharge prescription, this could cause 
problems.  
 
 
Mechanism of communication across the interface 
Several participants commented that a telephone call would be inefficient for the 
communication across the interface. 
“I don’t instinctively like the idea of phoning the community pharmacy. 
So would we have to ring the community pharmacy? And if we did that, 
could it end up taking a similar amount of time to dispensing it in the 
hospital?” Consultant Pharmacist 
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In addition to being a time intensive form of communication, one participant highlighted 
the risk of errors due to miscommunication. 
“A phone call to me is quite nice and very friendly, but is actually going to 
open up a can of worms and cause more problems. First of all it relies on 
you getting through on the phone and that is quite tricky. Secondly, you 
get misinterpretation. You have to spell out names of drugs and you 
might be given quite a lot of information.” Community Pharmacist 
Utilising technology to send the discharge prescription and any necessary additional 
information was considered a more efficient mechanism of communication between the 
hospital pharmacy team and the community pharmacist than a telephone call.  
 
GPs and community pharmacists routinely use the widely available EPS system to 
transfer prescriptions electronically. One problem highlighted by a GP familiar with the 
system was that the current EPS system is only a one-way communication system, which 
may not be appropriate for the new model of care.  
“If you were going to use the electronic note attached to the prescription 
for your system, you would have to have another way of confirming that 
the community pharmacist had read your note and were able to action it. 
You could attach a note saying ‘please deliver today’, but how will they 
then respond to this? How do they communicate any issues that they 
have? This is only a one-way communication system.” General 
Practitioner 
A two-way electronic communication system would be preferred. It could be used to 
send the discharge prescription to the community pharmacist, they could then 
acknowledge and respond to the request to dispense the discharge prescription using 
the same system.  
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“Some kind of system that would be incumbent on rechecking to see that 
they’ve physically acknowledged it. I don’t know, maybe I’ve sent it off, 
therefore a red traffic light appears against the patient. They 
acknowledge it, therefore an amber light appears. I know it’s been seen 
but not actioned, then a green light when it’s been actioned. Something 
like that.” Clinical Pharmacy Services Manager 
Participants highlighted that an alert to make the community pharmacist aware that a 
discharge prescription has been received would be useful. Without an alert, there is a 
risk that the discharge prescriptions will be missed and patients could go without their 
medication which could cause patient harm. 
“How are they going to be alerted, especially as there could be a locum 
pharmacist in unfamiliar with the system? It could be that they don’t look 
at their alerts for a few days and the patient is left without their 
antibiotics and ends up with septicaemia.” Consultant Pharmacist 
An essential part of the new model of care is ensuring that there is an alert for the 
community pharmacist to let them know that a discharge prescription has been received 
and when it is required. This will be incorporated into the electronic system used for the 
new model of care. 
 
It was highlighted that the new model of care did not take into account what would 
happen if the discharge prescription was sent to the community pharmacy and they are 
unable to supply the medication for the patient.  
“Decide whether they can act on [the discharge prescription], physically 
supply a patient, then there’s got to be some sort of feedback if they 
can’t.” Clinical Pharmacy Services Manager 
Subsequently, in the refined new model of care (see Figure 7-1) an additional stage has 
been added after stage 9 to indicate the process under such circumstances. There are 
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various reasons why community pharmacies may be unable to supply the discharge 
medication, these are discussed in Stage 13: Community pharmacy supply patient with 
medication. The recommendations for suitable alternative mechanisms of medication 
supply if the community pharmacist is unable to supply the discharge medication are 
based on the discussions had with stakeholders, detailed under Stage 13. 
 
Stage 10: Patient prepared for discharge 
During stage 10 of the discharge process the patient is prepared for discharge, during 
which a member of the pharmacy team gives the patient any medication already on the 
ward, explains the process and the arrangements for obtaining any medication 
outstanding from their community pharmacy and provides any last minute counselling. 
Participants considered this an appropriate role for the pharmacy team to take on. 
“I really like the idea about the pharmacy staff giving the medicines to 
the patient. I know certainly there is difficulty with that because the 
nurses obviously have got a lot to do. I think we may be able to put a 
richer focus on that. Not just in terms of making sure that they do get 
their medicines. But also about ensuring that they are happy with what 
they have been given. I'm not saying that that should be left until that 
point but in terms of counselling and information it’s a continual process 
through the patient's stay. It is time to reinforce that and address any 
concerns they have before they leave the hospital. Reinforce you know all 
the supplies going to be continued after discharge. That you are going to 
be talking to their community pharmacist as well as the GP about the 
medicines. So it is a good idea.” Medicines safety and Care of the Elderly 
Pharmacist 
Preparing the patient for discharge is currently a nursing role, however nurses thought 
that it would be appropriate for pharmacists to take on this role and that patients were 
likely to receive an improved service as a result. 
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“That's great I don't see it as taking the job from the nurses. I see it as 
freeing us up to do other things. We will still be involved in it. It will still 
be our job to say ‘have you spoken to the pharmacist? You've got your 
medicines, do you understand?’ I don't see it as taking anything away and 
if I'm honest I think you would also find with the pressures with a lot of 
the newly qualified, just with the demands generally, there are a lot more 
errors. We also don't have that knowledge that the pharmacists have so 
don't leave it to juniors who have only been qualified six months and who 
don't know medicines inside-out.” Nurse Ward Manager 
Participants thought that some of the errors in providing medication at discharge would 
be reduced by having a member of the pharmacy team check the medication given out 
to patients.  
 “Yes I mean we see so many errors, stuff just gets scooped out of the 
lockers and handed over to the patient. We had some medication that 
was about £1500 per box for use in ITU only and somehow this box 
managed to go home with the patient and I don't know how that 
happened. It was unbelievable. I know that is an extreme version but we 
see lots of errors like this. So I think this will be reduced with pharmacy 
involvement so that will be a good thing.” Senior Hospital Pharmacist 
This stage does not have to be an additional step in the process, it could occur at the 
same time that the patients’ own medication is assessed by the pharmacy team. As the 
pharmacy team is ward based, there should be no disruption by leaving the ward to 
carry out any tasks.  
“I don’t think you want to encumber the process by adding steps per-se. 
I wouldn’t want to be waiting for a member of the pharmacy team to 
come back up and check that before the patient can go. You’re potentially 
adding another step to delay the patient’s exit. But if it is a ward based 
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system, the whole process would take place at the same time on the 
ward.” Clinical Pharmacy Services Manager 
Stages 11 and 11a: Transfer of care and GP receives discharge information 
Transfer of care to the GP involves the electronic sending of information to the GP which 
should already be happening in practice. The quality of information sent to the GP can 
be poor, as discussed in section 2.7.2 Medication errors at discharge from hospital, 
although one GP thought that this had improved with the use of electronic systems.  
“GPs don’t always get accurate and complete information sent to them 
about patient discharge. To be fair, it’s been a lot better in recent months 
with things coming through electronically. But I think the quality of what 
we get is sometimes a bit disturbing and needs to be looked at.” General 
Practitioner 
Another GP highlighted that communication with district nurses could be improved. 
There may be scope to include other relevant healthcare professionals in the community 
in the transfer of discharge information.  
“The communication with district nurses isn’t always done well, so we 
may also get involved here. Making sure communication is good so that 
it is easier for different agencies and that everything is set up would be 
good.” General Practitioner   
Stage 12: GP Pharmacist Involvement 
More GP practices are employing pharmacists and there is scope for them to play an 
important role in the new model of care, ensuring patient care remains stable across the 
interface. Participants agreed that GP pharmacists could play an important role in the 
new model of care. 
“I believe highly that GP pharmacists are the future and I think we will be 
started to be asked more questions by this team of people. So this I think 
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is really important and it will become bigger. And questions will be asked 
about performance and making sure that things are right for patients. So 
the GP pharmacist involvement I think is a definite in my case.” Lead 
Pharmacist for Medicine 
Undertaking medicines reconciliation when the patient returns back to the community 
would fit in with guidance which suggests that medicines reconciliation should be 
carried out at any transfer of care setting. This should highlight issues and could 
potentially reduce patient harm and readmission to hospital. 
“This fits in with the NICE meds optimisation guideline that said that there 
should be medicines reconciliation when you change setting and also we 
know from some of our venalink audits and things like that, that it is not 
always actioned as quickly as it should be on to the system. So actually 
getting those pharmacists involved if the discharge prescriptions are 
going to them and then they can make sure that the meds rec is done on 
the GP system is actually probably a brilliant idea. It will probably solve 
quite a lot of our re-attendance [rates] because of the prescribing error 
issues ... GP pharmacists getting involved at discharge is definitely a good 
idea.” Medicines Management Pharmacist 
 
Stage 13: Community pharmacy supply patient with medication 
Although overall the community pharmacy dispensing discharge prescriptions was seen 
as a positive step, participants had some reservations. One participant suggested that 
to manage patient expectations, a time slot would be useful from the community 
pharmacy so the patient knows when to expect their medication. Updates could be 
provided by the community pharmacy via email or text message so that the patient is 
fully informed.  
“So community pharmacy supply patient with medication outstanding. 
So you’re probably going to want a time slot aren’t you … If you order 
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something online, you get an email that’s got a number of steps in the 
process. You’ve placed the order, they’ve dispatched it and it’s with their 
courier for delivery … Why don’t we. We could have that and patients 
could see their TTO going through the process and you’d be able to 
manage expectations. Something to instil confidence in the process. An 
unknown feels longer than a defined period of time” Clinical Pharmacy 
Services Manager 
One of the issues highlighted was that patients may be reliant on support from family 
members, friends or carers to use this model of care. Potentially by arranging to have 
medication delivered this would reduce this risk, however this may not be practical if 
patients are unsure what time they will arrive home.  
“That is another stop for a patient on the way home. This could be a 
problem if patient just wants to get home or if their hospital transport 
home means that they don’t know what time they will get home. You’re 
then relying on friends or family to collect them for you and not everyone 
will have someone nearby who can do that for them.” Consultant 
Pharmacist 
Logistics of community pharmacy supplying discharge medication 
The main issues highlighted by stakeholders in having community pharmacists dispense 
discharge prescriptions were around the logistics of making that supply and getting it to 
the patient in a timely manner. A range of logistical issues were discussed. Blister packs 
were seen as a barrier, because they take a long time to dispense and community 
pharmacists may not be able to provide them under short notice.  
“Blister pack patients could be problematic. I suppose the issue of blister 
packs with major changes, that is a real issue because community 
pharmacists don't turn round blister packs in a couple of hours. Whereas 
[hospitals] do, so although we say we are slow we actually do expect to 
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be able to turn around blister packs in a couple of hours.” Senior Hospital 
Pharmacist 
Conversely, another participant felt that because the community pharmacy usually 
arranges the supply of patients’ blister packs, they were best placed to make any 
changes to the blister packs. 
“I think it sounds brilliant, because when I used to do hospital discharges, 
there was the odd occasion where you needed to liaise with the 
community pharmacist, so you would phone them. You know, if someone 
had a tray that was due to be delivered that was going to be completely 
wrong. The problem being, on discharge if you phoned the community 
pharmacist, they’d already done a month’s worth of trays. So that was a 
waste. I don’t know how they got around that. We only did a week, so 
that was confusing because it was a different system.  And quite often I 
would receive phone calls from community pharmacists a few weeks 
down the line to say ‘I believe such and such a patient was in hospital, 
what were the changes?’ So we could fax or scan a copy of their discharge 
to the pharmacist, but it was only if they contacted us. So I think it’s a 
really good thing.” Outpatient dispensing pharmacist 
Community pharmacies have limited opening hours, although some are now open for 
longer hours. This will affect the timescale in which a discharge prescription can be sent 
to a community pharmacy, which could be problematic for patients requiring later 
discharge.  
“I’ve had situations where my mum has been discharged at 7 o’clock at 
night. Her pharmacy isn’t open at that time of night, so what would the 
situation be then if she is expected to get home and pick up her 
medication from the pharmacy. Because again, you’re time restricted.” 
Carer representative 
199 
 
The community pharmacy’s workload could affect when the discharge prescriptions are 
dispensed and how they are prioritised. This would affect the timeliness of the patient 
receiving their discharge medication. 
“Hospitals prioritise TTOs because we know patients are going home, but 
how will the community pharmacy be able to prioritise these over their 
other workload. If they have a lot of patients waiting in the shop, they’re 
obviously going to prioritise them.” Consultant Pharmacist 
There may also be stock issues for community pharmacies. The types of medication 
prescribed on discharge prescriptions may differ to the stock that they currently hold. 
They may have to order certain medication in, which could delay the patient receiving 
their medication. 
“Community pharmacies don’t carry necessarily the same things as 
hospital pharmacies. Whereas we would make a decision and find the 
patient an appropriate alternative and we have more options to find 
something suitable if we run out, in community pharmacies if it isn’t on 
the shelf they are unlikely to be able to get it. So there’s a risk of some 
people not being able to get what they need.” Consultant Pharmacist 
Community pharmacies can obtain the majority of medication quickly. However certain 
items can take a long time to source, such as specials.  
“The other problem is how quickly would a community pharmacy be able 
to get hold of a special? Sometimes it takes them two weeks.” Specialist 
Paediatric Pharmacist 
Additionally, patients who are prescribed hospital-only medication could have problems 
obtaining a supply at discharge, because these medications cannot be supplied by a 
community pharmacist.   
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Many patients would be reliant on the community pharmacy delivering the medication 
to them. Depending on the individual community pharmacy and how they run their 
delivery service this may not be possible.  
“Every place has a delivery service now. It's just a matter of how they run 
them. So little small places will have their drivers and you can just say 
‘you need to come back, you need to come and pick this up.’ Somewhere 
like Boots has, they strategically operate, you load up all of your deliveries 
onto the central system. They have a set of drivers and they plan their 
route out and then they go and pick them up and then they are told on 
which route to go and plan ahead and do that. But I'm not sure that gives 
you much scope for last-minute emergency deliveries. I'm assuming 
there's got to be some way round it because that situation can't be 
unique.” Community Pharmacist 
These logistical issues could all be worked through before the new model of care was 
implemented. By having the fail-safe mechanisms discussed in section 7.5.3 Ensuring 
quality and safety of new model of care, patients would not be discharged from hospital 
without a guarantee that they will receive a supply of their discharge medication.  
 
Prescription charges 
Hospitals do not currently charge patients for discharge medication supplied. 
Community pharmacies do enforce a prescription charge. The risk that if patients have 
to start paying for their discharge medication from the community that they will not 
collect the medication was highlighted. This could put patients at risk of harm and 
readmission to hospital. 
“Do you think for people that pay for prescriptions, would they pick it up? 
Because they wouldn’t have to pay for it if they got it here but they would 
at a community pharmacy. Then if they didn’t take the medication would 
they end up back in [hospital]?” Medicines Management Technician 
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If patients did have to pay for their discharge medication, one participant thought that 
it could lead to a cost saving for the NHS.  
“It could save the NHS a fortune really, if people are going to start paying 
for prescriptions that they normally get for free.” AMU medicines 
management technician 
Stage 14: Ability to contact hospital pharmacist 
By including the prescriber’s contact details on the discharge prescription, this allows 
healthcare professionals in the community and patients to contact the prescriber if 
there are any issues. Participants considered this beneficial for community pharmacists 
trying to contact the prescriber. 
“That is the other thing that I really liked about this that you have got the 
pharmacist that has done the prescription is more available to the 
community pharmacy, I think that is a really positive thing. That ticked a 
big box I think.” Senior Hospital Pharmacist 
It was also thought to be beneficial for GPs to have easy access to the prescriber.  
“If we have any queries with the discharge summary, having a contact 
number for someone involved in the patient’s care would be useful. For 
non-urgent questions it is easy to write to the patient’s consultant as their 
name is usually on the discharge summary. However for questions that 
we need a quick answer for, it would be useful to have someone that we 
could call up. For example the patient may have had problems with that 
drug before, but they didn’t tell anyone about it in hospital and now they 
are prescribed it.” General Practitioner 
From a feasibility perspective, participants were concerned that direct phone numbers 
to the prescriber may lead to telephone calls at inappropriate times and perhaps 
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providing the pharmacy telephone number so that calls can be screened may be an 
option. 
“I like the idea of being able to contact the hospital pharmacist. I just 
don't know whether you might want to… The consultant has got the 
screen of their secretary. You haven't got any screen so if you are giving 
out direct contact numbers. Where is the ‘right I will deal with this, but 
right now I need to be doing something else’ Do we give the details of the 
pharmacy secretaries who can then triage it out to people appropriately? 
In the same way that the consultant’s secretary would. Just because 
otherwise I can see pharmacists being pestered and also once you have 
got a ‘oh I know the cardiology pharmacists contact details I will just give 
her a call because this is a cardiology kind of problem’. So just something 
in there to give us a screen. I am not saying we shouldn't be contactable 
but you are not always free at the moment the call comes in.” Medicines 
Management Pharmacist 
Stage 15: Patient support and advice in community 
An additional stage for the new model of care was suggested. This was to include follow 
up of patients with the community pharmacist. Linking the patient with their community 
pharmacist provides an opportunity for the patient to make use of services such as 
MURs and NMS provided by their community pharmacy. This option could ensure that 
the patient has no issues with their medication after discharge and provides a point of 
contact if there are issues.  
“I also think that you could almost extend this model somewhat to have 
an ‘after discharge’ section. This would be mainly community pharmacy 
involvement, but there could be a lot of it. You’d probably want to 
consider how and where counselling by the community pharmacist would 
take place. As I think it is important that this happens. It’s also trying to 
see what follow up services the community pharmacy could provide. 
Could you link in the discharge MUR service, or the new medicines service, 
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depending on what medicines the patient was started on during 
admission.” Head of Clinical Pharmacy Operations for community 
pharmacy 
Stage 15 has therefore been added in the refined model of care, which can be seen in 
Figure 7-1. 
 
7.4.4 Themes 
In addition to the stepwise review of the new model of care, a separate qualitative 
analysis was undertaken to review the new model of care holistically. Three main 
themes emerged during this qualitative analysis. The themes are based around the 
aspects of the new model of care considered important to participants.  An overview of 
the themes followed by a description of the subthemes are presented throughout 
sections 7.4.4.1 – 7.4.4.3.  A list of the themes and subthemes can be seen in Table 7-2.  
 
Table 7-2 – Phase 4 List of themes and subthemes 
Theme Subthemes 
Impact of new model of care 
 
Positive impact of the new model of care 
Addressing delays at discharge 
Impact on other aspects of patient care 
Education 
 
Resources required for new model of care 
 
Infrastructure 
Training 
Payment or funding of new model of care 
Implementing the new model of care 
 
Ensuring quality and safety of new model 
of care 
 
Quality and safety issues 
Managing patient expectations 
Ensuring the success of the new model of care  
Healthcare professional competence 
Barriers to patients receiving medication 
Prescribing responsibility 
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7.4.4.1 Impact of new model of care 
This theme comprises the following four subthemes: positive impact of the new model 
of care, addressing delays at discharge, impact of other aspects of patient care and 
education.  
 
Overall, there were many positive comments about the new model of care along with 
some constructive feedback on the likely problem areas of the model. Stakeholder 
opinions on the new model of care are discussed throughout the findings section within 
the appropriate themes relating to the specific areas. 
 
7.4.4.1.1 Positive impact of the new model of care 
Participants anticipated many benefits from the new model of care. Participants liked 
the idea of the integrated ward team writing discharge prescriptions during ward rounds 
and counselling patients at this point would be an improvement in comparison to the 
current discharge process. 
“I think it is not just a good thing I think it's fabulous. It is the natural 
progression. In the old days when consultants did a ward round and they 
had all the people around them the consultant will be teaching them, 
asking questions and all the rest of it. They could take their time and then 
walk away and everything could be done in the afternoon. And that's 
entrenched in them that format. What they need to know is that 
everything that they can do TTOs and [discharge summaries] and 
everything else in real time then it is an enhanced service. But most 
especially the patient safety and the opportunity for someone to counsel 
patients about medication changes.” Nurse Ward Manager 
Participants agreed that there would likely be an improvement in speed and patient 
experience as well as patient flow.  
“So you’re thinking the specialist pharmacist will be the person writing 
the discharges... There will be a massive help in terms of time saving, bed 
205 
 
occupancy, patient journey. The journey will be better as they’ll be much 
happier and can leave the hospital sooner and so on.” Specialist 
Paediatric Pharmacist 
By having the pharmacist write discharge prescriptions, this effectively frees up the 
doctors time to complete other tasks. Their skills can be utilised elsewhere.  
“It is a very time intensive system, but then it does free up doctors so 
maybe in that model that is something we need to think about. What the 
doctors would do instead … So it improves the quality, but it also allows 
the doctors to use their skills elsewhere.” Senior Hospital Pharmacist 
From a GP perspective, the new model of care provides an additional mechanism of 
reducing the risk of patient harm, by informing the community pharmacy of the patients’ 
discharge medication.  
“Yes, I think that it could potentially have benefits, thinking about 
continuity especially, because we have had situations where the 
community pharmacists have not been made aware that the patient has 
had any changes to their medicines in hospital and continue to supply 
their previous medicines. The patient then gets a little confused about 
which medicines they should be taking and ends up defaulting back to 
their old medicines. So I think that communication with the community 
pharmacist is really important.” General Practitioner 
Additionally, by outsourcing the dispensing of discharge prescriptions, the hospital 
pharmacy team would have more time to focus on providing an improved clinical 
pharmacy service for patients. 
“It would allow us more time to spend on clinical activities” Consultant 
Pharmacist 
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7.4.4.1.1.1 Pharmacy ownership 
A further potential benefit mentioned by several participants was the pharmacy 
ownership within this model of care. This means that the pharmacy team would take 
responsibility for the process of supply of medication at discharge. This ownership will 
make pharmacy responsible for the success of the model. The new model of care would 
promote the use of pharmacy both in the hospital and the community by identifying the 
pharmacists involved in patients’ care.  
“I like that you’re actually putting a face to pharmacy. It’s pro-pharmacy 
and as a profession we’re not very good at doing that.” Medical 
Education Pharmacist 
Encouraging team-working and ensuring pharmacy services are ward-based will 
increase pharmacy ownership of patient care. Pharmacy team members will be more 
engaged in patient care as a result and therefore motivated to work efficiently.  
“Being more ward-based will give the pharmacy team more ownership 
over the patients especially those used to being in the dispensary. I think 
that if we move ownership to people, they will work more efficiently 
because they will want to work with the team and they'll be able to 
prioritise. It will also improve communication between different 
healthcare professionals because everyone is on the ward and easier to 
contact.” Lead Pharmacist for Medicine 
One downside to the increased pharmacy ownership within the new model of care is 
that pharmacy working hours are limited. For patients discharged out of pharmacy hours, 
this could be an issue as they may not receive the same level of service. 
“I think it keeps all of the ownership with pharmacy and I do think that is 
important, but it is just out of hours isn't it.” Independent prescriber 
Hospital Pharmacist 
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7.4.4.1.1.2 Continuity of care 
The new model of care was thought to assist community pharmacists in providing 
ongoing patient care after discharge. Providing detailed discharge information to the 
patients’ regular community pharmacist was seen to be helpful for correctly supplying 
future medication and providing continued care for patients as they will be aware of any 
issues or changes to medication.  
“Once they are done then they are back on the monthly prescriptions… it 
gives you, particularly if it is one of your regular patients you are then 
very much aware and you have dispensed the new prescriptions. So 
instead of waiting to see a copy of the discharge letter which sometimes 
doesn't always come to you and then you are dispensing off an old 
prescription. You're then seeing straightaway the changes in the 
medication and so you know for when you are ordering next time, if 
they're on your repeat ordering service, that actually there's been these 
changes when they came home on the TTO.” Community pharmacist 
In other countries, hospitals do not dispense discharge prescriptions for patients. These 
patients leave hospital and continue to get their medication from the GP. There is 
limited communication within this process and therefore a lack of continuity of care. The 
new model of care builds on the aspect of dispensing medication outside the hospital, 
but provides the continuity of care aspect that is missing in these existing systems by 
transferring discharge information to community healthcare providers.  
 “I first came across this actually when a pharmacist from Denmark came 
years ago to the hospital and they don't do discharges at all. And a lot of 
continental places don't do that. So there is no continuation of care which 
obviously is part of NICE and general common sense, but it is in the NICE 
medicines reconciliation thing. So I think certainly it increases our 
communication with community pharmacy and it may help them in the 
management of ongoing conditions.” Senior Hospital Pharmacist 
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One GP raised an interesting point about the nature of the continuity of care provided 
by the new model. Although it will improve the records kept at a patient’s community 
pharmacy, which will be beneficial for future care, a patient will not necessarily see the 
same community pharmacist each time they visit the community pharmacy. 
“What continuity of care exists at the moment with community 
pharmacies? Now, I can tell you that some of the small independents 
probably do have a reasonable degree of continuity of care. But some of 
the large chains, the pharmacist I would say changes quite frequently. So 
I don’t think there is that sort of continuity. So there may be continuity in 
terms of records that the pharmacists are keeping, but I’m not sure 
there’s necessarily that continuity of the individual personal touch.” 
General Practitioner  
7.4.4.1.1.3 Unintended benefits 
In addition to the intended benefits, participants noted potential unintended benefits 
of the new model of care. A prescribing pharmacist present on the ward round was 
thought by a range of participants to have other benefits, not just writing discharge 
prescriptions. The pharmacist would be able to resolve any medication issues at the 
point of the ward round, regardless of whether the patient was due for discharge.  
“So there will be other involvement for pharmacists on the ward round, 
they won't just be doing the discharges they will be getting involved in 
the patients who've got pharmaceutical care needs as well.” Medicines 
Management Pharmacist 
There are also potential benefits around reducing medicines waste. For patients with 
existing repeat prescriptions, community pharmacists would be familiar with any 
changes to the patient’s medication and be able to supply the most recent, correct 
medication rather than medication that may no longer be suitable.  
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 “I think it would be really good. There’s a lot of work going on around 
repeat prescribing systems and stuff like that and it supports that agenda 
completely because you’re taking away the risks of repeat prescribing 
because the medicines are there. What quite often happens now is when 
the patient is in hospital, community pharmacists order on their behalf. 
The prescriptions are there, try and get delivered and the patient’s in 
hospital and they come out with new meds that are different and they’ve 
just had a new prescription. So just within that one cycle there’s loads of 
waste. So by cutting it out and sending it straight to the pharmacy, it’s 
going to reduce the waste in the system.” Primary Care Prescribing 
Pharmacist 
7.4.4.1.2 Addressing delays at discharge 
As previously mentioned, one of the positive aspects of the new model of care is that it 
should speed up patient discharge from hospital.  A variety of stakeholders were in 
agreement that having a prescribing pharmacist write discharge prescriptions at the 
time of decision to discharge would start the process earlier than occurs currently and 
speed up the process.  
“I think it will obviously be quicker. In terms of there is no delay between 
the ward round and the writing of the TTO. It also stops that whole “I look 
at the TTO and there are a million things wrong because that shouldn't 
be”. So in terms of the whole shortening of the time I think that's really 
good.” Independent prescriber Hospital Pharmacist 
One participant familiar with a hospital that has started to utilise their prescribing 
pharmacists to write discharge prescriptions noted that it has sped up the discharge 
process in comparison to having junior doctors write them.  
“They do this at [a specialist hospital]. On the surgical wards there is now 
a pharmacist on the ward round solely there to write the TTOs. And that’s 
sped up the discharge process so much. So this happens, because the 
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pharmacist is on the ward round, the TTO gets called down to the 
pharmacy and is double checked by the pharmacist.” Rotational Hospital 
Pharmacist 
Participants did not think that the new model of care was infallible. Areas were identified 
where delays could potentially occur, which have been discussed throughout the 
relevant stages in section 7.4.3 Stepwise review of new model of care. 
 
Having community pharmacists dispensing discharge prescriptions was thought to 
reduce the delay to patient discharge, if patients could leave at the point their discharge 
prescription was written and sent to a community pharmacy. 
“I can see that from our point of view that this could be great. I mean the 
time patients stay in the hospital without needing to. They get told at 8 
in the morning that they can go home on the ward round, and they’re still 
lurking around at 4pm because of issues. If they could just pack their 
things and go.” Specialist Paediatric Pharmacist 
GPs agreed that this would speed up patient discharge, whilst preventing patients 
visiting their GP after discharge to organise a supply of their discharge medication.  
“I accept the fact that patients hanging around for six hours in an exit 
lounge waiting for a bag to arrive doesn’t make sense. Equally, I get 
annoyed when patients turn up here to say they left the hospital, they 
couldn’t be bothered to wait for their medicines and they want me to 
issue it. Or they were told that they’ve got to go back to the [hospital] to 
collect their medication and they don’t see why they should. I know there 
are those sorts of issues that clearly your proposals would do away with, 
which I think most GPs would think was a good idea.” General 
Practitioner 
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7.4.4.1.3 Impact on other aspects of patient care 
As previously discussed, hospital discharge is a complex, multistage process (see section 
2.6 Discharge from hospital). The new model of care focuses on the supply of medication 
for discharge. Participants were asked if they thought that the new model of care would 
impact on other aspects of patient care. 
 
Theoretically, by making the supply of medication at discharge more efficient, patients 
should be able to get home from hospital much quicker than in the current discharge 
process. However in reality, the wait for discharge medication is not the only cause of 
delay to patient discharge. There is a risk that if patients receive their medicines faster, 
other causes of delay to discharge will become apparent.  
 “I think the waits for other things are still going to be there. It is often 
medicines are the ones used as the excuse. And sometimes it's justified. 
But I am sure there are other factors. Maybe they will be less masked by 
the discharge, I don't think it's going to have a knock-on effect directly. 
What it might mean is that other delays could become more apparent 
because if they've got their medicines there then you know they are 
waiting for something else. I'm sure there are other delays, but I don't 
think I can come to see any problems as a result.” Medicines Safety and 
Care of the Elderly Pharmacist 
By implementing the new model of care, other important processes should not be 
overlooked as a result. An example highlighted by a consultant was that writing the 
discharge prescription is often a prompt for the junior doctors to write the discharge 
summary for a patient. If they are no longer required to complete this task, there is a 
risk that discharge summaries may not be written.  
“An important point to recognise is, the reason a lot of patients get their 
discharge letters done, is because it’s on the same thing as the TTO. Now 
if you get pharmacists doing the TTO, then you might reduce the number 
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of patients that get a detailed letter from the team about what actually 
has gone on.” Consultant, Acute Medicine 
7.4.4.1.4 Education 
The benefits of improved education for healthcare professionals within the new model 
of care due to improved team-working and collaboration were highlighted by a number 
of participants. Junior pharmacists could receive more support on the wards.  
“We’re quite isolated as a profession and by having this integration into 
the team you really are putting people together and you can get more 
day to day education. Whereas at the moment you probably get a lot at 
the start of a rotation, or with someone that’s new and then it becomes 
almost none existent. You can almost kind of partner up and there can be 
some other benefits from this.” Clinical Pharmacy Services Manager 
Having a pharmacist present whilst discussions around patient care take place on ward 
rounds provides a different perspective than the doctors. This will help to highlight other 
issues and teach the doctors to look out for those issues in the future. This will have a 
big impact on education for doctors of all levels of experience on prescribing issues. 
 “But also how much learning is going to be involved. ‘Have you noticed 
that the patient is on amlodipine and simvastatin 40mg?’ We learn so 
much from our ward pharmacist coming over to us. Having a prescribing 
pharmacist on the ward round is a massive opportunity for everyone, not 
just juniors. In fact, the consultants probably would benefit the most. 
Because we are not still being trained in that way. So having someone 
say, ‘do you want that?’ and it would be much better for patients for that 
reason as well.” Consultant, Acute Medicine 
Equally, the education for community pharmacists to enable them to provide the clinical 
service fits into the agenda of upskilling community pharmacists to perform more 
clinically-orientated roles. 
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 “So community pharmacists would have to undergo some form of 
training to carry out the level of clinical check that a hospital pharmacist 
would. This all fits in to the agenda of upskilling our community 
pharmacists, which would be huge for them.” Head of Clinical Pharmacy 
Operations for community pharmacy chain 
Learning to prescribe is a significant part of a doctor’s education. Participants raised the 
issue of the risk of de-skilling doctors if they are not routinely writing discharge 
prescriptions.  
 “There is an issue there about de-skilling doctors as with any [non-
medical prescribing] really.” Senior Hospital Pharmacist 
All participants could see that the risk was there, but the majority felt that by ensuring 
that the pharmacist writing the discharge prescriptions did so based on prescribing 
decisions made on the ward round with the integrated team, that this could actually be 
beneficial to the doctors. 
“I think it might enable them to prescribe better. Because ideally the 
pharmacist will be there as an advisor and point out the issues… You are 
working collaboratively and you are facilitating learning and improving 
their education. I think the education point is a big thing.” Nurse Ward 
Manager 
7.4.4.2 Resources required for new model of care 
This theme consists of the following four subthemes: infrastructure, training, payment 
or funding of the new model of care and implementing the new model of care. 
Participants highlighted a range of resources that would be required for the new model 
of care to be successful. 
 
7.4.4.2.1 Infrastructure 
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For the new model of care to be successful, it needs to have the infrastructure in place 
first. Two main areas were highlighted by participants, broadly the human infrastructure, 
in terms of staffing levels and integrated ward teams, and secondly having the 
technology to allow the new model to function.  
“So firstly the infrastructure. Such as having an embedded ward team but 
also having the technology to be able to do it. So in terms of the 
infrastructure of IT to be able to do TTOs in a timely manner but also to 
be able to send the TTOs to the community chemist as well.” Pharmacist 
Teacher Practitioner 
7.4.4.2.1.1 Staffing 
Staffing was seen an important part of the infrastructure to enable pharmacists to safely 
carry out their new role within the new model of care. One concern was that if 
pharmacists had competing priorities, there was a risk that the cause of the delay to 
discharge would shift from the doctors to the pharmacists, without any improvement 
for the patient.  
“One of the flaws that might occur with the process is currently the 
clinician has the conflicting priorities and therefore doesn't progress the 
prescription as quickly as possible. What does the pharmacist do at the 
moment that they are going to have to drop in order to take this role on? 
Otherwise a possibility is that what you are shifting is the delay from the 
consultant. The delay could then come from the pharmacist not being 
able to do it there and then.” Community pharmacist 
Participants highlighted that an ideal staffing level may not be achievable in every 
hospital due to their sizes and budgets. This could impact on workload for the pharmacy 
team.  
 “In some smaller hospitals that could pose complications in terms of their 
numbers. They may not have enough rotational pharmacists to have one 
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per ward. If the prescribing pharmacist is out doing additional duties and 
is taken away from their traditional pharmacist role, they may not have 
enough non-prescribing pharmacists to pick up the rest of the work.” 
Medicines Management Pharmacist 
One way in which the appropriate staffing infrastructure could be achieved is with a 
redistribution of current roles within the pharmacy team.   
“If we’re losing activity should we lose posts? Or can we redistribute those 
posts? As times are tight, you’ve got to argue that pharmacy should 
potentially ask if they can lose posts out of this. Are you just moving 
people elsewhere, to do a different job? It’s about how we are 
reconfiguring the workforce to get the most benefit and utilisation.” 
Clinical Pharmacy Services Manager 
 
7.4.4.2.1.2 Technology 
Another important aspect of infrastructure is having the technology in place and 
functioning to allow easy use of the new model of care. There are several areas of the 
new model of care which will rely on IT systems to function efficiently. Writing the 
discharge prescription, verification of the discharge prescription, sending the discharge 
prescription electronically to the community pharmacy and an electronic 
communication system between the hospital pharmacy and the community pharmacy. 
Suggestions for technology for each stage of the new model of care are discussed within 
section 7.4.3 Stepwise review of new model of care.  
“Having the technology to be able to do it. For example, things that slow 
us down here at the moment are probably the Wi-Fi connectivity. The 
number of tablets, if you are saying we want all TTOs to be done at the 
patient's bedside. Each trust will have to have an IT system that will be 
able to cope with that.” Pharmacist teacher practitioner 
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As highlighted earlier, the electronic discharge systems used within each hospital are 
different. One participant mentioned that to implement the new model of care, using 
the same systems nationally would give a joined up approach.   
“It would be better to look at this as a national project where everyone 
has the same system rather than doing in-house and everybody using 
different systems. We need to have something simple that everybody can 
have access to. The problem with the whole NHS is that each hospital has 
got a different way of doing things and they don't all talk and that's the 
barrier isn't it. We need to join the way of working.” Lead Pharmacist for 
Medicine 
Several participants were keen to utilise the NHS Spine for electronic transmission of 
discharge prescriptions, because community pharmacies are already using this system 
to receive prescriptions from GPs.  
 “So if there is a way of accessing hospital trusts accessing the Spine that 
will be a way of getting it to a hospital pharmacy. Because every 
pharmacy is up and running for EPS. It’s standard now.” Community 
Pharmacist 
It is equally important that there is sufficient access to electronic systems for pharmacy 
staff. Having a portable device accessible to each pharmacist who will be writing the 
discharge prescriptions was suggested to overcome issues with access. Otherwise the 
new model of care will be inefficient and not improve delays to patients leaving the 
hospital.  
“Most hospitals just haven't got enough IT equipment to be able to get 
to each patient and that is inefficient. Actually having a discharge 
computer or a device which the pharmacist could have which was theirs 
and they could access the machine would definitely make this process a 
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lot more efficient. So that is something that certainly needs to be on 
there.” Senior Hospital Pharmacist 
Any technology solutions used for the new model of care must be user friendly and quick, 
so as not to add steps and encumber the process or deter people from using the system.  
“I think that anything being sent out of the hospital needs to be a one-
touch system and that goes for anything in this process electronically. If 
anything is too long, for example sending it to the community pharmacy 
by fax, that's never going to work is it.” Lead Pharmacist for Medicine 
7.4.4.2.2 Training 
Some participants felt that limited additional training would be required, because the 
new model of care builds on current skills, particularly for community pharmacists. 
 “Well I don't think you need any, anything that you've talked about here 
is to me basic pharmacist common sense skill. It is essentially it’s just 
giving a prescription in a different form.” Community pharmacist 
The intensity of training to use any IT systems would depend on the IT system chosen. If 
a new electronic system was to be introduced, training would have to be provided to 
ensure that staff could access and use the system to ensure that the discharge 
prescriptions were actioned. 
“You’d have to train the community pharmacies in the electronic system 
that it’s coming in. Because certainly when they’ve tried [sending 
discharge information to community pharmacists], community 
pharmacies and GPs said they haven’t got the information but when it 
came to it they actually did have the information, they just didn’t know 
how to access it on the computers. So there’s big issues around training 
and how to access electronic prescriptions. I can just see them not 
opening the system to access the prescriptions.” Consultant Pharmacist 
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Community pharmacists may require further clinical training to provide an 
understanding of the discharge prescription and the medicines they are likely to be 
dispensing.  
“I would possibly say that community pharmacists might need to shadow 
a prescribing pharmacist to see what happens from the very beginning. 
So maybe shadow them for a week and see what their role involves … You 
would understand it better if you see where it begins at the ward round 
level. And see how it makes its way to them. I think it’s a good idea for 
them to do a diploma isn’t it anyhow, but that’s a political one with cost 
and everything, but yeah an improvement in clinical knowledge.” 
Outpatient dispensing pharmacist  
Participants felt that pharmacists writing discharge prescriptions should be sufficiently 
trained and competent in the area that they are prescribing in. See section 7.4.4.3.4 
Healthcare professional competence for a detailed discussion around this topic.  
 
7.4.4.2.3 Reimbursement for new model of care 
Participants were unsure of the best way for reimbursement of the new model of care 
to take place. Several participants thought that if the prescription was sent from the 
hospital to the community pharmacy, the hospital should be paying for the medication. 
“If you are sending the prescription, I think that you would be charged.” 
General Practitioner 
Currently, Clinical Commissioning Groups (CCGs) control the overall medication budget, 
which is split into the prescribing budget for community and for hospital. There is a 
difference in how much medication supplied by hospitals and community pharmacies 
costs. Several participants felt that it should not matter who is charged for the 
medication, provided it was the most cost effective option overall.  
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“Again, unfortunately whilst the overall budget for drugs comes from the 
CCGs, whether it’s one or the other it doesn’t make a difference. Of course 
there is a differential charge between hospital supplied medication and 
community supplied medication. So in the hospital, it pays VAT. 
Community pharmacy doesn’t pay VAT so you’ve got an issue there. We 
know that hospital services sometimes manage to get very good contract 
prices on certain medications, so that differential may also adversely 
affect people’s budgets. To my mind, I don’t mind which budget it comes 
from because overall it’s one budget. I’d want to look at what was going 
to be the most cost effective way of doing things. I think you’ve got to 
balance that cost effectiveness against improving the system and 
streamlining it.” General Practitioner 
The possibility of re-aligning the medication budget to cover any expenses incurred as a 
result of the new model of care was suggested.  
“You should see the reduction in the GPs prescribing budget because 
instead of it coming from the GPs it’s coming from the hospital instead. I 
don’t think there’s any extra funding required it’s just realigning it really 
as to where it needs to be.”  Primary Care Prescribing Pharmacist 
It was thought that to encourage success of the new model of care, a paid structured 
service should be commissioned for community pharmacy, similar to the idea of MURs 
or the NMS. This would require evidence that the new model of care leads to an 
improvement in service and cost savings.  
“Well pharmacies will want payment for it, but the government won't 
want to pay for it so I am not sure. In order for it to be recompensed as 
far as pharmacy is concerned it would need to demonstrate improvement 
in service. I think if it was paid it will be easier to monitor. But then you 
have got the job persuading policymakers that it is the right thing to do 
which you need to have strong evidence for. Anything that is a paid 
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structured service is more likely to happen in a community pharmacy.” 
Community pharmacist 
Conversely, one community pharmacist suggested that to receive and dispense an 
electronic prescription from the hospital is similar to receiving and dispensing a 
prescription from a GP. Subsequently, the service may not require additional funding or 
commissioning by CCGs. Having a payment structure similar to the current community 
pharmacy contract should be sufficient.  
“But essentially you are asking them to do what they already paid for 
within their pharmacy contract. As in to dispense prescriptions. It is just 
that normally we don't dispense against hospital prescriptions. But you're 
not asking them to do anything that is over and above their role as such. 
Now granted it is not, we do not dispense hospital prescriptions, but 
essentially all it is, is a different form type and as long as it legally meets 
the requirements of what is needed on a prescription.” Community 
Pharmacist 
7.4.4.2.4 Implementation of the new model of care 
Participants suggested that the initial implementation of the new model of care could 
cause some issues. When the new model of care is implemented, the number of options 
for the supply of discharge medication should be limited. Otherwise this could be 
confusing for staff.  
“The ideal situation would be, regardless of what time the patient is 
discharged that the TTO is distributed in the same way. At the moment, 
when community pharmacies aren’t 24/7 I think you’ll struggle to find 
one system that suits all. We know at the moment, there’s drug 
cupboards on the wards where TTOs can come out of, normal pharmacy, 
Lloyds. That’s three systems already, if you add in a forth system, it could 
get confusing.” Junior doctor, medical specialities 
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In terms of outsourcing dispensing discharge prescriptions to be dispensed by 
community pharmacies, this is a completely new idea for the NHS. The legality of 
community pharmacists dispensing discharge prescriptions requires review prior to 
implementation. To ensure that the discharge prescriptions received by community 
pharmacies are seen as urgent and important, community pharmacists should be made 
aware of the new model of care. One idea from a participant was to have the new model 
commissioned as a service by the CCGs. By having it as a commissioned service, 
community pharmacists are more likely to be familiar with the process and understand 
the urgency when they receive a discharge prescription.  
“I think if it's going to be done it needs to go through the CCGs to be 
commissioned as a service so it is known that this is an actual thing. So 
people recognise that the discharge prescription is different from the GPs 
prescription in terms of timeliness and understanding those kind of 
aspects to it whereas in the community frequently you have got to order 
your prescription to 3 days beforehand has got to be sent to the relevant 
pharmacy and they will then make it available the next day. It is 
understanding that those things which are okay for a GP system aren't 
okay for a discharge from hospital system.” Senior Hospital Pharmacist 
 
7.4.4.3 Ensuring quality and safety of new model of care 
This theme comprises the following five subthemes: quality and safety issues, managing 
patient expectations, ensuring the success of the new model of care, healthcare 
professional competence and prescribing responsibility. 
 
7.4.4.3.1 Quality and safety issues 
Quality was important to participants for developments within pharmacy practice.  
“My guiding philosophy for pharmacy and progress is that we should look 
at quality above everything else. Then there’s definitely elements of 
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speed. We need to be flexible. But first and foremost is quality.” Clinical 
Pharmacy Services Manager 
Several of the stages within the new model of care involve the pharmacy team taking 
on roles during patient discharge that are traditionally the roles of doctors or nurses. 
This includes writing the discharge prescription and giving any medication to the patient 
at the point of discharge. These are both roles that revolve around medication, 
something in which the pharmacy team specialise. One participant felt that to drive 
quality and efficiency, the pharmacy team were appropriate care providers to undertake 
these roles.  
“I do have some concerns around when medicines isn’t the focus of your 
attention, which it isn’t for doctors and nurses, it is part of what they do. 
It doesn’t receive the same level of focus that the pharmacy department 
give. I think there’s only so far you can take certain processes because 
they have so many other things to do and it’s not their priority, it’s further 
down the list…It’s a question of can you drive that quality up as high as 
the hospital wants it as part of nursing or doctor’s role. I think if you can, 
that’s fine. However, whoever can meet the exacting standards should be 
doing the role, be it they are adding value to the hospital, to the patients. 
But if it is pharmacy because we have that medication focus. If we can do 
that to a better quality at a reasonable speed and cost, then I think we 
should be looking at doing it.” Clinical Pharmacy Services Manager 
Participants thought that pharmacists writing the discharge prescription would improve 
the quality of the information on the discharge prescription as discussed in section 7.4.3 
Stepwise review of new model of care — Pharmacists writing the discharge prescription.  
 
In addition to driving quality, having pharmacists write the discharge prescriptions was 
also thought to improve safety.  
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“From a safety point of view, your training as a pharmacist makes you an 
appropriate person to do that role. I suppose you’re also focussed on 
doing one task, whereas the doctor... As an F1, you’re writing a TTO, 
you’ve got 6 things to do at the same time and I’ve made so many 
mistakes because of that. So actually I think it might be safer.” Junior 
doctor, surgical trainee 
 
7.4.4.3.1.1 Receiving medication from different sources 
One safety issue highlighted by participants was the risk with patients potentially 
receiving medication from a variety of sources. This could lead to confusion for patients 
and potentially cause patient harm. Communication with the patient is essential to 
explain fully what is happening and to reduce risk to patients. 
“In terms of the medication supply at discharge, there are several issues 
here. You are essentially creating a risk by supplying medicines from two 
sources. Sending some from the hospital, the patient’s own and supplying 
the rest from the community. This could be a problem for the patient and 
it would be important to identify a way of reducing the risk for patients. 
Communication is essential here. Both to reduce patient risk and also to 
explain fully what the new process is to the patients.” Head of Clinical 
Pharmacy Operations for community pharmacy 
 
7.4.4.3.1.2 Barriers to patients receiving medication 
Several participants noted their concerns about the potential for patients not receiving 
their medication as a result of this new model of care.  
“The difficulty with this is you are sending [patients] out on the premise 
that they get those medicines that day. And there are lots of unknown 
factors that can prevent that from happening. There are lots of things 
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that can prevent the patient from getting the medicine that you would 
have definitely given them.” Community pharmacist  
Participants discussed a variety of logistical issues that could occur with community 
pharmacists dispensing discharge prescriptions. These have been discussed in detail in 
section – Stage 13: Community pharmacy supply patient with medication. Any of these 
logistical issues could be a potential barrier to patients not receiving their discharge 
medication. 
 
7.4.4.3.2 Managing patient expectations 
Managing patient expectations is a large part of improving their experience. It is 
important that the patient is fully informed about what they should expect during their 
discharge from hospital. 
“And it's meeting the patient expectation let them know what else needs 
doing.” Lead Pharmacist for Medicine 
Patients familiar with the current discharge process may assume that discharge 
medication would be supplied by the hospital. Participant views were mixed over 
whether patients would be happy to receive their medication from their community 
pharmacy.  
“Would patients feel comfortable with the whole culture change? We are 
already trying to get the patient out of the culture where they think they 
come to hospital and you get a goody bag with all your medicines to go 
home. But I still think that they would anticipate that if they were started 
on something new that the hospital would supply it.” Consultant 
Pharmacist 
Other participants thought that patients were likely to be happy that they could go home.  
“In terms of the patients I think they will appreciate that they can just go 
home.” Independent prescriber Hospital Pharmacist 
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Patients are expected to remain in hospital until their discharge medication is ready. In 
some circumstances, nursing staff agree with patients that they can go home and return 
for their medication rather than wait.  
“But a lot of patients do go home and come back the next day. Well 
they're supposed to come back when it’s ready … But I think a lot of them 
will be more than happy to go to their local pharmacy or arrange a 
delivery rather than a two or three hour wait or even a return to us. So I 
do think that is really good.” Nurse Ward Manager 
A patient representative with experience of having to return to the hospital for 
discharge medication would prefer to collect discharge medication from the community 
pharmacy for convenience. 
“Oh it would be much better, because I had to come back at 8 o’clock in 
the evening to get my medicines. In the dark at night. They didn’t light 
the car park and there was all kinds of people hovering outside the 
hospital etc. So for me a community pharmacy would be so much better.” 
Patient representative 
Several participants wondered if there could be an element of patient choice in the new 
model of care. This may not be an efficient use of hospital time, but could help to 
manage patient expectations and therefore improve patient experience.  
“Would there be elements of patient choice in this? So could they choose 
to wait for it here? You would be running two systems, it’s not necessarily 
efficient, but it might be patient focussed. It’s about choice and 
empowering them. Maybe the choice would satisfy the wait. It may 
change their opinion of it that they’ve chosen that way.” Clinical 
Pharmacy Services Manager 
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7.4.4.3.3 Ensuring the success of the new model of care 
This subtheme looked at the issues raised by stakeholders around ensuring that the new 
model of care functions correctly and efficiently.  
 
Participants thought that it was important to integrate a fail-safe mechanism to 
guarantee that the new model of care will ensure that patients receive their discharge 
medication. 
“What I’d be worried about, is say if the patient went home. There’s got 
to be a lot of reassurance for the patient that someone has spoken to the 
community pharmacy and that they will be delivering their medicines at 
a set time. You need to ensure that it is fool proof.” General Practitioner 
Without a fail-safe, as one carer commented during a focus group, there is a risk that 
patients could be left to try and organise a supply of medication after they have been 
discharged from hospital. 
“I just worry that it would be me running round frantically looking for a 
community pharmacy that was open so that they could dispense mum’s 
medication.” Carer representative 
This will significantly impact on the patient experience in hospital and may also affect 
their opinion of the community pharmacy.  
“Making sure that you’re not in a situation where the patient is out 
without a TTO being sent and the patient turns up at [the community 
pharmacy] and they don’t know what they are supposed to be dispensing. 
Because then it’s just going to have a negative impact on the patient’s 
opinion of the service and the community pharmacy.” Medical Education 
Pharmacist 
One participant noted that monitoring the new model of care would be easier if it was 
arranged with just one community pharmacy, rather than all community pharmacies. If 
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there were any problems with patients failing to collect their medication, one 
community pharmacy would be more likely to notice this trend and let the hospital 
pharmacy know. If all community pharmacies were involved, they may only receive a 
small number of discharge prescriptions and problems could be less noticeable.  
“What about if you had a single community pharmacy nearby, could you 
not send it to them and the patient could collect it on the way out? 
Because then, if there’s a problem they know us and they can ring us. And 
the other thing is, if there are problems in general with the system, for 
example people not picking their prescriptions up. At the end of the week 
it would be easy to check on this. Whereas if you are sending the 
prescriptions to pharmacies around the city, no-one’s going to do 
anything if the odd patient doesn’t collect. Especially if they’ve only got 
one patient. So we could arrange it with one community pharmacy 
company.” Consultant Pharmacist 
 7.4.4.3.4 Healthcare professional competence 
This subtheme emerged as many participants highlighted that the different stakeholders 
involved in providing the new model of care should have the confidence and 
competence to provide their role.  
 
Community pharmacists may see a change in the types of medication that they will be 
used to dealing with in hospital prescriptions. Subsequently, some community 
pharmacists may not be comfortable dispensing some of the medication.  
“I suppose it depends on the individual community pharmacist and I 
suppose they'll see a lot of weird and wonderful things. Would they be 
happy with dispensing some of the stuff?” Rotational Hospital 
Pharmacist 
Regarding hospital pharmacists, one participant highlighted that just because a 
pharmacist has qualified as a non-medical prescriber, this does not automatically mean 
228 
 
that they will be confident to carry out that role. Prescribing pharmacists need to build 
up confidence in order to feel comfortable prescribing discharge prescriptions and that 
will come with experience.  
 “Well it’s the NMP role really. It's about not just qualifying as an NMP 
it's having the confidence and experience to provide that role isn't it.” 
Medicines safety and Care of the Elderly Pharmacist 
A variety of factors are involved in ensuring competence of prescribing pharmacists. 
Participants agreed that the pharmacist should have experience in the area that they 
are prescribing in. 
 “You would want somebody with experience in that area so you would 
want someone with respiratory experience to go on the respiratory ward 
round.” Senior Hospital Pharmacist 
Ideally pharmacists would be prescribing for patients that they are familiar with and had 
previously been involved in providing their care. 
“So then you’ve got the prescribing pharmacist, who would ideally have 
been involved in patient care. Otherwise it could potentially be dangerous, 
although medical staff have been doing it for years. There may be 
occasions where we have got to do it obviously.” Consultant Pharmacist 
One participant highlighted that junior pharmacists may not feel comfortable checking 
senior pharmacists’ work. This was discussed with other participants, who felt that this 
should be addressed from the outset of the new model of care to ensure that 
pharmacists of all levels are comfortable checking their colleagues prescribing.  
“I can see that it would be a concern and it is probably something that 
would need to be addressed from the outset of the system to enable those 
people to have the confidence to do it. But they should have the 
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confidence as a healthcare professional to challenge anyone.” Medicines 
Management Pharmacist 
Another participant raised the concern that junior pharmacists may not provide the 
same rigorous clinical check for prescribing pharmacists that they would for a doctor. 
This was because they may assume that discharge prescriptions have been written 
correctly when in fact there is a mistake, because their more experienced colleague has 
written it.  
“We are very good at junior pharmacists checking doctor’s prescriptions. 
If they know it's a senior pharmacist doing the prescription will it be a bit 
slack? If you have a very junior pharmacist just started and they are 
working alongside a senior pharmacist who has been in the role for a long, 
long time. Whether they would question as much as they should be doing. 
I think that might be a danger there as well.” Pharmacist Teacher 
Practitioner 
 
7.4.4.3.5 Prescribing responsibility 
Writing discharge prescriptions could be classed as transcribing rather than prescribing, 
as the discharge prescription is based on the medications prescribed on the inpatient 
chart. The medication on the discharge prescription should be based on a discussion 
with the doctors on the ward round. 
“It's transcribing but then you're making a decision, okay it’s led by the 
discussion with the doctors” Band 7 Haematology Pharmacist 
Traditionally, the responsibility of the discharge prescription lay with the doctor. 
However, if the pharmacist is writing the discharge prescription, it is debatable whether 
they should be responsible for this. It was suggested that the responsibility should be 
with the consultant and the team responsible for the patient.   
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“Who does the responsibility then lie with? It’s usually the prescriber that 
has the responsibility for not only the initiation but the monitoring and 
follow up of the drugs, and that’s what I teach the students. So therefore 
if the drug that was started in the hospital, making sure that it’s followed 
up in the community. So one concern is arguably, if the pharmacist has 
written that prescription, does the responsibility lie with them, or with 
the prescribing doctor? That would be a discussion to be had. My opinion 
would be that it would be a team thing, so it would still lie under the 
consultant and whoever had been involved in that team.” Medical 
Education Pharmacist  
Who the responsibility lies with becomes a particular issue if the pharmacist writing the 
discharge prescription disagrees with the doctors’ prescribing choices.  
“Or if you are unhappy with the doctor’s decision what do you do then? 
The consultants on my ward would often start things in bigger doses than 
I would ever start … It doesn't mean that they are wrong it's just not what 
I would do as a prescriber.” Independent prescriber Hospital Pharmacist 
A further issue highlighted by one participant is who the responsibility would lie with if 
problems with obtaining a supply of medication resulted in patient harm.  
“So what happens if the patient can’t get their Fragmin at discharge and 
they end up with a DVT? Whose fault is that? Ours because we didn’t give 
it when they went, the community pharmacy’s because they didn’t 
prioritise it or the patient’s because they didn’t go back and collect it?” 
Consultant Pharmacist 
 
7.5 Discussion 
Through analysis of the data collected, the new model of care was evaluated. The 
stepwise review highlighted specific issues with the new model of care, which have been 
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used to refine the model. The themes will be discussed which will be followed by a 
discussion of the relevance of the findings overall, considering all of the themes 
collectively.  
 
7.5.1 Impact of new model of care 
Overall general feedback for the new model was positive. During the sessions, 
participants either stated specifically that they thought the new model of care had 
potential, or this was implied from their responses. Although participants highlighted 
potential problems that may occur, comments were constructive and they identified 
potential problems to rectify and improve the model.  
 
Participants mainly thought the new model of care would speed up patient discharge 
and therefore patient flow through the hospital as well as improve patient experience, 
safety and medicines use. Provided the infrastructure was in place for the new model of 
care and the multidisciplinary team were able to hold earlier ward rounds, the new 
model of care could potentially dramatically reduce delays for patients at discharge. As 
discussed in the findings from phases 1 and 2, pharmacy is often perceived as the cause 
of delay to discharge. Using the new model of care, patients would not have to wait in 
hospital for their medication and the misconception that pharmacy is causing the delay 
could be corrected.  
 
Stakeholders thought there would be benefits to outsourcing dispensing of discharge 
prescriptions to community pharmacies. This would give the pharmacy team more time 
to spend improving the patient care provided in hospital, leading to benefits for patients 
throughout their admission, not just at discharge. Additionally, this will encourage a 
relationship between the patient and their community pharmacist and provide a route 
for patient follow up in the community. Developing this relationship is an important step 
towards improving continuity of patient care in terms of information. This does not 
necessarily give continuity of care in terms of the community pharmacist that the patient 
will see, as that will depend on the staffing of the individual community pharmacy. 
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Pharmacy ownership of the supply of medication at discharge within this new model of 
care was highlighted by participants and seen as beneficial to the profession as well as 
for patient care. This is both within hospital pharmacy and in community pharmacy.  
Currently, pharmacy is an underused resource and it is only in recent years that the 
services offered by community pharmacies are advertised. Whilst the new model of care 
encourages pharmacy ownership of medication supply at discharge, the main premise 
of this is disadvantaged by the lack of a consistent clinical pharmacy service provided 
seven days per week. As discussed in section 4.6.1 Planning for discharge, despite 
recommendations for hospital pharmacy departments to provide a full service seven 
days per week, this has not yet been implemented in practice universally. The new 
model of care may therefore require an adaptation for out of hours working.   
 
As stated, pharmacy is often perceived as the cause of delay to discharge (see section 
6.3 Problem areas within the current discharge process). By reducing the wait for 
discharge medication, there is a risk that other delays at discharge will become apparent 
and prevent patients from being able to leave hospital. Although the blame will no 
longer rest with pharmacy, this does not improve patient experience. Care must be 
taken to ensure that other issues do not arise a result of this new model of care. Those 
potential issues suggested by participants could be monitored.  
 
Stakeholders discussed how the new model of care could have an impact on education 
for healthcare professionals in a number of ways. The main concern around education 
was the potential risk of de-skilling doctors if pharmacists were to take over the role of 
writing discharge prescriptions. After discussions with a variety of different stakeholders 
around this topic, the conclusion was that writing discharge prescriptions was not the 
only route for junior doctors to learn how to prescribe. Discharge prescriptions are 
currently poorly written by doctors and provided they are still prescribing for inpatients, 
they will still receive appropriate training. Additionally, the pharmacist will be writing 
the discharge prescriptions on the ward round and any prescribing decisions can be 
made through discussions with the doctors. Junior doctors are more likely to be involved 
in these decisions and consider the prescribing issues that arise and learn from them. 
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Pharmacists on the ward round can highlight any prescribing issues for patients and 
stakeholders thought that this would be beneficial for the learning of doctors of all levels 
of experience. Having a more team-based approach can also be beneficial to junior 
pharmacists, who will work closely with the experienced pharmacist on the wards and 
have an increased level of support from them for longer than they may receive currently.  
 
Finally, this new model of care could change the role of a community pharmacist. 
Depending on the individual community pharmacist, they may only dispense the 
discharge prescription with no further input. However, other more clinically focussed 
community pharmacists could use this as an opportunity to provide follow up for 
patients and to start to push their role into a more clinical one. Community pharmacists 
could seek the additional training needed to provide a more clinical role. This fits in with 
the current drive to change the community pharmacy workforce.  
 
Clearly, the new model of care will have a big impact on various areas. Most of the 
impact was positive, however having the potential pitfalls highlighted ensures that they 
can be monitored to ensure that these problems are not occurring. 
 
7.5.2 Resources required for new model of care 
Stakeholders discussed the resources that would be required for the new model of care 
to be successful, both for implementation and for the sustainability of the new model of 
care.  
 
The infrastructure to allow the new model of care to be successful needs to be in place 
before the new model of care is initiated. This refers mainly to appropriate staffing and 
technology, however there are other aspects. Without the appropriate staffing levels 
and the stability of that role, pharmacists are not going to be able to safely and efficiently 
write discharge prescriptions for patients as they will have many other competing 
priorities. The risk with this is that patient discharge takes just as long as it does currently 
and the blame moves from the doctor not writing the discharge prescription fast enough, 
to the pharmacist not doing it. To allow the staffing levels to be able to meet the 
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demands of the new model of care, there needs to be a change in current roles. As 
discharge prescription dispensing would be outsourced, time is freed up from those 
pharmacy staff who would usually undertake this role. They can take on some of the 
tasks carried out by other members of the pharmacy team to free up their time. The 
shift in the workforce overall would allow prescribing pharmacists to take the time to 
write discharge prescriptions. This is a feasible change in the workforce, as many 
pharmacy technicians are able to undertake medicines reconciliation and other tasks 
traditionally carried out by a pharmacist. More time should be available if discharge 
prescriptions were outsourced to community pharmacy as less time would be spent on 
dispensing activities. Many larger hospitals may already be at or close to a staffing level 
appropriate to carry out the new model of care. This may not be the case for smaller 
district general hospitals and their ability to carry out the role would need to be 
reviewed on an individual basis.  
 
Technology will have a major impact on the new model of care. To be an efficient service, 
it really needs to be a fast, user friendly electronic system to transmit the discharge 
prescription and provide a platform for two-way communication with the community 
pharmacy. This relies on the community pharmacies and the hospital having access to 
the system. It also relies on enough access for users. For example, there should be 
sufficient numbers of portable devices to access the system on. Internet access also 
needs to be reliable and fast for transmission of information. 
 
One suggestion by stakeholders was to utilise the existing EPS system, as all community 
pharmacies have access to this and are familiar with its use. This is a reasonable 
suggestion, however there are a range of logistical issues with this that would have to 
be reviewed. One example would be how you would send a discharge prescription 
rather than an FP10 via this route and the legal aspects of doing so. 
 
Limited training was thought to be necessary, unless new electronic systems are 
involved, in which case it is essential that staff are able to use and access the systems. 
235 
 
There is a risk that discharge prescriptions will be missed and patients could go without 
their medication.  
 
With any change in process, training should be required to ensure that healthcare 
professionals are familiar with the systems and are competent to carry out the process. 
Without training, there is a risk that the new model of care would not be used, or would 
be used incorrectly and lead to issues. Clinical training around the types of medication 
that the community pharmacists will encounter could help them to become familiar and 
comfortable dispensing the discharge prescriptions.  
 
There was a debate around how the new model of care would be funded. As a result of 
the limited amount of money available in the NHS, additional funding would be difficult 
to obtain. The new model of care would have to prove that it would lead to cost savings 
for any investment. However as the discharge prescription would be sent from the 
hospital, stakeholders thought that the hospital should pay for the service. As the 
prescribing budgets for community and hospital care are not currently combined, there 
is a potential to move a proportion of the budget to align with any costs incurred from 
the new model of care. It could be inferred that due to potential savings as a result of 
bed days saved, reduced readmission rates and medication errors, that the new model 
of care would fund itself. A full economic evaluation would be required to determine 
this.  
 
Another debate was around how the community pharmacist would be reimbursed for 
dispensing discharge prescriptions. One community pharmacist felt that reimbursement 
could be similar to the current community pharmacy contract for dispensing FP10s, as 
the process would be similar. Another suggestion was having the new model of care 
commissioned as a community pharmacy service. By doing this, community pharmacists 
would be aware of the process and the importance of dispensing discharge prescriptions 
in a timely manner. It would also serve as an encouragement for community pharmacists 
to participate, as it would add to their income. This encouragement would be necessary 
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if the new model of care resulted in a large increase in workload for community 
pharmacists. 
 
In summary, this theme demonstrates that a large amount of investment in terms of 
staffing levels, technology, time and training will have to be made to implement the new 
model of care. Ensuring the appropriate resources are available will provide an efficient 
and user friendly discharge service that should benefit patients and healthcare staff alike.  
 
7.5.3 Ensuring quality and safety of new model of care 
The aim of phase 3 of the PoW was to develop an innovative model of care for patient 
discharge from hospital that provides safe, quality care in a timely manner and improves 
patient experience. This theme looks at the issues raised by the relevant stakeholders 
to determine if they thought that the new model of care would provide safe and quality 
care that improves patient experience.  
 
As previously discussed, the new model of care involves a variety of role changes in 
comparison to the current discharge process. This involves the pharmacy team taking 
on a variety of roles traditionally undertaken by other healthcare professionals. The two 
main examples of this were pharmacists writing discharge prescriptions and the 
pharmacy team giving out patients’ medication at discharge in place of the nurse. This 
was thought by stakeholders to drive the quality and safety of patient discharge. 
Although this is adding workload to the pharmacy team, the long-term benefits of 
improving these aspects of patient discharge are clear and they are currently poorly 
carried out, affecting patient care. In both of these instances, the pharmacy team are 
the appropriate healthcare professional to be carrying out that role safely and 
accurately and this will likely improve patient care and the patient’s experience. Equally, 
as well as improving the patient experience, having the pharmacy team involved in the 
discharge process can improve the quality of information sent to the GP. This will have 
a positive impact on continuity of care. 
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The question remains, what will happen out of hospital pharmacy hours. In theory, with 
the new model of care, patient discharge should take place earlier in the day when the 
pharmacy team is around. However there may be situations that are unavoidable and 
patient discharge has to take place later. If patients are discharged when the pharmacy 
team is not around to deal with patient discharge, the decision needs to be made about 
what the process will be under such circumstances.  
 
The risk of patients becoming confused by receiving medication from different sources 
was also highlighted. Potentially, patients could have some medication at home, some 
on the ward and some from their community pharmacy. If the new model of care were 
to stop providing medication in hospital or dispose of patients’ own medication, this 
could lead to unnecessary waste. This will require excellent communication with the 
patient and counselling to reduce patient risk. Alternative ways around this will need to 
be discussed. One way could be that for patients receiving medication from their 
community pharmacy, they could be advised to have their other medication with them 
so that the community pharmacist can go through all their medication in one go and 
provide complete counselling.   
 
Another issue with medication provided by the community pharmacist was the risk that 
patients would not receive their medication. Most of the issues highlighted by 
stakeholders around this issue were logistical problems that may arise, which all could 
be worked through before the patient left hospital, in which case it should not be a 
serious threat to patients. Equally, many patients leave without their medication in the 
current system. The best way to resolve this issue is with adequate patient counselling, 
to ensure they understand the importance of taking their medication.  
 
To improve patient experience during hospital discharge, patient expectations must be 
managed. In the current discharge process communication over likely time they can be 
discharged is poor and can impact on the patient experience. By ensuring there is good 
communication with the patient, they will be fully informed about the duration of their 
discharge process and hopefully this will help them to make any suitable arrangements 
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and manage their expectations. The new model of care is a complete change in culture 
for patients at discharge as patients with previous experience of being admitted to 
hospital will assume that they will receive their discharge medication from the hospital. 
Stakeholders had differing views over whether patients will be happy to receive their 
discharge medication from the community pharmacy instead of the hospital. From the 
findings of phase 2 of the PoW (see section 5.4.3.3 Suggestions for improvement of 
hospital discharge) more patients would prefer the community pharmacy to supply their 
discharge medication than the hospital. 
 
For those patient who are unhappy with receiving their medication from the community 
pharmacy, or unable to do so, stakeholders discussed the possibility of an element of 
patient choice in the new model of care. This would mean that if patients were happy 
to obtain a supply from the community pharmacy they could do so, but if not the 
hospital would still supply the medication. This would come down to the cost and 
logistics of having two systems running alongside each other at discharge for the 
hospital. However having the element of patient choice may help to manage patient 
expectations and improve the patient experience. Part of the new model of care 
includes the option to either collect from the community pharmacy or have a delivery. 
This constitutes patient choice and may help to improve the patient experience. 
 
Part of ensuring the quality of the new model of care is having a mechanism of ensuring 
that it is working correctly and efficiently. As the model differs from the current 
discharge process, there are a number of areas that are new and therefore will require 
monitoring. 
 
Checking that the new model of care is successful, and continues to work effectively is 
essential. There are a variety of ways in this needs to be achieved. Audit is an obvious 
tool for determining how the new model of care is working. With the new model of care 
being dependent on technology to run smoothly, this provides an easy audit trail to 
follow and ensure the steps are occurring in the process and the time taken for each. 
Another mechanism is through direct communication with the patients and people 
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involved in providing the service, so that any issues can be highlighted and discussed as 
they arise.  
 
In the current discharge process, if there was a problem obtaining any of the discharge 
medication for a patient, they would remain in hospital until the issue was rectified. 
With the new model of care, the patient receives the supply of medication from a 
community pharmacy and it is effectively out of the hospital’s control. If the patient does 
not receive their medication as a result of failings in the system, this puts the patient at 
risk of harm. Incorporating a fail-safe mechanism at the appropriate stages of the new 
model of care is essential to ensure that the patient will always receive a supply of their 
discharge medication.  
 
The new model of care will be a significant change in the way patients receive their 
medication and they will need to be reassured that it will occur. Communication with 
the patient to ensure that they are aware of the process is an important part of the new 
model of care. By having a fully informed patient, this will serve as another fail-safe in 
the new model of care as the patient can become involved if they notice anything amiss 
during their discharge. 
 
Flexibility of the new model of care is essential. There may be a variety of individual 
cases where through logistics, obtaining a supply of discharge medication via the new 
model of care route. Whilst attempting to make the model as broad as possible for all 
patients, it must be accepted that a degree of flexibility must be allowed in these 
instances.  
 
An important aspect of quality and safety is ensuring that the healthcare professionals 
providing the new model of care are competent and comfortable carrying out their roles. 
This applies to healthcare professionals in the community and in hospital. A range of 
issues around competence, confidence and feeling comfortable providing the service 
arose through discussions with the stakeholders.  
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For community pharmacists, stakeholders did not feel that the change would have much 
of an impact as it is a relatively similar process to dispensing the prescriptions that they 
are familiar with. Community pharmacists’ competence should therefore not be a big 
issue when dispensing discharge prescriptions. The change may be in the types of 
medication that they will be dealing with as a result of receiving hospital prescriptions. 
Providing any training regarding the types of medication that the community pharmacist 
is likely to deal with may be helpful here.  
 
From a hospital pharmacists’ perspective, there is a significant change in their role. 
Particularly for prescribing pharmacists. Many of the participants, both current 
prescribers and those pharmacists who are not prescribers highlighted the potential risk 
of some pharmacists not feeling comfortable enough or being competent to carry out 
the role. The pharmacists writing discharge prescriptions should ideally be qualified as 
a non-medical prescriber with sufficient experience and feel confident within that role. 
Ideally, they should write discharge prescriptions for patients who fall within their area 
of clinical expertise and that they have been involved in their care during the patients’ 
admission. This may not always be possible, but is the most appropriate way of providing 
competent staff to write the discharge prescriptions.  
 
Pharmacists at all levels of experience within the hospital are trained to check and 
question doctors’ prescribing. As the prescribing pharmacists start to write discharge 
prescriptions, they will still require a clinical check from another pharmacist. 
Stakeholders highlighted the concern that junior pharmacists may assume that their 
senior, more experienced colleagues are unlikely to make any errors and therefore not 
provide the same clinical check of the discharge prescription that they would with one 
written by a doctor. Equally, there was a concern that they may feel uncomfortable 
approaching another pharmacist with a potential error. This needs to be addressed from 
the offset of implementation of the new model of care. 
 
A decision will have to be made before implementation of the new model of care as to 
where responsibility lies for prescribing within the new model of care. Traditionally this 
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is with the doctor responsible for the patient, however if the pharmacist is prescribing 
for the patient does this responsibility become the pharmacists? One issue with this is 
that the consultant will still have the overall say over the medication prescribed for the 
patient and the prescribing pharmacist may not necessarily agree with the decisions. If 
the prescribing decisions are made as a multidisciplinary team, the responsibility should 
lie with that multidisciplinary team.  
 
 
7.5.4 Limitations 
This phase involved only a small number of participants, which could be seen as a 
limitation, because views are subjective and different experiences of participants will 
lead them to answer in their own way. The researcher tried to take this into account by 
ensuring that a range of different stakeholders were interviewed to ensure diversity of 
results. A large proportion of the participants have a pharmacy background. This was as 
a result of the researcher initially anticipating that a much larger sample size would be 
required before data saturation was reached. Pharmacy colleagues from a variety of 
backgrounds were approached first in larger numbers than other professional 
backgrounds, fewer participants from other backgrounds were required due to the 
study reaching data saturation. The study did not aim to quantify the number of 
participants that liked or disliked the new model of care, but to identify any issues and 
ways to improve the proposed model. It was therefore not essential to have a large 
sample of participants and data collection continued until no new information was 
elicited from participants.  
 
A further limitation to this study was the different methods of data collection used. The 
participants were busy and it would have been difficult to recruit all participants if focus 
groups were the only option. As a result, only a few focus groups were carried out which 
meant that they could not be repeated. If the phase were to be repeated, one method 
of data collection would be appropriate.    
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7.6 Refined innovative model of care for patient discharge 
As a result of feasibility testing the new model of care, several adjustments have been 
made to the new model to take into account the stakeholders’ opinions and improve 
the model. The individual reasons for these changes were discussed within the relevant 
stages throughout section 6.4.4. The refined innovative model of care can be seen in 
Figure 7-1. 
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Figure 7-1 – Refined innovative model of care for patient discharge from hospital 
flowchart 
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7.9 Conclusion 
To summarise this phase, the qualitative approach successfully evaluated the proposed 
new model of care for patient discharge. A detailed discussion of each stage of the new 
model was presented in section 7.4.3 Stepwise review of new model of care.  The three 
themes then cover a holistic view of the new model of care from the stakeholders’ 
perspective.  
 
Overall, the responses were positive towards the new model of care. All of the 
participants thought that the new model of care had potential for success. The new 
model of care involves part of the discharge process taking place in hospital and part 
taking place in the community. For the new model of care to be successful, both aspects 
need to run efficiently, with excellent communication between care settings. For the 
process that takes place within the hospital, a ward-based service is essential. There was 
an inherent reliance on the ward-based team to make it an efficient service. 
Stakeholders anticipated issues and delays if the pharmacy team had other 
commitments on other wards, or if they had left the ward whilst required to help with 
patient discharge.  
 
Speed of patient discharge is often not the main concern of healthcare professionals. 
Quite rightly, there are considerations such as patient safety, ensuring medication is 
supplied appropriately and information is transferred to the community for continuity 
of care. Whilst this is vital in the new model of care, to ensure quality and safety, it is 
often missed by patients, who just want to be discharged quickly from hospital. Each of 
the aspects are important and patients should be made aware of what is happening at 
discharge and why it is important, to manage their expectations.  
 
The findings highlight that a large amount of investment in terms of staffing levels, 
technology, time and training is required before the new model of care can be 
implemented. Once that is in place, the new model of care should be able to function 
efficiently. In theory, this initial investment will be returned once the new model of care 
is running. 
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The research method for this phase has successfully met the study aim by exploring 
stakeholder views of the proposed new model of care for patient discharge. 
Furthermore, the objectives for this phase were met. A variety of stakeholder 
perspectives were explored. The findings have identified which stages of the new model 
of care stakeholders thought would work well and where problems may arise. 
Stakeholders were enthusiastic about the proposed model of care and had many 
positive comments. Many thought that it would be successful. A variety of logistical 
issues were highlighted, mainly in two areas – pharmacists having the time to write 
discharge prescriptions during the ward round and logistical issues of community 
pharmacists supplying discharge medication. Many of the participants suggested a 
variety of solutions to such problems.  The knowledge, skills and resources required to 
deliver the new model of care were established. This phase has been essential to provide 
feedback on the proposed new model of care, which has been used to refine and 
improve the model. The innovative model of care resulting from this phase of the PoW 
is now at a suitable stage to test its feasibility.  
 
A number of recommendations resulted from this phase that will be essential to 
implement and maintain a successful model of care for the discharge of patients from 
hospital into the community. Although outside the scope of this study, further work will 
involve a pilot of the innovative model of care to determine the impact of the innovative 
model of care on patient discharge from hospital. The findings from the themes will be 
useful to facilitate implementation of the innovative model of care. 
 
This chapter has discussed in detail the findings from phase 4 of the PoW and how they 
have been used to improve the new model of care. Having successfully achieved the aim 
and objectives set out for the final phase of the PoW, the following chapter consists of 
a discussion and summary of the overall PoW. 
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Chapter 8 – Discussion 
This final chapter of the thesis considers the PoW as a whole. It draws together the 
conclusions from each of the phases and discusses the implications of these conclusions. 
A discussion around the proposal for further work concludes this chapter.  
 
8.1 PoW overview 
This thesis describes an integration of mixed research methods to consider the current 
discharge process from multiple perspectives and inform the development of a new 
model of care for patient discharge from hospital.  
 
Interviews and questionnaires explored the current discharge process with pharmacists 
and patients respectively. Triangulation of the findings informed the development of a 
new model of care. Interviews and focus groups then led feasibility testing of this 
proposed model of care. The new model of care was refined based on this feasibility test, 
resulting in the development of an innovative model of care for hospital discharge that 
will provide safe, quality and effective transfer for patients from hospital to community 
care. 
 
8.2 Methodological Appropriateness 
As previously discussed, the research was conducted using mixed methods. This 
included qualitative telephone interviews, quantitative questionnaires, triangulation of 
data, and qualitative face-to-face interviews and focus groups. The strengths and 
limitations of each method have been discussed throughout this thesis. The 
methodological limitations were discussed in detail within section 3.11 Methodological 
limitations of PoW. Despite the study limitations, the conclusions of the study are 
justified. The conclusions drawn from each phase are reasonable within the study 
setting. As the PoW was carried out within a limited study setting, it would not be 
reasonable to suggest that the findings were generalisable across the whole of the 
United Kingdom. If the research were to be carried out again, the researcher would likely 
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use a similar methodology but with larger sample of participants, more variety of 
stakeholders earlier in the research within a wider geographical area to improve 
generalisability of results. 
 
8.3 Reflexivity 
The concept of reflexivity was introduced in section 3.10 Reflexivity. Reflexivity was 
employed throughout the research process and assisted the researcher’s development 
as a qualitative researcher as well as helping to improve the robustness of the work. 
Reflexivity within the individual phases is discussed below.  
 
The researcher had several preconceptions before beginning phase 1, due to her 
experience as a hospital pharmacist. The main one was that a major cause of the delay 
to discharge was the time it took for the doctors to write the discharge prescriptions. 
This issue was highlighted by participants and the researcher strived to remain neutral 
during the interviews to not lead the discussion towards that conclusion. Another of the 
researcher’s initial preconceptions were that the larger, teaching hospitals would have 
the most innovative ideas. However after analysis, the findings show that a variety of 
hospital types are identifying novel methods to improve the discharge process.  The 
researcher noticed that her preconceptions were not always correct and that her 
opinions changed as a result of the discussions with participants.  
 
Although not a qualitative phase, reflexivity was still employed to a certain extent during 
phase 2. When commencing this phase of the PoW, the researcher not only had 
experience as a hospital pharmacist, but had also developed preconceptions based on 
the findings in phase 1. Despite the limited literature available suggesting patients were 
satisfied at discharge, the researcher’s experience with patient dissatisfaction at 
discharge in a busy acute city-centre hospital led to preconceptions that patients would 
not be satisfied with discharge and that the wait for medicines would be the cause of 
any delays to patient discharge. These preconceptions were useful during the 
development of the questions, as it meant that she knew the areas that needed to be 
investigated. By being aware of her preconceptions, the researcher managed to write 
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the questions objectively, without leading the respondents. Assistance was also sought 
from the supervisory team to ensure that questions were suitable. Utilising 
questionnaires in this instance was also useful as it meant that the respondents could 
complete the questionnaire themselves and their views were not hindered by the 
researcher’s during any discussions.  
 
A concern during phase 4 was that the researcher had been heavily involved in the 
design of the new model of care which may have influenced the discussions. The 
reflexive approach used in phase 1 to carry out the research was again utilised during 
this phase. The researcher attempted to remain open-minded during the interviews. 
Although familiar with the new model, the researcher was unsure how different 
stakeholders would view the proposed new model of care, which allowed her to remain 
open-minded about their responses. As topics and issues arose throughout the 
interviews and focus groups, the researcher questioned others about the same topics in 
later interviews to determine a variety of perspectives on the issues.   
 
The fluid, evolving and dynamic nature of qualitative research as described by Strauss(1) 
was a new experience for the researcher, whose limited background of research was 
based on a quantitative approach. This research programme was a learning curve – 
particularly during the first phase. By the final phase, qualitative research felt more 
natural to the researcher, as she became more familiar with the approach. Reflecting on 
the research process throughout the PoW helped the researcher to achieve this. 
 
8.4 Key findings 
Phase 1 was the first study to identify and evaluate the discharge process at a range of 
acute NHS hospitals across the North West of England. This phase alone is beneficial for 
those interested in improving the provision of pharmacy services within hospitals. It 
highlighted a number of significant findings, such as lack of staff training on patient 
discharge, lack of patient involvement in the discharge process and poor communication 
between hospital and community pharmacists. All of the issues identified within this 
phase are important to resolve in order to improve the discharge process. The findings 
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also discussed a range of solutions implemented by hospitals to overcome problems at 
discharge and found that most of these were based on small-scale pilots and had not 
become part of routine practice. The phase 1 findings led to the conclusion that in order 
to improve the discharge process, a new model of care for patient discharge was 
required, as the existing discharge process had too many obstacles to overcome.  
 
Phase 2 followed on from phase 1 by assessing patient experience of the current 
discharge process. Literature around patient experience at discharge was limited. This 
phase identified that despite the majority of patients feeling satisfied with their hospital 
discharge, issues commonly arose, supporting previous studies.(92) Furthermore, the 
study highlighted several areas requiring improvement to provide safe, quality care for 
patients and improve patient experience at discharge. In particular, the findings support 
phase 1 findings which suggested that both patient counselling by pharmacists and 
patient involvement in discharge are limited. Findings also show that patients perceive 
their discharge to take too long and is largely due to the wait for discharge medicines. 
These are issues that if improved, will positively impact the discharge process and 
patients’ experience of discharge from hospital. Phase 2 broadens the knowledge from 
existing literature and phase 1, of problems at discharge by adding the patients’ 
perspective to known issues. Patient experience is important to determine if services 
are providing high quality care. From the results of this phase there is much room for 
improvement. This supported phase 1 findings that suggested a new model of care was 
required. The findings were combined with the phase 1 findings and used to inform the 
development of the new model of care for patient discharge.  
 
Phase 3 successfully incorporated the findings from phases 1 and 2 of the PoW to 
develop a new model of care for patient discharge from hospital. The implications of 
developing a model of care for discharge, based on the requirements of healthcare 
professionals and patients are huge. As stakeholders in the discharge process, these are 
the people aware of the important matters regarding discharge. The highlighted issues 
discussed throughout this thesis, such as speed and quality of discharge have been 
targeted specifically and addressed by the new model of care. This could have a major 
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impact on patient experience, bed-blocking and readmission rates. All of which, as 
discussed in Chapter 2 are essential problem areas to target.  
 
The final phase, phase 4, was key to provide formative feedback on the proposed new 
model of care, which has been used to refine and improve the model. This phase 
demonstrated encouraging results. Stakeholders were aware of the issues were are 
keen to identify a more efficient discharge process. They were therefore all keen to 
embrace any improvement ideas. Many stakeholders anticipated that the new model of 
care for patient discharge would be successful. However a variety of logistical issues 
were highlighted. These were broadly in two areas – pharmacists having the time to 
write discharge prescriptions during the ward round and logistical issues of community 
pharmacists supplying discharge medication. The proposed model of care was refined 
based on the stakeholder feedback, with the suggestions for overcoming logistical issues 
taken on board. This phase resulted in the finalised, innovative model of care for patient 
discharge at a suitable stage to pilot (see Figure 7-1)  
 
If this new model of care is to improve the patient discharge process and outcomes of 
discharge it needs to be usable in practice to ensure successful uptake of the new model 
of care. This may be challenging in the present NHS climate, with the increased patient 
throughput in hospitals and the limited resources in many hospitals as discussed in 
Chapter 2. However, the findings from phase 4 indicate the new model of care described 
in Chapter 6 (see Figure 6-2) appeared feasible to stakeholders, provided any logistical 
issues are overcome. 
 
8.5 Originality of the PoW 
Despite the overwhelming amount of evidence showing that the current discharge 
process is ineffective, the literature review indicated that very little work had been 
undertaken to explore different models to enhance continuity of care on transfer 
between hospital and community care in the UK. The PoW was the first to consider 
multiple perspectives from both healthcare professionals and patients on the discharge 
process in the North West of England in order to determine local best practice and areas 
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where issues commonly arise. The findings subsequently informed the development of 
an innovative model of care for patient discharge from hospital. This model is original 
and contributes to the resolution of the known medication problems as a result of 
patient discharge (see section 2.7.2 Medication errors at discharge from hospital).  
 
8.6 Impact of the PoW 
Many policies and recommendations for hospital discharge have been published (see 
section 2.8 Improving hospital discharge), however they focus on the current discharge 
process and leave limited scope for the new model of care. Problems with current 
patient discharge have been ongoing for some time, and relying on improving some 
aspects of the current discharge process may not be an efficient mechanism to improve 
patient discharge. If this new model of care for patient discharge were to be 
implemented, new policies may have to be considered. 
 
The potential impact of this research is wide reaching. Ensuring a seamless discharge 
process that will provide safe, quality and effective transfer for patients could lead to 
many implications for practice and includes quality and timely patient care on discharge 
from hospital and could minimise patient safety incidents. The new model of care could 
also potentially lower hospital readmission rates which is part of the UK government 
policy, as the new model should reduce any medication errors that could put patients 
at higher risk of readmission. Another impact on resources will be a reduction in 
medication waste, as only appropriate supplies of medication will be provided. 
 
The potential for improved patient convenience and satisfaction with an efficient 
discharge system that will work for the patient as well as the hospital, will lead to a 
positive patient experience. To healthcare professionals, speed of patient discharge is 
not the main concern. Other factors are considered, such as patient safety, ensuring 
medication is supplied appropriately and information is transferred to the community 
for continuity of care. Whilst this is vital in the new model of care, to ensure quality and 
safety, it is often missed by patients, who just want to be discharged quickly from 
hospital. Factoring increased speed into the new model of care is important to improve 
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patient experience. By improving patient experience, this will improve the hospital’s 
reputation. 
 
The impact from this new model of care would not just be on the discharge process itself. 
As highlighted by the stakeholders in phase 4, there are many other potential benefits 
to the new model. Examples include the improved pharmaceutical care for patients, as 
a result of pharmacists having more time to spend with patients and being present on 
ward rounds where medical decisions are made. Equally, there is a huge potential 
benefit involved if signposting patients to community pharmacies. The ongoing support 
that they can provide for patients is beneficial, however many patients are unaware of 
the services such as MURs or NMS. The community pharmacist input will benefit 
patients that receive regular repeat medication as they will be able to anticipate any 
problems with further supplies of repeat medication and prevent medication errors.  
 
8.7 Conclusion 
The PoW has successfully met the overall aim which was to develop an innovative model 
of care for hospital discharge that will provide safe, quality and effective transfer for 
patients from hospital to community care. 
 
Specific objectives were achieved during the PoW. These included: to identify the 
current discharge process used in a range of acute NHS hospitals which was achieved 
during telephone interviews with Chief Pharmacists in phase 1. The second objective, to 
explore the perceptions of pharmacists and patients of the current discharge process, 
which were achieved in phases 1 and 2 respectively, using a qualitative approach in 
phase 1 and quantitative questionnaires in phase 2. The third objective, to develop an 
innovative model of care to resolve the issues associated with patient discharge from 
hospital was achieved in phase 3, based on the findings from the earlier phases. The final 
objective, to evaluate the proposed model of care using stakeholder feedback was 
achieved during phase 4, using a qualitative approach involving interviews and focus 
groups.  
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8.8 Proposal for future work 
Whilst they can be hypothesised, implications of the new model of care on delays to 
discharge, cost, healthcare staff providing the service and patients receiving the service 
are currently unknown. The new model of care for patient discharge requires a full 
evaluation to determine its true impact. The new model of care is considered a complex 
intervention as it contains several interconnecting components. Problems often arise in 
the evaluation of complex interventions because researchers have not fully defined and 
developed the intervention.(110) This PoW, specifically phases 3 and 4, set about fully 
defining and developing the new model of care for discharge which will assist the 
evaluation.  
 
A randomised controlled trial is considered the most reliable method of determining 
effectiveness(110) and should be used to evaluate how the new model of care for 
discharge influences the discharge process and affects patient outcomes. As described 
by Campbell et al,(110) it can be useful to break the process down into several phases, 
beginning with an exploratory trial before the randomised controlled trial. A possible 
research design could involve a pilot of the new model of care for patient discharge 
would as an initial step. Once the pilot had been fully evaluated, which could take up to 
12 months depending on how long it took to set up, the data collected could then inform 
the randomised controlled trial. 
 
For feasibility, the pilot could involve one hospital and a small number of community 
pharmacies across a geographical location. Implementing a pilot across all community 
pharmacies initially would not be practical. The new model of care would be carried out 
as described in Figure 7-1. The continuity of care aspect of utilising the patients’ own 
community pharmacy would not be involved during this pilot, so it would be difficult to 
measure the impact that the continuity of care would have on the patient. However, for 
a small scale pilot any logistical issues described by stakeholders within phase 4 could 
be investigated, prior to involving all community pharmacies. As described in phase 4 
(see section 7.4.4.2.1 Infrastructure) the appropriate infrastructure in place is required 
before a pilot could be undertaken.  
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For the purpose of determining effectiveness, the pilot would need to involve an 
appropriate alternative as a comparator. This could involve some of the patients to be 
discharged using the new model of care for patient discharge and the others using the 
traditional discharge process used in current practice. Consideration regarding 
appropriate sample sizes and selection of participants will be essential for an 
appropriate evaluation. Issues around patient capacity and consent to participate will 
also be important during the planning of this pilot.  
 
A range of aspects of the innovative model of care for patient discharge will be 
important to evaluate. A service evaluation, including the length of time that it would 
take a patient to be discharged using the new process, compared to the current 
discharge process. An economic analysis will be important, to determine the potential 
cost implications of full implementation of the new model. Other aspects such as the 
implications for healthcare staff and their workload would be interesting to determine 
during a pilot. In particular, the impact on community pharmacists’ and hospital 
pharmacists’ workload. In addition to the impact on pharmacists’ workload, an 
evaluation should establish whether it frees up nurses and doctors time as anticipated 
by stakeholders in phase 4. Finally, the implications of the new model of care for patient 
discharge for patients are vital. Assessing the patient experience will be important, along 
with evaluating patient outcomes. Particularly whether the new model of care affects 
readmission rates to hospital. Additional funding will be pursued by the researcher to 
carry out this further work. 
 
This pilot would involve a combination of quantitative and qualitative methods in order 
to efficiently evaluate the model of care. Quantitative data would be required to 
establish outcomes such as the length of time the process takes, the cost of providing 
the service and patient outcomes (for example hospital readmission rates). Structured 
data capture forms would need to be developed to evaluate such outcomes. A 
qualitative approach would be required to capture the impact of the new model of care 
on both patients and the healthcare professionals delivering the new model. Semi-
structured face-to-face interviews or focus groups would be an appropriate method of 
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data collection to determine healthcare professionals views and the impact that 
providing the service has had on their role. A more structured interview would be 
appropriate for patients, to ask focussed questions on how they perceive the new model 
of care. 
 
This thesis concludes having achieved all that it set out to do. The overall PoW aim and 
objectives have been met, resulting in the development of an innovative model of care 
for patient discharge from hospital. Stakeholder feedback of the model of care was 
positive, with suggestions for improvement. The model was refined based on this 
feedback and is at a suitable stage to pilot to assess its impact, as described in the section 
for further work.  
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Allied and 
Complementary 
Medicine 
discharge (with limit: english language) 2799 20 1 
1985 to 
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discharge; medication 74 7 1 
Allied health 
professions, 
complementary 
medicine 
continuity of patient care 136 9 3 
 
"continuity of patient care" 0 0 0 
 
"continuity of care" 136 9 3 
 
transitional care 54 4 2 
 
"transitional care" 18 2 2 
 
discontinuity 29 1 0 
 
patient discharge; patient compliance 3 3 0 
 
adherence; patient discharge 7 1 1 
 
adverse events; patient discharge 4 4 4 
 
medication error 16 0 0 
 
"medication error" 3 0 0 
 
pharmacist 88 4 0 
 
healthcare quality; patient discharge 18 0 0 
 
drug therapy; patient discharge 8 2 0 
 
community pharmacy services 6 1 0 
 
ambulatory care; drug therapy 14 0 0 
 
patient discharge; drug therapy 8 1 1 
 
primary healthcare; patient discharge 1 1 1 
 
primary healthcare; drug therapy 14 0 0 
 
patient outcomes; patient discharge 36 0 0 
 
delivery of healthcare; patient discharge 47 5 0 
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transition of care; drug therapy 4 0 0 
 
"transition of care" 7 0 0 
 
hospital readmission 71 0 0 
 
"hospital readmission" 22 0 0 
 
handover 5 1 1 
 
"information technology" 101 10 3 
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"medic* use review*" 57 0 0 
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patient perspectives   
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continuity of care 1966 
  
Nursing, 
midwifery, 
health visitors 
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